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Preface 
The core of the Engineering Doctorate (EngD) program is the solution to significant and 
challenging science or engineering problems with an industrial context. The EngD requires 
the research to be published in a minimum of three peer-reviewed publications and with an 
accompanying 20,000 word thesis.   
 
The research described within this thesis employs N-acyliminium ion cyclisation strategies to 
access heterocycles with potential for biological activity. The research has been carried out in 
collaboration with Charnwood Molecular Ltd, which is a leading provider of synthetic 
organic chemistry support to the fine chemical, agrochemical, pharmaceutical and 
biotechnology industries. 
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Abstract 
We describe the application of N-acyliminium cyclisation strategies to access a range of 
heterocycles with potential for biological activity.  We have described an asymmetric 
approach towards the anti-tumour pyrroloisoquinoline alkaloid (R)-(+)-crispine A, A.1 We 
have achieved a synthesis of the pyrrolo[2,1-a]benzazepine template B, which is a sub-unit of 
the Homoerythrina alkaloids,2 and the functionalised dodecahydrobenz[a]indolo[3,2-
h]quinolizine template, C, which is a sub-unit of the manadomanzamine alkaloids.3  
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In addition, we have described an asymmetric synthesis of the !-hydrazino 
pyrroloisoquinoline ring system, D, towards the synthesis of conformationally restricted 
peptidomimetics. 4 
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1Allin, S. M.; Gaskell, S. N.; Towler, J. M. R.; Page, P. C. B.; Saha, B.; McKenzie, M. J.; Martin, W. P. J. Org. Chem. 2007, 72, 8972. 
2 Allin, S. M.; Towler, J. M. R.; Elsegood, M. R. J.; Saha, B.; Page, P. C. B.; McKenzie., M. J. Synth Comm. Accepted 2010. 
3 Allin, S. M.; Duffy, L. J.; Towler, J. M. R.; Page, P. C. B.; Elsegood, M .R. J.; Saha, S. Tetrahedron 2009, 65, 10230. 
4 Allin, S. M.; Towler, J.; Gaskell, S. N.; Saha, B.; Martin, W. P.; Page, P. C. B. Tetrahedron 2010, 66, 9538. 
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1.1 N-Acyliminium Ions 
Traditional cyclisations involving the iminium cation, 1, such as those of the Mannich 
reaction,1,2 the Bischler-Napieralski reaction,3,4 or the Pictet-Spengler reaction5 have been 
intensely studied and applied in organic synthesis.6  More recently, the alternative N-
acyliminium ion, 2, has become an increasingly popular intermediate for cyclisations (Figure 
1).  Originally, the N-acyliminium ion, 2, was designed for Mannich type condensations with 
primary amines.7   
 
N
R3
R4
R1
O
R2
1 2
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Figure 1:The Iminium ion 1 and N-acyliminium ion 2 
 
The carbonyl functionality alpha to the nitrogen atom increases the electrophilicity of the N-
acyliminium ion, 2, when compared to the traditional iminium ion, 1. N-Acyliminium ion 
formation closely resembles an SN1 reaction and requires subjecting the precursor, 3, to acidic 
conditions, which promotes formation of the ion, 2, in equilibrium.  Subsequent nucleophilic 
addition then irreversibly affords the amide product 4 (Scheme 1).   
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Scheme 1: General approach for the generation of  
an N-acyliminium ion and nucleophilic attack. 
 
Iminium ions are regularly isolated in their salt form whilst the N-acyliminium counterpart is 
rarely isolated and is generated in situ owing to its higher reactivity and reduced stability.  
1.2 Research Aim 
The aim of this research was to apply N-acyliminium cyclisation strategies towards achieving 
biologically active heterocycles. 
1.3 Research Objectives 
There are four objectives: 
1. To apply an asymmetric N-acyliminium cyclisation strategy towards the 
pyrroloisoquinoline alkaloid (R)-(+)-crispine A. 
2. To apply an asymmetric N-acyliminium cyclisation strategy towards the tricyclic 
pyrrolo[2,1-a]benzazepine template, a core of the Homoerythrina alkaloids. 
3. To apply an asymmetric N-acyliminium cyclisation strategy towards the access of a 
functionalised dodecahydrobenz[a]indolo[3,2-h]quinolizine template, present as the 
heterocyclic core of the manadomanzamine alkaloids. 
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4. To stereoselectively construct the !-hydrazino pyrroloisoquinoline template, by 
applying an enolate amination using azodicarboxylate functionality.  To apply both 
symmetrical and unsymmetrical electrophilic amination reagents and to employ an 
orthogonal deprotection strategy upon the aminated intermediates. 
1.4 Research Context 
In 1998 Charnwood Molecular Ltd was founded to provide synthetic organic chemistry 
support to the fine chemical, pharmaceutical and biotechnology industries. This EngD 
research involves collaborative research linking the industrial stakeholders Charnwood 
Molecular Ltd with academic stakeholders from both Loughborough University‘s 
Departments of Chemistry and Chemical Engineering. Target driven research was undertaken 
to deliver heterocycles of biological interest to industry through the application of 
intramolecular N-acyliminium cyclisation strategies. 
1.5 Research Justification 
Many naturally derived compounds have been shown to exhibit biological activity and often 
we require a more sustainable source of these compounds if they are to be of use to us as 
researchers, and so the development of synthetic routes to such targets is of great interest.  
Over recent years the application of asymmetric intramolecular N-acyliminium cyclisation 
strategies has delivered a wide range of important biologically active heterocyclic 
compounds, many of which have taken their inspiration from Nature. This research has 
sought to access biologically active heterocyclic templates as targets of interest to the 
agrochemical and pharmaceutical sectors.  
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1.6 Research Scope 
The scope for this research was to apply intramolecular N-acyliminium cyclisation strategies 
to access four biologically active heterocyclic templates: 
1. The naturally occurring pyrroloisoquinoline alkaloid (R)-(+)-crispine A. 
2. The pyrrolo[2,1-a]benzazepine template, a core of the Homoerythrina alkaloids. 
3. The pentacyclic dodecahydrobenz[a]indolo[3,2-h]quinolizine template, a core of the 
manadomanzamine alkaloids. 
4. The !-hydrazino pyrroloisoquinoline template a polycyclic lactam scaffold for use in 
peptidomimetics. 
1.7 Thesis Structure 
In chapter one the concept of the N-acyliminium ion has been introduced and the aims, 
objectives, research context, justification and scope for this EngD research has been stated. 
Chapter two is a review of previous applications of intramolecular N-acyliminium cyclisation 
strategies, which have been reported in the literature by Allin, Lete and Bosch in access to 
biologically interesting isoquinoline and indolizinoindole heterocycles. The proceeding four 
chapters are a discussion on the four heterocyclic targets according to the objectives described 
in chapter one.  Chapter three reports a synthetic asymmetric approach towards the naturally 
occurring anti-tumour pyrroloisoquinoline alkaloid (R)-(+)-crispine A. Chapter four describes 
an intramolecular N-acyliminium cyclisation approach to access the pyrrolo[2,1-
a]benzazepine, a sub-unit of the biologically interesting Homoerythrina genus of naturally 
occuring alkaloids which show potential biocidal activity. Chapter five reports an asymmetric 
approach to the construction of a functionalized dodecahydrobenz[a]indolo[3,2-h]quinolizine 
template, which is a sub-unit of the manadomanzamine alkaloids that have shown anti-
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tuberculosis activity. Chapter six examines enolate aminations upon the pyrroloisoquinoline 
template towards novel peptidomimetics for use in potential therapeutics. The thesis 
concludes with our findings and implications, which are described in chapter seven.  This 
section summarises the research, meeting the objectives, the innovative and original 
contribution and finally the implications for this research and future work. In Appendix A we 
have presented the experimental data supporting each of the four projects reported through 
chapters three, four, five and six.  The X-ray crystallography data have been included as 
Appendix B, and copies of the published papers have been presented as Appendix C, 
Appendix D and Appendix E. 
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Chapter 2  
Literature Review 
2.1 Applications of N-Acyliminium Cyclisation Strategies to 
Access Biologically Active Heterocycles 
Over recent years the Allin, Lete and Bosch research groups have independently and 
collaboratively developed intramolecular N-acyliminium cyclisation strategies targeting a 
range of heterocyclic templates by promoting a nucleophilic aromatic attack upon an in situ 
generated N-acyliminium ion. This short review examines their intramolecular N-acyliminium 
mediated cyclisation strategies towards achieving four main heterocyclic templates and their 
derivatives.  These templates are the isoquinoline alkaloids that consist of the pyrrolo[2,1-
a]isoquinoline template, 5, and the benzo[a]quinolizidines template, 6, and the 
indolizinoindole alkaloids to include the indolizidino[8,7-b]indole template, 7, and the 
indolo[2,3-a]quinolizidine template, 8 (Figure 2). The intramolecular N-acyliminium 
cyclisation strategies discussed within the scope of this review have formed the foundations 
for this EngD research. 
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Figure 2: Isoquinoline 5, 6 and indolizinoindole alkaloids 7, 8. 
 
2.1.1 The Isoquinoline Alkaloids: The Pyrrolo[2,1-a]isoquinoline Template 
 
N
R
 
Figure 3: Pyrrolo[2,1-a]isoquinoline 5. 
 
Biological Activity 
The pyrrolo[2,1-a]isoquinoline template, 5, is a major structural motif of the naturally 
occurring Erythrina family of alkaloids.  Erythrina alkaloids are common in tropical and 
subtropical regions of the world and have been used in indigenous medicine for many 
centuries.8   Members of the Erythrina family display curare-like and hypnotic activity and 
have exhibited a variety of pharmacological effects including sedative, hypotensive, 
neuromuscular blocking and central nervous system activity.9  Examples of biologically 
interesting Erythrina alkaloids include 3-demethoxyerythratidinone, 9, erythramine, 10, and 
erysotramide, 11 (Figure 4).10,11  
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Figure 4: Biologically interesting Erythrina alkaloids. 
 
Racemic Synthesis of the Tricyclic Pyrrolo[2,1-a]isoquinoline Template 
A one-pot racemic synthesis of the pyrrolo[2,1-a]isoquinoline template, 15, was reported by 
Lete et al. using a tandem organolithium addition intramolecular N-acyliminium cyclisation 
strategy.  This approach required an intermediate N-phenethylimide, 12,12 which, on treatment 
with an organolithium reagent afforded 13, and under the protic acid conditions of 
trifluoroacetic acid, promoted an in situ generation of the N-acyliminium ion, 14, and an 
intramolecular cyclisation by aromatic nucleophilic attack to deliver the target compound, 15 
(Scheme 2).  Lete et al. reported that the choice of organolithium reagent allows for the 
construction of more complex pyrroloisoquinoline derivatives, and increasing the size of the 
substituent at the C-10b position requires raising the temperatures and applying longer 
reaction times.10,11,13  
MeO
MeO
N
O
O
MeO
MeO
N
O
OH
MeO
MeO
N
Bu
O
N
Bu
O
MeO
MeO
(i), (ii), (iii) (iv)
Bu
12 13
14
rac-15  
Scheme 2: (i) n-BuLi, THF, "78 °C, 6 h; (ii) H2O; (iii) rt; (iv) TFA, DCM, rt, 95%. 
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Asymmetric Syntheses of the Tricyclic Pyrrolo[2,1-a]isoquinoline Template 
To achieve a stereoselective approach to this template, Lete et al. reported the use of a 
hydroxymethyl protected L-dihydroxyphenylalanine (L-DOPA) derivative, 17, to act as the 
chiral inducer, derived through the synthetic manipulation of L-DOPA, 16. Subjecting 
compound 17 to a cyclocondensation with succinic anhydride, 18, afforded the intermediate 
chiral succinimide building block, 19 (Scheme 3).14 
 
OH
O
NH2
MeO
MeO
O
O
NHBoc
MeO
MeO
OH
NHBoc
MeO
MeO
OTBDPS
NHBoc
MeO
MeO
OTBDPS
NH2
MeO
MeO
OTBDPS
N
MeO
MeO O O
(i), (ii) (iii)
(iv)
(v)(vi)
OO
O
16
17
19
18  
Scheme 3: (i) (Boc)2O; (ii) SO4Me2, 92%; (iii) LAH, 87%; (iv) TBDPSCl, 95% (99% ee); (v) TFA, 
86%; (vi) Ac2O, AcONa, 95% (95% ee). 
 
Treatment of compound 19 with an organolithium reagent delivered the corresponding 
oxamide, 20, which, when subjected to the Lewis acid-boron trifluoride etherate, promoted an 
in situ generated N-acyliminium ion, 21, and subsequent intramolecular N-acyliminium 
cyclisation with hydrolysis of their t-butyldiphenylsilyl (TBS) hydroxymethyl protecting 
group on work-up to afford the single product diastereoisomer cis-22 without the 
epimerisation of the stereogenic centre (Scheme 4).  The stereochemical outcome of this 
system can be attributed to conformational factors in the chair like transition state. 15 
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Scheme 4: (i) RLi, THF, "78 °C, 6 h; (ii) BF3.OEt2 
 
Expanding upon Lete et al.’s approach to access the pyrrolo[2,1-a]isoquinoline template, cis-
22,14 Allin et al. applied an alternative stereoselective intramolecular N-acyliminium 
cyclisation strategy to deliver compound trans-25 by applying Meyers’ chiral bicyclic lactam, 
23, as an intermediate.15 The construction of the bicyclic lactam, 23, required (S)-
phenylalaninol as the source of chirality. Many authors have reported high diastereoselectivity 
in the formation of similar bicyclic lactams derived from #-amino alcohol substrates, and 
have reported the relative stereochemistry of the major diastereoisomer most commonly to be 
trans with respect to the hydrogen atoms at positions C-3 and C-7a.16,17,18 Allin took 
advantage of the masked N-acyliminium moiety present in Meyers’15 bicyclic lactam, 
subjecting it to Lewis acid conditions of low temperature titanium tetrachloride to afford the 
single product diastereoisomer trans-25 in a pleasing 80% yield, with as expected,19,20 
inversion of stereochemistry observed at the newly created chiral centre (Scheme 5).21,22  
Although bicyclic lactams have been widely used in asymmetric synthesis, employing 
bicyclic lactams as precursors in an intramolecular N-acyliminium mediated cyclisation 
Page | 12  
 
reaction leading to the pyrroloisoquinoline template demonstrated a novel approach to access 
the pyrrolo[2,1-a]isoquinoline templates.21,22 
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Scheme 5: (i) TiCl4, DCM, "10 °C, 80%, 99% ee. 
 
Allin et al. also applied an alternative intramolecular N-acyliminium strategy through an 
imide intermediate, 26, to deliver the trans-25 template.  This imide intermediate is accessible 
by the cyclocondensation of (S)-phenylalaninol with succinic anhydride, 18.  Reduction of the 
intermediate, 26, with sodium borohydride in ethanol yielded the corresponding 
ethoxylactam, 27, which was cyclised under protic acid conditions of 2 M solution of 
hydrochloric acid in ethanol to generate the chiral bicyclic lactam, 23.  Interestingly, when the 
ethoxylactam intermediate, 27, was treated directly with the Lewis acid titanium tetrachloride 
at low temperature, a direct clean conversion to the target trans-25 was observed.  Presumably 
the reaction proceeded via the same N-acyliminium ion 24 (Scheme 6). 21 22 
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Scheme 6: (i) NaBH4, EtOH; (ii) 2 M HCl aq. in EtOH; (iii) TiCl4,  
DCM, "10 °C; (iv) TiCl4, DCM, "10 °C, 80%. 
 
Comparable with Lete et al.’s approach to the pyrrolo[2,1-a]isoquinoline template 22,14 a 
stereoselective approach to an analogous methyl substituted template, 30, was achieved by 
Allin et al. by employing the bicyclic lactam intermediate, 28, synthesised by the 
cyclocondensation of (S)-phenylalaninol with levulinic acid.  Subsequent treatment with the 
Lewis acid titanium tetrachloride mediated the in situ formation of the N-acyliminium ion, 29, 
and an intramolecular cyclisation to afford a 2:1 mixture of cis and trans-30 diastereoisomers 
respectively. In contrast to the stereochemical outcome observed in the formation of template 
25, the major product diastereoisomer cis-30 was formed with retention of stereochemistry at 
the chiral centre.  This observation can be attributed to the bulky methyl group at the iminium 
carbon atom and the mechanistic favouring of the opposite spatial arrangement consequently 
leading to the cis relative stereochemistry (Scheme 7).21,22  
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Scheme 7: (i) TiCl4, DCM, "10 °C, 87%. 
 
The hydroxymethyl auxiliary group acts as an asymmetric “handle” and is paramount for 
installing the appropriate stereochemistry within the template.  However, to demonstrate the 
potential synthetic utility of cis-30, and to access a variety of other target templates including 
natural products, Allin et al. sought to remove the hydroxymethyl auxiliary group from 
product cis-30 by applying the methodology reported by Moody.23,24 This required Dess-
Martin oxidation25 of the primary alcohol, cis-30, to afford the aldehyde, 31, and this was 
achieved in an 89% yield. A rhodium-catalysed decarbonylation strategy was then applied to 
achieve the enamide, 32, in a moderate 64% yield.  The enamide, 32, was ultimately treated to 
a catalytic hydrogenation process to afford the target amide compound (S)-33 in an 89% yield 
(Scheme 8). 21 22  
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Scheme 8: (i) DMP, DCM, 89%; (ii) Rh(PPh3)2(CO)Cl, dppp,  
xylene, !, 64%; (iii) H2/10% Pd/C, EtOH, 89%. 
 
Aligned with the research of Lete et al., and also the many naturally derived alkaloids 
containing methoxy substitution on the nucleophilic aromatic ring, Allin et al. reported the 
application of their efficient intramolecular N-acyliminium cyclisation strategy to access 
further methoxy-substituted pyrroloisoquinoline templates.  The 5,6-dihydropyrrolo[2,1-
a]isoquinolinone template, 35, is a sub-unit of the Erythrina alkaloids, and was accessed by 
Allin et al. using the appropriate nucleophilic methoxy-substituted bicyclic lactam, cis-34, 
and subjecting this to Lewis acid conditions of low temperature titanium tetrachloride, 
mediated the intramolecular N-acyliminium cyclisation to afford the single product 
diastereoisomer, trans-35 (Scheme 9).21 22  
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Scheme 9: (i) TiCl4, DCM, "78 °C. 
 
An alternative stereoselective synthesis of the same trans-5,6-dihydropyrrolo[2,1-
a]isoquinolinone product diastereoisomer, 35, was achieved through use of an imide 
intermediate, 36, using the methodology reported by Speckamp et al.;12 followed by the 
application of a sodium borohydride reduction strategy en route to the expected ethoxylactam 
target.  Interestingly, the expected ethoxylactam was not isolated, and instead a direct 
stereoselective cyclisation to the target trans-35 template was observed in an excellent 91% 
yield (Scheme 10).22  
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Scheme 10: (i) NaBH4, EtOH, 2 M HCl aq. in EtOH, 91%. 
 
By application of their intramolecular N-acyliminium cyclisation strategy Allin et al. sought 
to access the same methyl-substituted pyrroloisoquinoline template, 22, already achieved by 
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Lete et al.14 Allin et al. applied a Lewis acid mediated intramolecular N-acyliminium 
cyclisation upon the appropriately functionalised bicyclic lactam template 37 to afford a 2:1 
diastereoisomeric mixture of cis and trans-22, of which the major product, cis-22, was 
afforded with the retention of stereochemistry at the newly created chiral centre (Scheme 
11).22  
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Scheme 11: (i) TiCl4, DCM, "78 °C, 87%. 
 
The results published by Allin et al.22  encouraged Lete et al. to re-visit their original 
organolithium addition intramolecular N-acyliminium cyclisation approach (Scheme 4).14 
Lete et al. investigated different substituents and various acidic cyclisation conditions to 
conclude that the stereoselectivity of the intramolecular N-acyliminium cyclisation reaction 
depends on the nature of the alkyl substituent at position C-10b and the nature of the acidic 
conditions used to induce the N-acyliminium ion formation.  Lete et al. concluded that 
application of protic acid conditions results in the formation of a trans product, whilst, 
application of Lewis acid conditions results in the formation of the cis product (Scheme 12).26   
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Scheme 12: (i) MeLi, TFA; (ii) MeLi, Lewis acid (e.g. TiCl4 or BF3.Et2O). 
 
Asymmetric Syntheses of the Tetracyclic Pyrrolo[2,1-a]isoquinoline Template 
In accordance with the tetracyclic nature of many Erythrina alkaloids Allin et al. sought a 
facile and highly stereoselective route towards the tetracyclic Erythrina template, 42 (Scheme 
13).  This stereoselective approach required the functionalised tricyclic lactam building block 
40, to act as the N-acyliminium precursor for the cyclisation, and this was synthesised using a 
cyclocondensation reaction between the appropriate chiral amino alcohol substrate, 39, and 
the racemic keto-acid substrate, 38, which was prepared according to the methodology of 
Regan et al.27,28 A Lewis acid promoted intramolecular N-acyliminium ion cyclisation upon 
compound 40 afforded a 10:1 mixture of cis and trans diastereoisomers.  The major 
diastereoisomer, cis-41, was formed with retention of stereochemistry as expected as a result 
of the steric bulk.  To further advance this template and demonstrate the synthetic utility, 
Allin applied a three-step rhodium decarbonylation strategy21,22 to access the decarbonylated 
target tetracycle cis-42, and this was achieved in an excellent 98% yield (Scheme 13).29 
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Scheme 13: (i) Dean-Stark conditions, toluene, !, 58%; (ii) TiCl4, DCM, "78 °C, 98%. 
 
Building on their established methodology Allin et al. attempted an asymmetric synthesis of 
both enantiomers of the naturally occurring Erythrina alkaloid 3-demethoxyerythratidinone, 9 
(Figure 5).30 This alkaloid was first isolated from Erythrina lithosperma by Barton et al. in 
1973.31  
MeO
MeO
N
O  
Figure 5: 3-Demethoxyerythratidinone 9. 
 
To access this natural product required the use of the appropriately substituted tricyclic lactam 
building block, 44, synthesised from the cyclocondensation of the chiral amino alcohol 
substrate 39, and the racemic keto acid substrate 43.27,28 Upon this highly functionalised 
tricyclic lactam template, 44, a Lewis acid mediated intramolecular N-acyliminium 
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cyclisation strategy was employed to achieve the tetracyclic product as a 10:1 mixture of cis 
and trans diastereoisomers, afforded in a high 92% overall yield.  The stereochemistry of the 
major product, cis-45, was in-line with previously reported related systems.29 Compound 46 
was achieved through the removal of the hydroxymethyl auxiliary group using the established 
three-step rhodium decarbonylation methodology,21 22 and then re-protection of the ketone 
functionality to afford the target tetracycle, 47 (Scheme 14).30 Tsuda et al. have previously 
reported the formation of this natural product 9 in four steps from compound 47, albeit in 
racemic form.32 
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Scheme 14: (i) Dean-Stark conditions, toluene, !, 63%; (ii) TiCl4, DCM, "78 ºC, 92%;  
(iii) 3-step decarbonylation procedure; (iv) ethylene glycol,  pTSA, toluene, !. 
 
Allin et al. approached the formal synthesis of the alternative unnatural enantiomer enantio-(-
)-demethoxyerythratidinone, 49, following an analogous synthetic route to the methodology 
described above, but using the alternative enantiomeric form of the chiral amino alcohol 
substrate, 48 (Scheme 15).30  
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Scheme 15: (i) Dean-Stark conditions, toluene, !, 63%; (ii) TiCl4, DCM, "78 ºC 92%;  
(iii) 3-step decarbonylation procedure; (iv) ethylene glycol, pTSA, toluene, !. 
 
2.1.2 The Isoquinoline Alkaloids: The Benzo[a]quinolizidine Template 
 
N
R
 
Figure 6: Benzo[a]quinolizidine 6. 
 
Biological Activity 
The benzo[a]quinolizidine template, 6 (Figure 6), is found as the sub-unit of a variety of 
naturally occurring and pharmacologically interesting alkaloids, including (-)-protoemetinol, 
50, which was first isolated by Battersby et al. from the flowering plant Alangium lamarckii.33 
This system is structurally related to psychotrine, 51, and O-methylpsycotrine, 52, which have 
been accessed en route to protoemetinol, 50.34 Alkaloids 51 and 52 are known to be potent 
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inhibitors of HIV-1 reverse transcriptase and such biological significance demonstrates the 
importance for the stereoselective synthesis of these functionalised benzo[a]quinolizidine 
templates for use in therapeutics.35  The alkaloid alangine, 53, was also isolated from 
Alangium lamarckii, and contains the benzo[a]quinolizidine template, 6, but differs 
stereochemically from compounds 50, 51 and 52, owing to the trans relative stereochemistry 
observed at positions C-2 and C-11b compared to the alternative C-2, 11b-cis configuration 
(Figure 7).34  
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Figure 7: Benzo[a]quinolizidine natural products. 
 
Racemic Synthesis of the Tricyclic Benzo[a]quinolizidine Template 
A one-pot, racemic synthesis of a the racemic benzo[a]quinolizidine template, 57, was 
reported by Lete et al. via application of their tandem organolithium addition intramolecular 
N-acyliminium ion cyclisation approach,10,11 which required in this case, the synthesis of the 
appropriate imide intermediate, 54, prepared according to the methodology of Speckamp.12 
Treatment of imide, 54, with an organolithium reagent afforded the alkoxide derivative, 55, in 
a 68% yield.  When this alkoxide derivative was subjected to protic acid conditions, the N-
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acyliminium ion was generated in situ and subsequent cyclisation by aromatic nucleophilic 
attack afforded the racemic benzo[a]quinolizidine template, 57, in a high 94% yield (Scheme 
16).13  
 
MeO
MeO
N
MeO
MeO
N
MeO
MeO
(i), (ii) (iii)
O
O
MeO
MeO
N
HO
Bu N
Bu
O
O
Bu
54 55
57
56
 
Scheme 16: (i) n-BuLi, THF, "78 °C, 6 h, 68%; (ii) H2O, rt; (iii) TFA, 94%. 
 
Asymmetric Syntheses of the Tricyclic Benzo[a]quinolizidine Template 
In an alternative stereoselective approach to access the benzo[a]quinolizidine template, 61, 
Allin et al. used a suitably substituted chiral 5,6-bicyclic lactam N-acyliminium precursor, 60, 
prepared according to the methodology of Amat and Bosch through the condensation of keto-
ester substrate, 58, with the amino alcohol 59, to afford a 4:1 mixture of cis-60 and trans-60 
diastereoisomers.36,37,38 Both diastereoisomers were subjected to a Lewis acid mediated 
cyclisation that resulted in the formation of only one product diastereoisomer, the template 
trans-61.  Presumably, both the lactam diastereoisomers generate the same N-acyliminium ion 
intermediate on activation (Scheme 17).39 Bicyclic lactams derived from #-amino alcohols 
containing fused 5,5-40,41 and 5,6-36,37,38 are widely used in asymmetric synthesis, however, 
Allin et al.’s use of this fused 5,6-system, 60, as an N-acyliminium cyclisation precursor 
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towards a stereoselective synthesis of the trans-61 benzo[a]quinolizidine derivative is thought 
to be the first application of this kind.39  
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Scheme 17: (i) Dean-Stark conditions, toluene, $, 36 h, 50%;  
(ii) TiCl4, DCM, "10 °C, 20 h, 65%. 
 
Significantly higher yields of both the bicyclic lactam, 62, (formed in a 6:1 ratio in favour of 
the trans stereochemistry) and the product of N-acyliminium cyclisation, trans-63, were 
reported by Allin et al. when the methoxy-substituted amino alcohol substrate, 39, was 
employed in an analogous synthesis (Scheme 18).39  
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Scheme 18: (i) Dean-Stark conditions, toluene, $, 36 h, 94%; (ii) TiCl4,
  
DCM,  "10 °C, 20 h,  68%. 
 
Bosch et al. approached the benzo[a]quinolizidine system from a racemic aldehyde diester, 
65, which is a known synthetic equivalent of secologanin, 6442 (Figure 8).   Secologanin, 64, 
is a secoiridoid glucoside and a key intermediate in the biosynthesis of naturally occurring 
benzo[a]quinolizidine alkaloids.43  
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Figure 8: Secologanin and synthetic equivalent aldehyde diester. 
 
Bosch et al. applied the aldehyde diester, 65, to a stereoselective cyclocondensation with #-
amino alcohol, (S)-39, to afford the target lactam, 66, in a 60% yield, and with three 
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stereogenic centres created in the single synthetic step.  Minor amounts of a second 
diastereoisomer were also observed.44,45 Treatment of lactam, 66, with the Lewis acid boron 
trifluoride etherate promoted an N-acyliminium cyclisation to deliver the 
benzo[a]quinolizidine template, (R)-67, in a 40% yield (Scheme 19),43 with the 
stereochemistry in line with previously reported and related systems.39  
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Scheme 19: (i) Dean-Stark conditions, toluene, !, 10 h, 60%; (ii) BF3.OEt2, DCM, !, 40%. 
 
Bosch et al. broadened the scope of their cyclocondensation methodology to report the novel 
application of an amino acid as the chiral inductor, as an alternative to the typically utilised 
amino alcohol, to access the bicyclic lactam, 68.  The lactam was synthesised by subjecting 
methoxy-substituted phenylalanine, 16, to a cyclocondensation with racemic aldehyde diester, 
65, which afforded the target bicyclic lactam 68, although afforded in a disappointingly low 
15% yield.  The enamide, 69, formed the major product of the reaction being isolated in a 
42% yield. A boron trifluoride etherate promoted N-acyliminium cyclisation upon the bicyclic 
lactam, 68, afforded the expected product trans-70 in an 82% yield (Scheme 20).43  
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Scheme 20: (i) Toluene, !, 10 h, 15% (68), 42% (69); (ii) BF3.OEt2, DCM, !, 82%. 
 
Asymmetric Syntheses of the Tetracyclic Benzo[a]quinolizidine Template 
To further functionalise the benzo[a]quinolizidine templates, Allin et al. employed a more 
functionalised racemic acid substrate, 71,46 and cyclocondensed this with the (R)-amino 
alcohol, 48, to afford the tricyclic lactam, cis-72, in a 71% yield.  Treatment of cis-72 with 
Lewis acid conditions mediated the in situ generation of an N-acyliminium ion, 73, and 
subsequent N-acyliminium cyclisation to afford the tetracyclic product, 74 (Scheme 21).47  
The resulting stereochemistry was identical to that seen previously in related N-acyliminium 
cyclisations, which have targeted the homologous series of pyrroloisoquinoline alkaloids30 
with the cyclopentane ring fused anti to the hydroxymethyl auxiliary group.47  
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Scheme 21: (i) Dean-Stark conditions, toluene, !, 48 h, 71%;  
(ii) TiCl4, –78 °C, 48 h, DCM, 73%. 
 
The availability of enantiomerically pure #-amino alcohol reagents is a significant 
progression in access to heterocyclic templates, and Allin et al. approached the synthesis of 
the alternative product stereochemistry, 75, through use of the (S)-amino alcohol, 39, (Scheme 
22).47 The stereochemical outcome was found to be in line with that observed for the 
pyrroloisoquinoline alkaloids.30  
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Scheme 22: (i) Dean-Stark conditions, toluene, !, 48 h,  
76%; (ii) TiCl4, –78 °C, 48 h, DCM, 68%. 
 
A variation upon the typical stereoselective N-acyliminium cyclisation strategy was reported 
by Allin et al. when they encountered an unprecedented retro-Diels Alder/N-acyliminium 
cyclisation cascade sequence en route to the target functionalised tetracyclic 
benzo[a]quinolizidine template, 78, and instead obtained a cyclopentane containing 
tetracyclic product 80. Lete et al.’s highly funtionalised polycyclic lactam, 77, in which a 
masked olefin moiety was introduced in the form of a Diels-Alder adduct,48 was accessed by 
Allin et al. in a 45% yield as a single diastereoisomer via the cyclocondensation of racemic 
keto acid, 76, and (S)-amino alcohol, 39. It was anticipated that a subsequent intramolecular 
N-acyliminium ion cyclisation upon treatment with titanium tetrachloride at low temperature 
would afford the target tetracycle, 78. However, titanium tetrachloride conditions failed to 
induce the cyclisation and resulted only in the degradation of the lactam.  Treatment of 
lactam, 77, with the alternative Lewis acid boron trifluoride etherate in refluxing 
dichloromethane resulted in the formation of an iminium ether salt, 79, and it was isolated in 
Page | 30  
 
a high 91% yield. An excess of boron trifluoride etherate promoted a cascade, although it is 
not known when the retro-Diels Alder reaction actually occurs in the sequence.  The iminium 
ether salt, 79, was subjected to a reductive ring opening reaction using diisobutyaluminium 
hydride which afforded the tetracyclic benzo[a]quinolizine template, 80 (Scheme 23),47 and 
with the resulting stereochemistry analogous with that observed in previous related models.47  
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Scheme 23: (i) Dean-Stark conditions, toluene, !, 48 h, 45%; (ii) TiCl4, "78 °C, DCM;  
(iii) BF3.OEt2, !, DCM, 91%; (iv) DiBAL, DCM, 0 °C, then !, 5 h, 65%. 
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2.1.3 Indolizinoindole Alkaloids: The Indolizidino[8,7-b]indole Template 
 
N
N
H R  
Figure 9: Indolizino[8,7-b]indole template 7. 
 
Biological Activity 
The indolizidino[8,7-b]indole template, 7 (Figure 9), is found as the sub-unit of a variety of 
naturally occurring and pharmacologically interesting alkaloids and is of immense 
pharmacological interest since analogues have found application in the preparation of 
diuretics and they have shown analgesic and anti-inflammatory activity.49 
Asymmetric Syntheses of the Indolizidino[8,7-b]indole Template 
Allin et al. reported the synthesis of the methyl-substituted template, 84, by subjecting the #-
amino alcohol derivative of (S)-tryptophan, 81, to a cyclocondensation reaction with racemic 
keto acid substrate 82.  The bicyclic lactam product, 83, was achieved in a surprisingly low 
3% yield; with the major product of the reaction being the target template cis-84, and 
achieved in 55% yield (Scheme 24).50  Retention in stereochemistry was observed in line with 
related models.21 22  
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Scheme 24: (i) Dean-Stark conditions, toluene, !, 48 h, 3% (83) and 55% (84). 
 
Through an imide intermediate, 85, Allin et al. were able to report an alternative synthetic 
approach to access the indolizidino[8,7-b]indole template, 86. Imide, 85, was synthesised in a 
54% yield through the cyclocondensation of #-amino alcohol, 81, and succinic anhydride, 18. 
A sodium borohydride reduction upon imide, 85, promoted direct N-acyliminium ion 
formation and cyclisation to afford the target template, 86, as a 9:1 mixture of trans and cis 
diastereoisomers in an overall 45% yield (Scheme 25).50 The stereochemical outcome of the 
major diastereoisomer, trans-86, is consistent with that reported for related isoquinoline 
models.39  
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Scheme 25: (i) Dean-Stark conditions, toluene, $, 48 h,  
54%; (ii) NaBH4, EtOH, 2M HCl aq. in EtOH, 20 h, 0 °C, 45%. 
 
By application of their tandem organolithium addition N-acyliminium ion cyclisation strategy, 
Lete et al. reported a route to a library of racemic substituted indolizidino[8,7-b]indole 
templates, 90.  Their methods required the acylation of tryptamine, 87, with succinic 
anhydride, 18, to afford the corresponding succinimide, 88, followed by the nucleophilic 
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addition of the organolithium reagent to afford the corresponding oxoamides, 89.  Treatment 
with trifluoroacetic acid, to promote an N-acyliminium cyclisation, afforded a racemic library 
of indolizidino[8,7-b]indole derivatives, 90 (Scheme 26).51   
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Scheme 26: (i) AcOH, !; (ii) RLi, THF, "78 °C; (iii) TFA, DCM, rt. 
 
Building on this racemic approach,51 Lete et al. sought a stereoselective tandem 
organolithium addition N-acyliminium ion cyclisation synthesis of the methyl substituted 
indolizidino[8,7-b]indole template.  Employing a chiral succinimide, 92, synthesised from a 
protected derivative of (S)-tryptophanol, 91, and subjecting succinimide, 92, to methyllithium 
afforded the corresponding oxamide, 93.  Treatment with Lewis acid mediated an N-
acyliminium cyclisation and the simultaneous hydroxyl deprotection to deliver the target 
compound, cis-84, in a low 35% yield but, with a high 99% ee (Scheme 27).51  
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Scheme 27: (i) Et2O, !, then NaOAc, Ac2O; (ii) MeLi, THF, "78 °C;  
(iii) BF3.OEt2, DCM, !, 35%, 99% ee. 
 
With the indolizidino[8,7-b]indole template trans-86 in hand,50 Allin et al. were able to build 
upon the template to access the naturally occurring biologically active alkaloid (R)-(+)-
harmicine, 94 (Figure 10).52 This natural product was first isolated from the leafy extract of 
the Malaysian plant Kopsia griffithii by Kam and Sim and was shown to exhibit anti-
leishmania activity.53  
 
N
N
H H  
Figure 10: (R)-(+)-Harmicine 94. 
 
To access (R)-(+)-harmicine, 94, required the removal of the hydroxymethyl auxiliary group 
from template trans-86. A direct decarboxylation strategy was employed which required the 
oxidation of the alcohol to the carboxylic acid, 95, through an aldehyde intermediate, and a 
tert-butyl carbamate protection.  From the carboxylic acid, 95, an acyl selenide derivative was 
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generated which was treated to a tin-mediated deacylation to yield compound 96.  
Deprotection of the indole nitrogen afforded the desired lactam, 97, and a final hydride 
reduction of the lactam carbonyl completed the synthesis of this natural product, (R)-94 
(Scheme 28).52 The optical rotation of Allin et al.’s product was comparable to the optical 
rotation of the natural isolate.53  
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Scheme 28: (i) IBX, DMSO, rt, 24 h, 72%; (ii) Et3N, (Boc)2O, DMAP, THF, rt, 4 h 73%;  (iii) 
NaClO2, NaH2PO4, CH3CN, t-BuOH, cyclohexene, 0 °C to rt, 18 h, 79%; (iv) (PhSe)2, PBu3, CH2Cl2, 
0 °C to rt, 18 h, 66%; (v) n-Bu3SnH, AIBN, toluene, !, 2 h, 90%; (vi) TBAF, THF, !, 2 h to rt, 9 h, 
69%; (vii) LAH, THF, !, 3 h, 80%. 
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2.1.4 Indolizinoindole Alkaloids: The Indolo[2,3-a]quinolizine Template 
 
N
N
H R
 
Figure 11: Indolo[2,3-a]quinolizine template 11. 
 
Biological Activity 
The indolo[2,3-a]quinolizine alkaloids are of immense pharmacological interest since they 
have found application in the preparation of diuretics and exhibit analgesic and anti-
inflammatory activity.49 The template, 11 (Figure 11), is found as the sub-unit of a variety of 
naturally occurring and pharmacologically interesting alkaloids. 
Racemic Synthesis of the Indolo[2,3-a]quinolizine Template 
By application of their tandem organolithium addition N-acyliminium ion cyclisation 
methodology Lete et al. were able to access a library of racemic indolo[2,3-!]quinolizine 
templates, 101, and all dependent on choice of organolithium reagent.54  Initial acylation of 
tryptamine, 87, with cyclic anhydride, 98, afforded the corresponding imide, 99, which upon 
nucleophilic addition of the organolithium reagent yielded the corresponding oxoamide, 100.  
Subsequent treatment with protic acid induced the formation of an N-acyliminium ion and 
cyclisation to deliver a library of racemic indolo[2,3-a]quinolizine templates, 101, in high 
yields (Scheme 29).54  
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Scheme 29: (i) AcOH, !; (ii) RLi, THF, "78 °C; (iii) TFA, DCM, rt. 
  
Asymmetric Syntheses of the Indolo[2,3-a]quinolizine Template 
Allin et al. applied an asymmetric approach to access the indolo[2,3-a]quinolizine template, 
trans-103, through the bicyclic lactam intermediate, 102.55  The resulting bicyclic lactam, 
102, was synthesised in a 58% yield and as a 5:1 mixture of separable diastereoisomers from 
the cyclocondensation of chiral inducer (S)-tryptophanol, 81, with the keto-acid substrate 58. 
This indole containing bicyclic lactam is an example of the fused 5,6-ring system favoured by 
Amat and Bosch.36 37 38 Subjecting the major bicyclic lactam, cis-102, to Lewis acid 
conditions promoted the in situ formation of the N-acyliminium ion.  The resulting N-
acyliminium cyclisation with the indolic nucleophile afforded the indolo[2,3-a]quinolizine 
template, 103, in a 52% yield, although as a low 5:2 mixture of trans and cis 
diastereoisomers.  Allin et al. were able to increase the stereoselectivity of this reaction by 
subjecting the mixture of lactams, 102, to protic acid conditions (2 M solution of hydrochloric 
acid in ethanol), which resulted in the exclusive formation of a single diastereoisomeric 
product trans-103 in an excellent 95% yield (Scheme 30).55  
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Scheme 30: (i) Dean-Stark conditions, toluene, !, 58%;  
(ii) 2 M HCl aq. in EtOH, rt, 20 h, 95%. 
 
Allin et al. approached the synthesis of the alternative stereochemistry, trans-105, via 
substrate (R)-tryptophanol, 104, and by the application of analogous reactions conditions 
(Scheme 31).55  
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Scheme 31: (i) Dean-Stark conditions, toluene, !; (ii) 2 M HCl aq. in EtOH, rt, 20 h. 
 
With the indolo[2,3-a]quinolizine template, trans-105, in-hand,55 Allin et al. were able to 
access the naturally occurring alkaloid (S)-(")-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-
a]quinolizine, 106 (Figure 12).55 This alkaloid was originally isolated from Dracontomelum 
mangiferum B1 by Akimoto et al.56  
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Figure 12: (S)-(")-1,2,3,4,6,7,12,12b-Octahydroindolo[2,3-a]quinolizine, 106. 
 
To access this alkaloid Allin removed the hydroxymethyl auxiliary group through the 
application of their decarboxylation strategy, previously described in access to (R)-(+)-
harmicine, 94.55 By application of this strategy Allin et al. were able to achieve the target (S)-
(")-106 with a greater than 95% ee (Scheme 32).55  
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Scheme 32: (i) IBX, DMSO, rt, 24 h, 65%; (ii) Et3N, (Boc)2O, DMAP, THF, rt, 4 h, 54%;  
(iii) NaClO2, NaH2PO4, CH3CN, t-BuOH, 1-methyl-1-cyclohexene, H2O, 0 °C to rt, 18 h  
70%;  (iv) (PhSe)2, PBu3, DCM, 0 °C to rt, 18 h, 66%; (v) n-Bu3SnH, AIBN, toluene, !, 2 h, 98%; (vi) 
TBAF, THF, !, 3 h, then rt for 9 h, 63%; (vii) LAH, THF, !, 9 h, 96%. 
 
Allin et al. recognised that access to the naturally derived and biologically active alkaloid (R)-
(+)-deplancheine, 107 (Figure 13),57 could be achieved through the manipulation of the 
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established indolo[2,3-a]quinolizine template, trans-103.55  (R)-(+)-Deplancheine is naturally 
isolated from the New Caledonian plant Alstonia deplanchei.58 
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H H
 
Figure 13: (R)-(+)-Deplancheine 107. 
 
With the template trans-103 in-hand, removal of the hydroxymethyl auxiliary group was 
achieved using the decarboxylation strategy,52 to deliver the target template, (R)-108 (Scheme 
33).57  
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Scheme 33: (i) IBX, DMSO, rt, 24 h, 70%; (ii) Et3N, (Boc)2O, DMAP,  
THF, rt, 4 h, 98%; (iii) NaClO2, NaH2PO4, CH3CN, t-BuOH, 1-methyl-1-cyclohexene, 
H2O, 0 °C to rt, 18 h 83%; (iv) (PhSe)2, PBu3, DCM, 0 °C to rt, 18 h, 83%; 
(v) n-Bu3SnH, AIBN, toluene, !, 2 h, 73%. 
 
The next step in the approach towards (R)-(+)-deplancheine, 107, required the construction of 
the ethylidene moiety, and this was achieved using a three-step procedure involving the 
generation of the lithium enolate from compound 108, followed by an aldol reaction with 
acetaldehyde, activation of the hydroxymethyl auxiliary group by mesylation, and subsequent 
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DBN-induced elimination to afford compound (R)-109.  Deprotection of the indole nitrogen 
via tetra-n-butyl ammonium fluoride freed the lactam intermediate, (R)-110, and then 
reduction applying the methodology of Martin59 delivered the target alkaloid (R)-(+)-
deplancheine, 107, and this alkaloid was obtained with an ee of greater than 95% (Scheme 
34).57  
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Scheme 34: (i) LDA, CH3CHO, THF, -78 °C to rt, 24 h; (ii) Et3N, MsCl, DCM, "40 °C to rt, 3 h; (iii) 
DBN, THF, rt, 16 h; (iv) TBAF, THF, !, 9 h; (v) Me3OBF4, 2,6-di-t-Bu-Py, DCM, rt, 21 h; (vi) 
NaBH4, MeOH, 0 °C, 0.5 h. 
 
In an analogous procedure, Allin et al. applied the substrate (R)-tryptophanol with the 
alternative stereochemistry, to construct template (S)-111  (Figure 14).  This target was 
achieved via a bicyclic lactam intermediate in an analogous procedure, and the target template 
was isolated and shown to have a greater than 95% ee.57  
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Figure 14: (S)-(-)-Deplancheine 111. 
 
Analogous to the secologanin, 64, inspired approach to access the substituted 
benzo[a]quinolizidines templates, Bosch et al. attempted to target the indolo[2,3-
a]quinolizine template.  Using both (S)-tryptophanol, 81, and (S)-tryptophan, 112, as the 
chiral auxiliaries in independent cyclocondensation reactions with the aldehyde diester, 65, 
Bosch et al. were able to deliver the bicyclic lactams, 113 and 114, respectively.  Application 
of N-acyliminium cyclisation strategies upon these lactam templates, 113 and 114, yielded the 
target substituted indolo[2,3-a]quinolizidine templates, 115 and 116, respectively (Scheme 
35).43  
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 Scheme 35: (i) Toluene, !, 10 h, 62% (113); benzene, !, 48 h, 30% (114);  
(ii) BF3.OEt2, DCM, ! 35%; (115); TFA, DCM, rt, 90% (116). 
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(+)-12b-Epidevinylantirhine, 117, was first synthesised by Wenkert et al. during their studies 
towards the synthesis of the natural products geissoschizine, 118, and geissoschizol, 119 
(Figure 15).60 
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Figure 15: (+)-12b-Epidevinylantirhine, geissoschizine and geissoschizol. 
 
Allin et al. recognised that access to this biologically interesting alkaloid (+)-12b-
epidevinylantirhine, (R)-117, was possible by first construction of the core indolo[2,3-
a]quinolizidine ring system, (R)-108, then manipulation through stereoselective conjugate 
addition of the !-#-unsaturated lactam, (R)-120.61 Addition of the lithiated methyl 1,3-
dithiolane-2-carboxylate resulted in exclusive formation of the addition product (R)-121 in a 
47% yield, and the protons at positions C-2 and C-12b were found to exhibit cis 
stereochemistry.  Subsequent desulfurisation of the dithioacetal moiety with nickel boride 
furnished compound (R)-122 in a 73% yield.  Deprotection of the indole nitrogen generated 
compound (R)-123, and simultaneous reduction of both the lactam carbonyl and the methyl 
ester moieties furnished the desired target (R)-(+)-12b-epidevinylantirhine, (R)-117, in a 50% 
yield (Scheme 36).61  
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Scheme 36: (i) LDA, PhSeBr, THF, "78 °C to rt, 24 h; then NaIO4, NaHCO3, MeOH, H2O, rt, 18 h, 
85%; (ii) methyl 1,3-dithiolane-2-carboxylate, n-BuLi, THF, "78 °C to rt, 24 h, 47%;  
(iii) NiCl2.6H2O, NaBH4, THF-MeOH, 0 °C to rt, 4h, 73%; (iv) HCOOH, rt, 28 h, 71 h;  
(v) LAH, THF, !, 3 h, then rt 12 h, 50%. 
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2.1.5 Summary 
Over recent years the Allin, Lete and Bosch research groups have independently and in 
association applied N-acyliminium cyclisation strategies using the nucleophilic addition of a 
pendant electron rich aromatic substitute towards achieving heterocycles of biological 
interest. This literature review has summarised key work reported within recent literature 
targeting the isoquinoline alkaloids: the pyrrolo[2,1-a]isoquinoline template, 5, and the 
benzo[a]quinolizidine template, 6, and the indolizinoindole alkaloids: indolizidino[8,7-
b]indole template, 7, and the indolo[2,3-a]quinolizidine template, 8 (Figure 2). Although this 
review has described related substrates, reagents and conditions for promoting N-acyliminium 
cyclisations to afford the heterocycles of interest, these are not rules, merely guides upon 
which form the foundations for this EngD research. 
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Chapter 3  
Project One: Asymmetric Synthesis of the Anti-
tumour Alkaloid (R)-(+)-Crispine A 
3.1 Introduction 
 
N
H
MeO
MeO
 
Figure 16: (R)-(+)-Crispine A 124. 
 
3.1.1 Aims 
To develop an asymmetric synthesis of the pyrrolo[2,1-a]isoquinoline alkaloid crispine A 
124. 
3.1.2 Objectives 
To apply an asymmetric N-acyliminium cyclisation methodology towards the 
pyrroloisoquinoline alkaloid (R)-(+)-crispine A. 
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3.2 Literature Review 
3.2.1  Biological Activity 
The alkaloid (R)-(+)-crispine A, 124, depicted in Figure 16, is an example of a bioactive 
pyrrolo[2,1-a]isoquinoline.  This alkaloid was first isolated in 2002 by Zhao et al. from 
Carduus crispus, a thistle plant native to parts of Asia and Europe.62  Since ancient times, 
extracts of this thistle have been applied in indigenous medicine for the treatment of cold, 
rheumatism and stomach ache.  Furthermore, recent pharmacological screening has revealed 
that (R)-(+)-crispine A, 124, shows exciting cytotoxic activity against SKOV3, KB and HeLa 
human cancer cell lines.62 This important biological activity has meant that many synthetic 
approaches have been reported to better understand the efficacy of this potential anti-cancer 
agent.  
3.2.2 Racemic Syntheses Towards Crispine A 
Owing to the exciting potential biological activity, there have been numerous reports of 
racemic syntheses of crispine A during recent years.  In 2005, Knolker et al. achieved a three-
step total synthesis of racemic crispine A.  This approach involved the addition of a propargyl 
Grignard reagent to an isoquinoline derivative, 125, followed by silver (I) promoted oxidative 
cyclisation and chemoselective hydrogenation (Scheme 37).63  
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Scheme 37: (i) BF3.Et2O, THF, "23 °C; (ii) 3-trimethylsilylpropargylmagnesium bromide, Et2O, 61%; 
(iii) AgOAc, DCM, 14 h, rt, 58%; (iv) 5% Rh/C, H2 HOAc, MeOH, rt, 66%. 
 
Opatz et al. reported a synthetic approach towards racemic crispine A through basic 
deprotonation of an amino nitrile, 126, followed by a 1,4-addition to acrolein and reduction of 
the resulting unstable intermediate by sodium cyanoborohydride (Scheme 38).64 
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Scheme 38: (i) KHMDS, THF, "78 °C; (ii) CH2CHCHO;  
(iii) AcOH, EtOH; (iv) NaCNBH3, 13%. 
 
Of particular interest to our research area, King et al. reported the first N-acyliminium 
cyclisation approach to access racemic crispine A, 124, achieving a high yield and only in 
three-steps (Scheme 39).65 
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Scheme 39: (i) Et3N, DCM 80%; (ii) AlCl3, DCM,  
2 h, rt, 87%; (iii) LAH, H2SO4, THF, 80%. 
 
In the same year, Baskaran et al. successfully applied an intramolecular Schmidt reaction 
upon an azido-ketone, 127, to access a derivative of racemic crispine A, 128 (Scheme 40).66,67 
 
rac-128
MeO
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N
O
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(i)
127  
Scheme 40: (i) TfOH, DCM, "5 °C to 0 °C, 15 mins, 57%. 
 
More recently in 2009, Chiou et al. reported a rhodium-catalysed cyclohydrocarbonylation-
bicyclisation of N-allylic amides of aryl acetic acid, 129, as an efficient synthesis of racemic 
crispine A, 124 (Scheme 41).68 
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Scheme 41: (i) Rh(acac)(CO)2, BIPHEPHOS, CO, H2, pTSA, AcOH, 60 °C, 16 h;  
(ii) LAH, Et3NHHCl, THF, 0 °C to rt. 
 
Also in 2009, a short total synthesis of racemic crispine A, 124, was reported by Coldham et 
al. using a cascade condensation-cyclisation-intermolecular dipolar cyclo-addition strategy 
upon the aldehyde, 130 (Scheme 42).69 
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Scheme 42: (i) CH(OEt)3, BF3.OEt2, rt, 2.5 h, 45%; (ii) CH3COCl, !, 3.5 h, 70%;  
(iii) glycine, (E)-PhSO2CHCHSO2Ph, PhMe, 110 °C, 24 h, 70%; (iv) NaHg, Na2HPO4, CH3OH, 0 °C, 
2 h, 55%; (v) H2, 10% Pd/C, CH3OH,  rt, 2 h, 80%. 
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3.2.3 Asymmetric Synthesis of (R)-(+)-Crispine A 
In contrast to numerous racemic approaches towards crispine A, 124, asymmetric routes are 
limited within the literature.  In 2005, the first enantioselective synthesis of (R)-(+)-crispine 
A, 124, was reported by Czarnocki et al. and achieved in an excellent 91% yield.70   
Czarnocki et al. achieved their synthesis through the asymmetric transfer hydrogenation of an 
iminium salt, 131 using the Ru catalyst 132 (Scheme 43).  The enantiomeric purity of their 
(R)-(+)-crispine A, 124, was determined within the limits of 400 MHz 1H-NMR spectroscopy 
and using the chiral additive: (R)-(+)-t-butylphenylphosphinothiolic acid, 133 (Figure 17).70,71 
The stereoselectivity of the synthesis reported by Czarnocki et al. was improved by Hou et al. 
using iridium-based catalysts to achieve a 97% yield with a 90% ee.72 
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Scheme 43: (i) p-xylene, !, 95%; (ii) POCl3, !, 93%;  
(iii) Et3N/HCOOH, Ru complex, 132, 0 °C, 91%, 92% ee. 
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Figure 17: Chiral shift reagent 133. 
3.3 Results & Discussion 
3.3.1 N-Acyliminium Cyclisation Reaction 
Our asymmetric approach towards crispine A, 124, required following Allin et al.’s reported 
methodology to access the 5,6-dihydropyrrolo[2,1-a]isoquinolinone template, trans-35.73 The 
substrate #-amino alcohol, 39, was obtained by applying the methodology of Giannis and 
Sandhoff74 to reduce the corresponding amino acid, 3,4-dimethoxyphenylalanine, 16, via the 
reducing agent lithium borohydride in the presence of trimethylsilyl chloride in anhydrous 
tetrahydrofuran for 24 hours.  The #-amino alcohol was afforded in a 90% yield (Scheme 44). 
 
MeO
MeO
NH2
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MeO
NH2
OH
O
(i)
16 39  
Scheme 44: (i) LiBH4, TMSCl, THF, 24 h, 90%. 
 
A cyclocondensation of the #-amino alcohol, 39, and succinic anhydride, 18, in the presence 
of triethylamine afforded the cyclic imide, 36, in a 54% yield. Treatment of imide 36 to a 
sodium borohydride reduction in ethanol resulted in a direct and highly stereoselective 
cyclisation to deliver the template trans-35 in an excellent 91% yield (Scheme 45).  
Presumably, under the acidic reaction conditions, the electron rich methoxy-substituted aryl 
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ring is able to cyclise directly onto the N-acyliminium intermediate, which is generated in 
situ. Data attained for this cyclised template was consistent with the previously reported 
data.73 
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Scheme 45: (i) Dean-Stark conditions, NEt3, toluene, !, 18 h, 54%;  
(ii) NaBH4, EtOH, 2 M HCl aq. in EtOH, 0 °C to rt, 20 h, 91%. 
 
3.3.2 Removal of the Hydroxymethyl Auxiliary Group 
With the desired stereochemistry installed at the C-10b stereocentre, the next step required the 
removal of the pendant hydroxymethyl auxiliary group. Allin and Gaskell attempted this 
removal via application of a Raney nickel induced decarbonylative strategy.75,76 Allin and 
Gaskell achieved their target transformation in an excellent 98% yield to deliver the 
corresponding amide product, 134.77  Reduction of the amide carbonyl via lithium aluminium 
hydride in anhydrous tetrahydrofuran completed a racemic synthesis of crispine A in 76% 
yield (Scheme 46).77 The partially racemic nature of their product was realised by application 
of a 400 MHz 1H-NMR study using the chiral shift reagent (R)-(+)-tert-
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butylphenylphosphinothioloic acid, 133, previously used by Czarnocki et al. in their studies 
for the synthesis of crispine A, (R)-(+)-124.70 71  Allin and Gaskell determined their product 
to have a disappointingly low 50% ee.  Most probably, epimerisation of the benzylic-
stereocentre, C-10b, was occurring during the transformation.77  
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Scheme 46: (i) Ra-Ni, toluene, !, 98%; (ii) LAH, THF, !, 4 h, then rt, 12 h, 76%.  
 
We achieved an asymmetric approach to crispine A, 124, through the application of a 
rhodium-induced decarbonylation sequence which, had previously been reported in 
approaches to the Erythrina alkaloid series.78,79 Compound 35 was oxidised to the aldehyde, 
135, in an excellent 96% yield using 2-iodoxybenzoic acid in refluxing ethyl acetate 
according to the methodology of Finney et al.80  The aldehyde, 135, was then subjected to 
bis(triphenylphosphine)rhodium(I) carbonyl chloride and 1,3-bis(diphenylphosphino)propane, 
in refluxing xylene78,79 and the reaction monitored by thin layer chromatography for 240 
hours, after which time a new spot indicated a new product formation. Interestingly, the new 
spot represented the desired amide, 136, afforded in a 46% yield and as the major product of 
the reaction, and not as an enamide as expected from previous examples where this 
methodology has been employed.78,79 The final reductive step in the synthesis of crispine A 
was carried out using lithium aluminium hydride in anhydrous tetrahydrofuran at 0 °C with 
gradual warming to room temperature for 15 hours. Reduction was achieved in a 58% yield.  
The optical rotation of our product, (R)-124, was determined to be +95.2 (c 1.5, MeOH) 
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(Scheme 47). This optical rotation result was comparable to that reported by Zhao et al. who 
report an optical rotation of +95.2 in methanol for their natural product isolate.62  Our result 
was also comparable to Czarnocki et al. who reported an optical rotation of +100.4 (c 1.0) in 
chloroform for their asymmetrically synthesised compound.70  
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Scheme 47: (i) IBX, EtOAc, !, 4 h, 98%; (ii) Rh(PPh3)2(CO)Cl,  
dppp, xylene, !,  240 h,  46%; (iii) LAH, THF, 20 h, 58%. 
 
3.3.3 Determination of Enantiomeric Excess 
With the chiral shift reagent (R)-(+)-tert-butylphenylphosphinothioloic acid, 133, kindly 
provided to us by Czarnocki et al.70 we were able to undertake an equivalent 400 MHz 1H-
NMR study. The diagnostic signal in the 1H-NMR spectrum used in the determination was the 
aromatic C-10 proton, which in the presence of the chiral shift reagent showed one single 
peak, allowing us to conclude that our asymmetrically synthesised compound, 124, has an ee 
of greater than 95%.77 
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3.4 Conclusion 
We have met the research objectives having achieved an asymmetric synthesis of the anti-
tumour pyrroloisoquinoline alkaloid (R)-(+)-crispine A, 124, and in a greater than 95% ee, 
using a highly diastereoselective N-acyliminium cyclisation strategy as the key synthetic step. 
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Chapter 4  
Project Two: N-Acyliminium Cyclisation as an 
Approach for an Asymmetric Synthesis of the 
Pyrrolo[2,1-a]benzazepine Ring System 
4.1 Introduction 
N
O
 
Figure 18: Pyrrolo[2,1-a]benzazepine ring system, 137. 
 
4.1.1 Aim 
To develop an asymmetric synthesise of the pyrrolo[2,1-a]benzazepine template, 137. 
4.1.2 Objectives 
To apply an asymmetric intramolecular N-acyliminium cyclisation strategy towards the 
tricyclic pyrrolo[2,1-a]benzazepine template, a sub-unit of the Homoerythrina alkaloids. 
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4.2 Literature Review 
4.2.1 Biological Activity 
The pyrrolo[2,1-a]benzazepine ring system, 137, as depicted in Figure 18, is the core sub-unit 
in the Homoerythrina family of naturally occurring alkaloids. Several synthetic approaches 
towards the synthesis of Homoerythrina alkaloids, and the structurally simpler, pyrrolo[2,1-
a]benzazepine, 137, have been reported,81 but few involve the intermediacy of an N-
acyliminium intermediate to induce the cyclisation and the construction of the characteristic 
seven-membered ring. An example of a naturally occurring Homoeryrthrina alkaloid of 
interest to the agrochemical industry is dyshomoerythrine, 138 (Figure 19), isolated as the 
major alkaloid in the Lagarotrobus colensoi, and more commonly known as the silver pine 
tree of New Zealand.  This exciting alkaloid has been shown to exhibit biological activity 
against some agricultural pests.82  
 
N
O
O
MeO
OMe
 
Figure 19: Dyshomoerythrine 138. 
 
4.2.2 N-acyliminium Cyclisation Approaches to Access the Pyrrolo[2,1-
a]benzazepine and Related Templates 
Katritzky et al. reported a synthesis of the racemic pyrrolo[2,1-a]benzazepine ring system 
using the Lewis acid titanium tetrachloride to promote cyclisation of a mixture of 
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benzotriazole isomers Bt1 and Bt2, 139.  Using this method they were able to deliver the target 
racemic pyrrolo[2,1-a]benzazepine ring system, 137, in a 52% yield (Scheme 48).83  
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Scheme 48: (i) BtH, CH3COOH, 60-70 °C, 48 h, 56%; (ii) TiCl4, DCM, 36 h, 20 °C, 52%. 
 
Padwa et al. reported an approach to access the tetracyclic core, 143, of a related furan-based 
Homoerythrina alkaloid called selaginoidine, 144. The application of an aza-Wittig reaction 
upon a furanyl azide substrate, 140, and keto-acid, 141, afforded hexahydroindolinone, 142, 
as the major product of the reaction and in an 80% yield.  The second product of the reaction 
was the desired tetracyclic target, 143, in a 15% yield.  Subjecting the hexahydroindolinone 
intermediate, 142, to acidic conditions promoted the cyclisation to afford the target tetracyclic 
core, 143, in an excellent 90% yield (Scheme 49).84 
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Scheme 49: (i) Bu3P, !, 0.5 h, 80%; (ii) TFA
 , 90%. 
 
Flynn et al. reported an acid induced asymmetric N-acyliminium cyclisation of the chiral 
phenylalanine-derived enamide, 145, to afford the analogous compound 146, (Scheme 50) 
during their studies on the construction of novel conformationally restricted dipeptide 
mimics.85 
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Scheme 50: (i) TfOH, DCM, !, 77%. 
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4.3 Results & Discussion 
4.3.1 Synthesis of the N-Acyliminium Precursor 
In chapter three we described an asymmetric synthesis of the anti-tumour alkaloid (R)-(+)-
Crispine A, 124, via a highly diastereoselective N-acyliminium cyclisation reaction as the key 
synthetic step,86 and we realised that an analogous N-acyliminium cyclisation strategy 
appeared perfectly suited to access the Homoerythrina pyrrolo[2,1-a]benzazepine sub-unit, 
137.   
 
To embark upon this template we required the #-amino alcohol substrate (S)-
homophenylalaninol, 149, and this was obtained by neutralisation of the commercially 
available (S)-homophenylalanine hydrochloride salt, 147, to afford the corresponding amino 
acid, (S)-148. The amino acid (S)-148 was then reduced using lithium borohydride in the 
presence of trimethylsilyl chloride in anhydrous tetrahydrofuran for 24 hours to afford the 
required (S)-amino alcohol in a 90% yield (Scheme 51).87  
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Scheme 51: (i) MeOH, Na2CO3, 5 mins, rt, 94%; (ii) LiBH4, TMSCl, THF, 24 h, 75%. 
 
(S)-Homophenylalaninol, 149, and succinic anhydride, 18, were subjected to a 
cyclocondensation under Dean-Stark reaction conditions to afford an intermediate imide, 150, 
in a 60% yield. Subjecting the imide, 150, to a reduction-cyclisation cascade in an ethanolic 
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solution of sodium borohydride, followed by treatment with 2 M solution of hydrochloric acid 
in ethanol delivered exclusively the bicyclic lactam, N-acyliminium precursor, trans-151, in a 
57% yield (Scheme 52).  The relative stereochemistry of the bicyclic lactam was confirmed 
by 1D nOe studies with respect to the protons at positions C-3 and C-7a. No enhancement of 
the signal associated with the proton at the C-3 position was observed when irradiating the 
proton at C-7a, thus suggesting a trans arrangement of the H-atoms.  This trans 
stereochemical outcome is in line with analogous bicyclic lactam templates reported by Allin 
et al.88 
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Scheme 52: (i) Dean-Stark conditions, toluene, Et3N, !, 18 h, 60%;  
(ii) NaBH4, EtOH, 2 M HCl aq. in EtOH, 0 °C, 3 h; (iii) 2 M HCl aq. in EtOH, 20 h (57% over two 
steps). 
 
4.3.2 N-Acyliminium Cyclisation Reaction 
With the novel compound trans-151 in-hand, we turned our attention to the key N-
acyliminium cyclisation step. To access the target pyrrolo[2,1-a]benzazepine ring system, 
137, trans-151 was treated with titanium tetrachloride at "78 °C in dichloromethane, and 
attempts with both 1.5 and 3 equivalents of Lewis acid present; boron trifluoride-diethyl 
etherate at "78 °C in dichloromethane; no solvent under microwave conditions (100 °C for 5 
mins); and 2 M solution of hydrochloric acid in ethanol at room temperature was attempted. 
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Under each Lewis or protic acid condition described the desired cyclisation did not occur, 
resulting instead in either re-isolation of the starting material, 151, or in the formation of a 
complex, intractable mixture of products. The desired cyclisation was ultimately achieved in 
almost quantitative yield, 97%, by treatment of the bicyclic lactam, trans-151, with 1.5 
equivalents of titanium tetrachloride in dichloromethane at the lower temperature of "96 °C, 
followed by a gradual warming to room temperature overnight (Scheme 53). Under these 
conditions the desired pyrrolo[2,1-a]benzazepine ring system was formed via the N-
acyliminium intermediate, 152, and as a 4:1 mixture of separable diastereoisomers, trans-153 
and cis-153, in an excellent 97% combined yield.  
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Scheme 53: (i) TiCl4 (1.5 eq), DCM, "96 °C, 97%. 
 
The relative stereochemistry of each diastereoisomer was confirmed by 400 MHz 1H-NMR 
nOe studies.  With the major diastereoisomer, trans-153, we observed no enhancement of 
signal for the proton at position C-11b when irradiating the signal of the proton at position C-
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5, and vice versa, thus suggesting a trans-relationship between the two protons. With the 
minor diastereoisomer, cis-153, we observed a signal augmentation for the proton at position 
C-5 when irradiating the C-11b signal, therefore concluding a cis relationship between these 
two protons in this case (Figure 20).  
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Figure 20: Structural elucidation of trans and cis-153 respectively. 
 
It is postulated that at the higher reaction temperatures the oxyanion, 152, cyclises to 
regenerate the starting material, 151 (the thermodynamic product). Lowering the temperature 
acts to promote the cyclisation of the aromatic ring to yield the kinetic product and slow the 
reversible formation of the 5,5-bicyclic lactam, 151. The stereochemistry of the major product 
of the reaction, trans-153, was found to be in line with the observed stereochemistry in the 
asymmetric approach towards (R)-(+)-crispine A discussed in Chapter three.  
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4.3.3 Removal of the Hydroxymethyl Auxiliary Group 
To demonstrate the potential utility of our methodology we attempted to remove the 
hydroxymethyl auxiliary group from the major diastereoisomer trans-153 using the rhodium 
catalysed decarbonylation strategy previously applied by us to access (R)-(+)-crispine A.86 
Oxidation of the primary alcohol, trans-153, to the aldehyde 154, was achieved using 2-
iodobenzoic acid following the methodology of Finney et al89 and achieved in a low 53% 
yield.  An alternative procedure using Dess-Martin periodinane90 in dichloromethane at room 
temperature improved the yield to 60%.  The transformation was accompanied by 
epimerisation of the amino aldehyde stereocentre; however, this was of little consequence 
since this functionality was removed completely in the next step.  Treatment of aldehyde 154 
with a rhodium-induced decarbonylation over 240 hours, in accordance with the conditions 
applied by us to access (R)-(+)-crispine A, delivered the target amide (R)-(+)-137, in a 57% 
yield (Scheme 54).  
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Scheme 54: (i) IBX, EtOAc, !, 24 h, 53% or DMP, DCM, rt, 2 h, 60%;  
(ii) Rh(PPh3)2(CO)Cl (5 mol.%), dppp (20 mol.%), xylene, !, 240 h, 57%. 
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4.3.4 Attempted Synthesis of the Homoerythrina Tetracyclic Template 
The structure of the Homoerythrina alkaloids, as exemplified by dyshomoerythrine, 138,82 is 
characterised by a core tetracyclic template and with our successful asymmetric approach 
towards the pyrrolo[2,1-a]benzazepine template, 138, we attempted to access the further 
functionalised tetracyclic template, 155 (Figure 21).   
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Figure 21: Dyshomoerythrine, 138, and the target tetracyclic template, 155. 
 
To access this tetracyclic template, 155, we required the appropriately substituted tricyclic 
lactam substrate, 156, synthesised in a comparable procedure to that described by Regan et al. 
using (S)-homophenylalaninol, 149, and racemic keto-acid, 38. The keto-acid substrate, 38, 
was synthesised in 72% yield by the method reported by Allin et al. for the hydrolysis of the 
corresponding ester (Scheme 55). 91 
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Scheme 55: (i) LiOH, THF, H2O, 72%. 
 
(S)-Homophenylalaninol, 149, and keto-acid, 38, were subjected to a cyclocondensation 
reaction under Dean-Stark conditions to afford the lactam, 156, and as a single 
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diastereoisomer in a 55% yield. The lactam, 156, was subsequently treated with a range of 
Lewis acids to attempt to promote cyclisation to form the target tetracycle, 155. Five 
alternative attempts to promote cyclisation with Lewis acids failed, resulting in either re-
isolation of the starting material, 156, or in the formation of a complex, intractable mixture of 
products.  The first attempt used 1.5 equivalents of titanium tetrachloride at "96 °C in 
dichloromethane.  The second used titanium tetrachloride at "78 °C in dichloromethane with 
both 1.5 and 3 equivalents of the Lewis acid being applied.  The third attempt used boron 
trifluoride-diethyl etherate at "78 °C in dichloromethane and both 1.5 and 3 equivalents of the 
Lewis acid were applied.   The fourth failed attempt involved applying microwave conditions 
of 100 °C for 5 mins and using 3 equivalents of boron trifluoride-diethyl etherate without 
solvent. Reaction of 156 promoted by a 2 M solution of hydrochloride in ethanol at room 
temperature for 20 h resulted in the formation of the conjugated lactam product, 157, as a 
single diastereoisomer in an 80% yield (Scheme 56). 
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Scheme 56: (i) Dean-Stark conditions, toluene, Et3N, !, 48 h, 55%;  
(ii) 2 M HCl aq. in EtOH, rt, 18 h, 80%; (iii) Lewis/protic acid conditions. 
 
The structure of lactam 157 was confirmed by X-ray crystallography (Figure 22) and can be 
explained by initial formation of the expected N-acyliminium intermediate followed by a 
series of proton losses and corresponding double bond migrations from the N-acyliminium 
species, through enamide to the more favoured conjugated lactam, 157 (Scheme 57). Tietze et 
al. reported the formation of an analogous conjugated amide as a by-product in a related N-
acyliminium cyclisation reaction, albeit in the racemic series.92 
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Figure 22: Crystal Structure of 157. 
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Scheme 57: Proposed formation of the conjugated lactam, 157. 
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4.4 Conclusion 
In conclusion, we have had considerable success in meeting the research objectives and 
developed an asymmetric approach to access the tricyclic pyrrolo[2,1-a]benzazepine 
template, (R)-(+)-137, using a highly diastereoselective N-acyliminium cyclisation reaction 
upon a novel template.  We were unable to expand upon this strategy to access the tetracyclic 
template 155, which is characteristic of many Homoerythrina alkaloids, and instead observed, 
the formation of a conjugated lactam product, 157.    
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Chapter 5  
Project Three: Facile Asymmetric Construction 
of a Functionalised Dodecahydrobenz[a]indolo 
[3,2-h]quinolizine Template 
5.1 Introduction 
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Figure 23: Dodecahydrobenz[a]indolo[3,2-h]quinolizine manadomanzamine alkaloids  A 158 and B, 
159, and the target core template, 160. 
 
5.1.1 Aim 
To synthesise the functionalised dodecahydrobenz[a]indolo[3,2-h]quinolizine template, 160. 
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5.1.2 Objectives 
To apply an asymmetric N-acyliminium cyclisation strategy towards a functionalised 
dodecahydrobenz[a]indolo[3,2-h]quinolizine template, 160, which is found as the 
heterocyclic core of the manadomanzamine alkaloids. 
5.2 Literature Review 
5.2.1 Biological Activity 
In 2003, the manadomanzamine alkaloids A, 158, and B, 159, as depicted in Figure 23, were 
isolated by Hamann et al. from the Indonesian sponge Acanthostongylophora sp.93 Upon 
isolation they were subjected to biological screening studies and these alkaloids were found to 
exhibit strong activity against Mycobacterium tuberculosis (Mtb), with minimum inhibitory 
concentration values of 1.9 and 1.5 µg/mL respectively for manadomanzamines A and B.  
Furthermore, the manadomanzamine alkaloids also exhibit activities against HIV-1 and AIDS 
opportunistic infections. Consequently, there is significant interest in understanding the 
structure activity relationship associated with these manadomanzamine alkaloids for use as 
new therapeutic agents.93  
5.2.2 Asymmetric Syntheses of the Manadomanzamine Core 
To the best of our knowledge, no total synthesis of manadomanzamine A or B have yet been 
reported, and both general and asymmetric approaches to access the simpler core template, 
dodecahydrobenz[a]indolo[3,2-h]quinolizine, 160, are lacking.  Prior to the isolation from the 
natural resource, Morrison et al. prepared a racemic, dodecahydrobenz[a]indolo[3.2-
h]quinolizine, also known as an ‘inside yohimbane,’ during their work on the total synthesis 
of racemic yohimbane.94  This system was accessed by the condensation of (S)-tryptamine, 
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87, with the racemic aldehyde substrate 161 (with the trans-161 isomer predominating) to 
afford two trans epimers 162a and 162b, upon which a lithium borohydride reduction 
delivered the trans series of inside yohimbanes 163a and 163b (Scheme 58).94  
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Scheme 58: (i) H+; (ii) LAH. 
 
Allin et al. recognised that an intramolecular N-acyliminium cyclisation strategy appeared 
perfectly suited to access the manadomanzamine core.95  The template was accessed by the 
condensation of (S)-tryptophanol, 81, with racemic aldehyde, 164 (with the trans-164 isomer 
predominating), to afford two trans diastereoisomers, 165a and 165b, in a 69% yield (Scheme 
59).  The ratio of diastereoisomers in the crude reaction mixture was determined to be 1:1 by 
400 MHz 1H-NMR studies.95  
 
Page | 81  
 
N O
HN
H
H
H
O
H
N O
HN
H
H
H
O
H
OMe
ON
H
NH2
OH
(i)
OH
81
rac-164
165a 165b
1
24
10
1
24
10
 
Scheme 59: (i) Dean-Stark conditions, toluene, !, 24 h, 69%. 
 
The structural elucidation at the three contiguous chiral centres present in template 164a was 
achieved by application of a 400 MHz 1H-NMR nOe study.  Signal augmentation was 
observed for the proton at C-24 when irradiating the proton at position C-1, and vice versa. 
Irradiation of the proton at C-1 highlighted a positive signal to the proton at the tryptophanol 
stereocentre. No enhancement in signal was observed for the proton at C-10 when irradiating 
the protons at positions C-24 or C-1 (Figure 24).  The absolute stereochemistry at the three 
contiguous centres C-1, 10 and 24 matched that of the manadomanzamine natural product.95  
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Figure 24: Structural elucidation of 165a. 
 
The stereochemical elucidation of template 165b was confirmed through X-ray 
crystallography, and confirmed a trans relationship across the C-10 to C-24 ring junction, 
concluding this diastereoisomer to be an unnatural analogue of the manadomanzamine 
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alkaloids.95 With the required functionalised bicyclic lactams 165a, and 165b in hand, Allin et 
al. turned their attention to the key stereoselective N-acyliminium cyclisation step. Reaction 
of 165a, promoted by a 2 M solution of hydrochloride in ethanol at room temperature for 18 
hours, gave a clean cyclisation to afford a single product diastereoisomer, 166, which was 
obtained in a 73% yield (Scheme 60).95  
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Scheme 60: (i) 2 M HCl aq. in EtOH, 18 h, rt, 73%. 
 
Application of a 400 MHz 1H-NMR nOe study confirmed the stereochemical elucidation of 
template 166.95  No signal enhancement was observed for the proton at position C-10 when 
irradiating proton signals at positions C-1 or C-24. Irradiation of the proton at ring position C-
1 gave a positive nOe between the protons at position C-24 and one of the hydroxymethyl 
protons (Figure 25). It was concluded that the absolute stereochemistry at the three 
contiguous centres C-1, 10 and 24 matched that of the manadomanzamine natural product.95  
 
Page | 83  
 
10
1
24
N
H
NO
H
HO
H
H
H
positive nOe
interaction
positive nOe
interaction
H
 
Figure 25: Structural elucidation of the natural product diastereoisomer, 166. 
 
The clean cyclisation of 165b, promoted by 2 M solution of hydrochloric acid in ethanol at 
room temperature for 18 hours afforded a single product diastereoisomer, 167, which was 
obtained in 73% yield (Scheme 61).95  
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Scheme 61: (i) 2 M HCl aq. in EtOH, 18 h, rt, 75%. 
 
The stereochemical elucidation of template 167 was confirmed by 400 MHz 1H-NMR nOe 
studies. Irradiation of the proton at position C-1 resulted in a signal enhancement of both the 
protons at position C-10 and the hydroxymethyl group, and when irradiating the proton at 
position C-10 the proton at position C-1 showed a positive nOe.  There was no enhancement 
in signal observed between the protons at positions C-10 and C-24. Therefore, the three 
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contiguous chiral centres present in 167 did not match the manadomanzamine natural product, 
thus concluding compound 167 to be an unnatural analogue of the manadomanzamines.95  
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Figure 26: Structural elucidation of the unnatural product diastereoisomer, 167. 
 
5.3 Results & Discussion  
In collaboration with colleagues, it was recognised that an analogous N-acyliminium 
cyclisation strategy to that used to access template, 166, could allow access to the further 
functionalised pentacyclic dodecahydrobenz[a]indolo[3,2-h]quinolizine template 160.96  As 
described in chapter two, highly diastereoselective N-acyliminium cyclisations to afford 
indolic heterocycles are well established.97,98,99,100 
5.3.1 Synthesis of a Functionalised N-Acyliminium Precursor 
The required trifunctional substrate, 170, was synthesised by enolate alkylation of the 
commercially available 1,4-cyclohexanedione monoethylene acetal, 167, to deliver the 
corresponding ethyl ester, 168. Treatment of compound 168 with standard Wittig conditions 
delivered the alkene 169 in a 62% yield. An in situ hydroboration oxidative protocol 
mirroring a procedure applied to 1,4-cyclohexanedione monoethylene acetal, which has been 
Page | 85  
 
reported by Bonjoch,101 afforded us with the required key aldehyde, 170, in a 70% yield over 
two steps (Scheme 62).  Although, aldehyde 170 was afforded as an inseparable mixture of 
cis and trans isomers, the trans isomer was afforded predominately (ca. 4:1).  
 
O
O O
O
O
O O
O
O
O O
O
O
(ii) (iii), (iv)
OHO
O O
(i)
167 168 rac-170169  
Scheme 62: (i) KHMDS, ethyl bromoacetate, THF, "78 °C, 72%;  (ii) CH3PPh3Br, NaH, THF, rt, 
62%; (iii) H3BSMe2, THF; (iv) PCC, DCM, rt, 56% (over two steps). 
 
The condensation of (S)-tryptophanol, 81, with the racemic aldehyde, 170, afforded two trans 
products, 165a and 165b, in a combined 45% yield (Scheme 63). The diastereomeric ratio 
was revealed in the crude 400 MHz 1H-NMR spectrum as a 1:1 ratio.  This ratio is 
comparable to the ratio afforded during the analogous synthesis of lactams 165a and 165b.95  
The yield is only fair, but the 400 MHz 1H-NMR spectrum of the crude reaction mixture 
showed 171a and 171b to be the major products of the reaction with no evidence of any 
unreacted aldehyde substrate, 170.  
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 Scheme 63: (i) Dean-Stark conditions, toluene, !, 24 h, 45%. 
 
The relative and absolute stereochemistry of precursor 171a was confirmed by X-ray 
crystallography on a recrystallised sample (Figure 27). The stereochemistry was found to 
match the simpler analogue 165a95 and to be consistent with the stereochemistry of the 
natural isolate at the stereocentres C-1, C-10 and C-24.93  
 
 
Figure 27: X-ray structure of 171a 
 
The stereochemical elucidation of the second lactam, 171b, was determined by a 400 MHz 
1H-NMR nOe study carried out by Duffy on the equivalent template, 171b, synthesised 
utilising an alternative racemic aldehyde substrate, 172.96 This alternative racemic acid 
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aldehyde, 172, was synthesised in an analogous procedure to that described for the synthesis 
of racemic 170, however, with the substitution of ethyl bromoacetate by methyl bromoacetate 
during the alkylation step (Scheme 64).96 
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Scheme 64: (i) KHMDS, methyl bromoacetate, THF, "78 °C; (ii) CH3PPh3Br, NaH, THF, rt,  99%; 
(iii) H3B.SMe2, THF; (iv) PCC, DCM, rt, 70% (over two steps);  
(v) Dean-Stark conditions, toluene, !, 24 h, 45%. 
 
During the nOe study on compound 171b, Duffy reported the signals representative of the 
protons at positions C-1 and C-24 to show a positive enhancement towards each other, whilst 
the proton at C-1 did not show a positive nOe to the proton positioned at the tryptophanol 
stereocentre.  Duffy observed no signal augmentation of the proton at the C-10 position when 
neighbouring protons at positions C-1 and C-24 were irradiated and thus concluding structure 
171b to be consistent with the simpler unnatural analogue 165b.96  
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5.3.2 N-Acyliminium Cyclisation Reaction 
With the required functionalised bicyclic lactams 171a, and 171b in hand, we turned our 
attention to the key asymmetric N-acyliminium cyclisation reactions and subjected each 
functionalised chiral lactam precursor to conditions similar to those reported for the 
dodecahydrobenz[a]indolo[3,2-h]quinolizine templates, 165a and 165b.95  Reaction of 171a, 
promoted by 2 M solution of hydrochloric acid in ethanol at 70 °C for 72 hours, gave a clean 
cyclisation with simultaneous deprotection of the acetal protecting group, to afford a single 
product diastereoisomer, 173, in a 77% yield (Scheme 65).  Allin and Duffy achieved a 56% 
yield for the same product, 173, using 2 M solution of hydrochloric acid in ethanol at the 
lower temperature of 50 °C for 3 hours.96 The reaction conditions required for the cyclisation 
were slightly harsher than those reported by Allin et al. for the simpler unfunctionalised 
template, 166, which required room temperature for the cyclisation.95  
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Scheme 65: (i) 2 M HCl aq. in EtOH, 70 °C, 72 h, 77%. 
 
The stereochemical elucidation of template 173 was confirmed by 400 MHz 1H-NMR nOe 
studies to conclude that the stereochemistry of the three contiguous chiral centres, C-1, C-10 
and C-24, matched those of the manadomanzamine natural product.  No signal enhancement 
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was observed for proton at position C-10 when irradiated by the proton at position C-1. 
Irradiation of the proton at ring position C-1 gave a positive nOe between the proton at 
position C-24 and one of the hydroxymethyl protons, therefore the protons must be on the 
‘same face’ and with the stereochemistry of positions C-10 and C-24 known from X-ray 
crystallography, the stereochemistry of 173 was confirmed to be as depicted in Figure 28.96  
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Figure 28: Structural elucidation of the natural product diastereoisomer, 173. 
 
Reaction of the other diastereoisomer, 171b, promoted by 2 M solution of hydrochloric acid 
in ethanol at 70 °C for 72 hours, gave a clean cyclisation and simultaneous deprotection of the 
acetal protecting group to afford the single diastereoisomer product, 174, in a 70% yield 
(Scheme 66).  Duffy achieved a lower 58% yield of the same product, 173, using 2 M 
solution of hydrochloric acid in ethanol at the lower temperature of 50 °C and with reduced 
time of 18 hours.96 The reaction conditions required for the cyclisation were slightly harsher, 
with a higher temperature required, and a longer reaction time when compared to the simpler 
unfunctionalised template 167, which was cyclised at room temperature.95 
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Scheme 66: (i) 2 M HCl aq. in EtOH, 70 °C, 72 h, 70%. 
 
The stereochemical elucidation of template 174 was confirmed using 400 MHz 1H-NMR nOe 
studies, which concluded that the stereochemistry at the three contiguous chiral centres, C-1, 
C-10 and C-24, did not match the manadomanzamine natural products, concluding this 
structure to be consistent with the simpler unnatural analogue, 167.  During the study, the 
irradiation of the proton at position C-1 resulted in a signal enhancement of both the proton at 
position C-10 and the hydroxymethyl group, and when irradiating the proton at position C-10, 
we observed a positive nOe for the proton at position C-1.  There was no enhancement in 
signal between protons at positions C-10 and C-24.96  
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Figure 29: Structural elucidation of the unnatural product diastereoisomer, 174. 
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5.4 Conclusion 
In conclusion, we have met the third research objective and have developed an asymmetric 
approach to the funtionalised dodecahydroben[a]indolo[3,2-h]quinolizine template, 173, a 
heterocycle found within the core of the manadomanzamine alkaloids, which has shown 
activity against Mycobacterium tuberculosis.  We were able to achieve an asymmetric route 
towards this funtionalised dodecahydrobenz[a]indolo[3,2-h]quinolizine, 173, via the 
asymmetric building block, 171a, with stereochemical elucidation by X-ray crystallography.  
Subjecting this precursor to a highly diastereoselective N-acyliminium cyclisation, with 
control over the formation of the correct relative and absolute stereochemistries at the three 
contiguous chiral centres at positions C-1, C-10, C-24, we have delivered the target 
funtionalised dodecahydrobenz[a]indolo[3,2-h]quinolizine, 173, in a 77% yield and with the 
stereochemical outcome in line with the natural product.  The alternative unnatural analogue 
of the manadomanzamine alkaloids has also been achieved in a 70% yield through an 
equivalent cyclisation strategy upon the asymmetric building block with opposite 
stereochemistries at the three contiguous chiral centres at positions C-1, C-10, C-24.   The 
asymmetric building blocks 171a and 171b were formed as a 1:1 ratio and in a combined 
45% yield from (S)-tryptophanol, 81, and the chiral keto acid substrate 172. 
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6.1 Introduction 
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Figure 30: !-Hydrazino pyrrolo[2,1-a]isoquinoline 175 
6.1.1 Aim 
To develop a synthesis of the !-hydrazino pyrroloisoquinoline template, 175. 
6.1.2 Objectives 
To apply an asymmetric N-acyliminium cyclisation strategy towards the pyrroloisoquinoline 
template trans-25,102,103 followed by the application of an enolate amination protocol using 
azodicarboxylate functionality to afford the !-hydrazino pyrroloisoquinoline template. Both 
symmetrical and unsymmetrical electrophilic amination reagents will be applied and an 
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orthogonal deprotection strategy will be investigated to deliver the target !-hydrazino 
pyrrolo[2,1-a]isoquinoline template 175.  
6.2 Literature Review 
In nature peptide interactions modulate diverse and specific biological processes such as 
signal transduction, enzymatic specification and immunomodulation. These characteristic 
interactions are controlled by molecular recognition, highlighting the importance of the spatial 
orientation of the interacting amino acids, which make up the peptide chain. Peptides are 
promising pharmaceutical leads, but natural peptides can suffer from rapid metabolism, poor 
bioavailability, and short duration of action, limiting their therapeutic application.  Current 
research endeavours to improve the pharmacological properties of many natural peptides by 
the modification of the amino acid constituents to enhance activity and metabolic stability.104 
 
An important secondary structural feature found within peptide chains is the #-turn motif. #-
Turn motifs consists of four amino acids, which act to reverse the direction of peptide chains 
and function as loci for receptor binding, antibody recognition and post translational 
modifications.104  
 
Polycyclic lactams are useful templates for the introduction of reverse-turn motifs, including 
#-turn activity, especially in the study of conformationally restricted peptide analogues.  
Polycyclic lactam formation is a method for constraining the torsion angles for the synthesis 
of peptidomimetics.  The insertion of lactam functionality has been proposed for dipeptide 
mimetic replacements, particularly for the i + 1 and i + 2 residues of #-turns. Type I and type 
II’ #-turns are among the most important reverse-turns and are defined by the % and & torsion 
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angles of the i + 1 and i + 2 residues occupying the turn region.  A hydrogen bond between 
the carbonyl of residue i and the amide hydrogen of residue i + 3 is commonly an indication 
of the existence of a #-turn, although not an essential characteristic (Figure 31).104  
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Figure 31: Schematic representation of a #-turn. 
 
Pyrroloisoquinoline-based peptidomimetics are of increasing interest to bioorganic chemists 
with literature syntheses having been reported by Meldal105 and O’Donnell.106 More recently, 
Silvani et al. prepared pyrroloisoquinoline-based analogues such as template 176 (Figure 32), 
and have reported that these compounds exhibit type II’ #-turn activity.107  These approaches 
to pyrroloisoquinoline containing peptidomimetics have involved the application of Pictet-
Spengler chemistry to construct the heterocyclic core with the required amino acid residues in 
place courtesy of the corresponding !-amino acid substrate employed in the cyclisation.  
Application of an N-acyliminium cyclisation approach to construct the heterocyclic core 
followed by enolate amination would represent a novel approach to access these templates. 
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Figure 32: Pyrroloisoquinoline-based peptide analogue 176. 
 
To structurally modify the peptide by the replacement of an !-amino acid residue with a !-
hydrazino acid is of interest because several synthetic hydrazinopeptides have shown turn-
mimetic activity.108  Furthermore, the hydrazine moiety has exhibited biological activity to 
include the inhibition of a variety of enzymes.109   Also, the hydrazine moiety offers 
additional opportunities for structural modifications at either of the hydrazine N-atoms and 
offers potential for the formation of novel hydrogen-bonded organisation in secondary protein 
structures.  
6.3 Results & Discussion 
6.3.1 Synthesis of the Pyrroloisoquinoline Template 
The synthesis of the !-hydrazino pyrrolo[2,1-a]isoquinoline template, 175, depicted in Figure 
30, required the construction of the pyrroloisoquinoline template, trans-25, using the 
established N-acyliminium cyclisation strategy reported by Allin et al.102 103  This trans-25 
template was prepared through an imide intermediate, 27, synthesised by the 
cyclocondensation of (S)-phenylalaninol, 59, with succinic anhydride 18.102 103  (S)-
Phenylalaninol, 59, was prepared in an 85% yield using the methodology of Giannis and 
Sandhoff for the reduction of the amino acid, (S)-phenylalanine with lithium borohydride in 
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the presence of trimethylsilylchloride in anhydrous tetrahydrofuran for 24 hours (Scheme 
67).110  
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Scheme 67: (i) LiBH4, TMSCl, THF, 24 h, 85%. 
 
(S)-Phenylalaninol, 59, and succinic anhydride, 18, were subjected to condensation under 
Dean-Stark conditions to afford the intermediate imide, 26, in a 62% yield. Subjecting imide, 
26, to a reduction-cyclisation cascade in an ethanolic solution sodium borohydride (10 
equivalents), followed by 2 M solution of hydrochloric acid in ethanol afforded the 
ethoxylactam which, without purification and isolation, was treated to a titanium tetrachloride 
induced cyclisation to afford the product, trans-25, as a single diastereoisomer and in a 52% 
yield.  The stereochemistry was confirmed by comparison with published spectroscopic 
data.102 103 The pyrroloisoquinoline template, trans-25, was converted to the corresponding 
silyl ether, 177, in a near quantitative yield (Scheme 68).111  
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Scheme 68: (i) Dean-Stark conditions, toluene, !, 48 h, 62%; (ii) NaBH4, EtOH; (ii) 2M HCl aq. in 
EtOH, 20 h, (52% over two steps); (iii) TiCl4, DCM, "10 °C, 52%; (iv) DMAP, imidazole, 
TBDMSCl, DCM, rt, 20 h, 98%. 
 
6.3.2 Application of a Symmetrical Aminating Reagent 
The application of a symmetrical aminating reagent to afford the !-hydrazino pyrrolo[2,1-
a]isoquinoline template, 179, was achieved in collaboration with a colleague by a highly 
diastereoselective enolate amination.111  Treatment of the silyl ether, 177, with LDA in 
anhydrous tetrahydrofuran at low temperature, followed by the addition of the electrophilic 
aminating reagent, di-tert-butyl azodicarboxylate, afforded the target !-hydrazino product, 
178, in a pleasing 85% yield (Scheme 69). The diastereomeric ratio was confirmed as 15:1 
mixture by analysis of the crude 400 MHz 1H-NMR spectrum. Owing to significant 
broadening of the 400 MHz 1H-NMR signals at ambient temperature in deuterated 
chloroform, the spectrum of compound 178 was obtained in deuterated-DMSO at 100 °C.111  
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Scheme 69: (i) LDA, "78 °C, THF, 15 mins; (ii) DBAD, "78 °C to rt, 20 h, 85%. 
 
The stereochemical elucidation of template 178 was carried out in collaboration with Gaskell, 
using a 400 MHz 1H-NMR nOe study to determine a cis relationship with respect to the 
newly added hydrazine substitutent at position C-2 and the tert-butyldimethylsilyl (TBS) 
protected hydroxymethyl at position C-5. The stereochemistry at position C-5 is 
unambiguous, relating to the original enantiomerically pure (S)-amino alcohol substrate.  
Irradiation of the proton at position C-10b resulted in a signal enhancement of the axial #-
proton, together with the positive interaction of its equatorial partner with the !-position 
proton at position C-2.  Furthermore, signal enhancement was observed for the proton at 
position C-2 when irradiating the proton at position C-5 (Figure 33).111 The relative 
stereochemistry displayed by our compound, 178, is comparable to that displayed by Silvani’s 
pyrroloisoquinoline #-turn lead template 176 for the three chiral centres.107  
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Figure 33: Structural elucidation of compound 178 
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The removal of the TBS-protection from compound 178 was achieved using tetra-n-
butylammonium fluoride to afford the primary alcohol, 179, in a 45% yield.  Subsequent 
removal of both Boc-protecting groups was then achieved by treating the alcohol, 179, with 
50 equivalents of TFA at room temperature for 24 hours.  After this time, the novel !-
hydrazino pyrroloisoquinoline template, 175, was afforded in a 70% yield (Scheme 70).  
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Scheme 70: (i) TBAF, THF, rt, 5 mins, 45%; (ii) TFA, rt, 24 h, 70%. 
 
6.3.3 Application of an Unsymmetrical Aminating Reagent  
The use of di-tert-butyl azodicarboxylate as the electrophilic aminating reagent suffers from 
the disadvantage of having the same protecting groups on both of the hydrazine nitrogen 
atoms in the resulting aminated product 178.  It would be of significant advantage, and 
provide added flexibility, if a suitable aminating reagent containing orthogonal protecting 
groups could be used.   Orthogonal protection would allow for selective deprotection of each 
nitrogen atom of the !-hydrazine substituent in turn, and so offering the potential for complex 
target structures through derivatisation at either N-centre of the !-hydrazino group.  
 
Jørgensen et al. reported the use of a suitably differentiated azodicarboxylate reagent, 182, in 
the synthesis of aminated 2-naphthols,112 and we were interested to see how this reagent 
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would perform in our own work. The azodicarboxylate reagent, 182, was prepared by 
adapting the methodology of MacKay et al. for their synthesis of methyl ethyl 
azodicarboxylate113 by substituting methyl chloroformate for benzyl chloroformate, 181, and 
ethyl hydrazine for tert-butyl carbazate, 180.  We were able to generate our target 
azodicarboxylate reagent, 182, in a 20% yield (Scheme 71).111 
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Scheme 71: (i) DCM, "78 °C, 24 h, 98%; (ii) NBS, Pyridine, DCM, rt, 0.5 h, 20%. 
 
Enolate amination was achieved through the treatment of 177 with lithium diisopropylamide 
in anhydrous tetrahydrofuran at low temperature.  Treatment of the resulting lithium enolate 
with the unsymmetrical electrophilic aminating reagent, 182, delivered the target !-hydrazino 
product, 183 (Scheme 72).111 
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Scheme 72: (i) LDA, 182, THF, "78 °C to rt, 20 h, 41%. 
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The target !-hydrazino product, 183, was formed as the main product of the reaction and was 
isolated in a 41% yield following flash column chromatography. Owing to significant 
broadening of the 400 MHz 1H-NMR signals at ambient temperature, the spectra of 
compound 183 were obtained in deuterated-DMSO at 100 oC.  Other unidentifiable by-
products were observed by TLC analysis and also observed in the 400 MHz 1H-NMR 
spectrum of the crude reaction mixture.  However, we were unable to isolate and characterise 
these by-products.  As a result we are unable to comment confidently at this stage on the 
diastereoselectivity of the amination step, or on the overall regioselectivity when using 
reagent 182 in this enolate amination reaction.   The relative stereochemistry of template 183 
was confirmed by 400 MHz 1H-NMR nOe studies, where we observed a cis relationship with 
respect to the newly added hydrazino substitutent at position C-2 and the TBS-protected 
hydroxymethyl at position C-5. The stereochemistry at position C-5 is unambiguous, relating 
to the original enantiomerically pure (S)-amino alcohol substrate. The protons at positions C-5 
and C-10b did not show a positive nOe effect towards each other, suggesting a trans 
relationship between them.  Also, no signal enhancement was observed between the protons 
at positions C-2 and C-10b (Figure 34). The relative stereochemistry displayed by compound 
183 for the three chiral centres, is comparable to the stereochemistry displayed by our 
symmetrical amination product, 178, and also Silvani’s pyrroloisoquinoline #-turn lead 
176.107  
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Figure 34: Structural elucidation of compound 183 
 
With the unsymmetrical amination product, 183, in hand, we found that we were readily able 
to remove the protecting groups in an orthogonal fashion.  Following the method reported by 
Jørgensen,112 the Cbz-group was selectively removed from the secondary amine moiety by a 
catalytic hydrogenation approach to yield the mono Boc-protected pyrroloisoquinoline, 184, 
and this was achieved in an 88% yield.  This product also provided information on the 
regiochemistry of the amination itself.  From the 400 MHz 1H-NMR spectrum of compound 
184 we identified a new broad singlet peak at 4.3 ppm (integrating accurately for 1 H) and 
also, a 1 H signal (NH) for the existing t-butyl carbamate functionality at 6.4 ppm.  This is 
evidence that the Cbz protection in compound 184 is situated on the !-N-atom and not the 
alternative "-position.  If the Cbz-group were located at the "-position then the new amine 
peak would be expected to integrate to 2.  There would also be an absence of the additional 
NH signal at 6.4 ppm. It was notable that removal of the Cbz-group resulted in simplification 
of the 400 MHz 1H-NMR analyses because the spectra for compound 184 could be obtained 
in deuterated chloroform at ambient temperatures.  From compound 184 we were able to 
remove the TBS-protecting group using TBAF to generate the primary alcohol, 185, in a 45% 
yield.  Subsequent removal of the Boc-protecting group was achieved by treating the alcohol, 
185, with 20 equivalents of TFA at room temperature for 24 hours.  The resulting novel !-
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hydrazino pyrroloisoquinoline template, 175, was afforded in a 55% yield (Scheme 73). 
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Scheme 73: (i) NH4
+HCO2
-, Pd/C, MeOH, 2 h, 88%; (ii) TBAF,  
THF, rt, 5 mins, 48%; (iii) TFA, 24 h, 55%. 
 
6.4 Conclusion 
In conclusion, we have met the research objectives, having stereoselectively constructed the 
!-hydrazino pyrroloisoquinoline template by building on the pyrroloisoquinoline template 
trans-25, and applying an enolate amination using azodicarboxylate functionality.  We have 
applied both symmetrical and unsymmetrical electrophilic aminating reagents to afford the 
symmetrical, 178, and unsymmetrical, 183, aminated products.  We have employed an 
orthogonal deprotection strategy upon the aminated intermediates to afford the target 
functionalised pyrroloisoquinoline ring system, 175.  
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Chapter 7  
Findings and Implications 
7.1 Research Summary 
This EngD research thesis describes the application of N-acyliminium ion cyclisation 
strategies and functional group manipulations to access the following heterocycles with 
potential for biological activity: 
1. The anti-tumour pyrroloisoquinoline alkaloid (R)-(+)-crispine A. 
2. The pyrrolo[2,1-a]benzazepine template, a sub-unit of the Homoerythrina alkaloids. 
3. The functionalised pentacyclic dodecahydrogen[a]indolo[3,2-h]quinolizine template, a 
sub-unit of the manadomanzamine alkaloids. 
4. The !-hydrazino pyrroloisoquinoline template, a potential polycyclic lactam scaffold 
for peptidomimetics. 
7.1.1 The Anti-Tumour Pyrroloisoquinoline Alkaloid (R)-(+)-Crispine A 
In chapter two we explored N-acyliminium prompted cyclisation strategies which have been 
reported within the literature to access pyrroloisoquinoline templates.  In chapter three we 
recognised an opportunity to further manipulate the functionality installed within the 
pyrroloisoquinoline template, trans-35, to transform it into the anti-tumour alkaloid (R)-(+)-
crispine A, 127.  Having achieved a synthesis of the pyrroloisoquinoline template, trans-35, 
using established N-acyliminium induced cyclisation methodology, we then oxidised the 
pendent hydroxymethyl auxiliary group to an aldehyde and applied a rhodium-induced 
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decarbonylation strategy for the removal of this pendant group.  Finally, a lithium aluminium 
hydride reduction of the lactam carbonyl was applied to afford the target alkaloid (R)-(+)-
crispine A, in an overall 24% yield with greater than 95% ee.  Our strategy represents a novel, 
efficient and highly stereoselective approach to this anti-tumour alkaloid, and is achievable in 
only four synthetic steps from the readily available and enantiomerically pure imide starting 
material, 37 (Scheme 74).  
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Scheme 74: (i) NaBH4, EtOH, 2M HCl aq. in EtOH, 0 °C to rt, 20 h, 91%;  
(ii) IBX, EtOAc, !, 4 h, 98%; (iii) Rh(PPh3)2(CO)Cl, dppp, xylene, !, 240 h, 46%; (iv) LAH, THF,  
20 h,  58%. 
 
7.1.2 The Pyrrolo[2,1-a]benzazepine Template, the Core of the 
Homoerythrina Alkaloids. 
In chapter two we explored a number of syntheses that utilise N-acyliminium cyclisation 
strategies to access the Erythrina alkaloids, and as described in chapter four, we then 
recognised an opportunity to investigate whether an N-acyliminium cyclisation could be used 
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as an approach to access the related pyrrolo[2,1-a]benzazepine template, which is the core of 
the Homoerythrina alkaloids. We were able to achieve an asymmetric route towards the 
pyrrolo[2,1-a]benzazepine template, 137, through an enantiomerically pure novel imide 
substrate, 150.  Subjecting the imide, 150, to a highly diastereoselective reduction N-
acyliminium cyclisation cascade delivered the target bicyclic lactam, 151.  The proceeding N-
acyliminium cyclisation step required a low temperature of "96 °C.  This difficult cyclisation 
is not unexpected given that we were attempting to generate a seven membered ring.  To 
demonstrate the synthetic utility of this template, the same rhodium-induced decarbonylation 
strategy used to remove the pendant hydroxymethyl group in our approach to (R)-(+)-crispine 
A was applied to successfully afford the target pyrrolo[2,1-a]benzazepine template, 137 
(Scheme 75). 
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Scheme 75: (i) Toluene, Et3N, !, 18 h, 60%; (ii) NaBH4, EtOH, 2 M HCl aq. in EtOH, 0 °C,  
3 h; (iii) 2 M HCl aq. in EtOH, 20 h, 57% (over two steps); (iv) TiCl4 (1.5 eq), DCM, "96 °C, 97%; 
(v) IBX, EtOAc, !, 24 h, 53%; or DMP, DCM, rt, 2 h, 60%; (vi) Rh(PPh3)2(CO)Cl (5 mol.%), dppp 
(20 mol.%), xylene, !, 240 h, 57%. 
 
The structure of the Homoerythrina alkaloids is most commonly characterised by a tetracyclic 
template, and we attempted to access this tetracyclic template, 155, through a tricyclic lactam, 
156, as an N-acyliminium precursor.  Application of Lewis and protic acid conditions failed 
to induce the cyclisation.  Notably, when treated with protic acid the N-acyliminium ion was 
generated in situ, however, rather than a cyclisation a series of proton losses and 
corresponding double bond migrations led, through the enamide, to the resulting conjugated 
lactam product, 157 (Scheme 76). 
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Scheme 76: (i) Dean-Stark conditions, toluene, Et3N, !, 48 h, 55%;  
 (ii) 2 M HCl aq. in EtOH, rt, 18 h, 80%; (iii) Lewis Acid, DCM. 
 
7.1.3 The Pentacyclic Dodecahydrobenz[a]indolo[3,2-h]quinolizine 
Template: the Core of the Manadomanzamine Alkaloids. 
In chapter two we explored a number of syntheses whereby N-acyliminium cyclisation 
strategies have been successfully employed to access target indolizinoindole templates.  In 
chapter five we recognised the opportunity to apply a related intramolecular strategy to 
approach the funtionalised dodecahydrobenz[a]indolo[3,2-h]quinolizine template, 173, which 
is found within the core of the manadomanzamine alkaloids.  We were able to achieve the 
synthesis of a funtionalised dodecahydrobenz[a]indolo[3,2-h]quinolizine template, 173, 
through an N-acyliminium mediated cyclisation of the asymmetric building block 171a.   The 
subsequent protic acid mediated cyclisation induced the correct relative and absolute 
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stereochemistries at the three contiguous chiral centres at positions C-1, C-10, C-24, to 
deliver the target functionalised dodecahydrobenz[a]indolo[3,2-h]quinolizine template, 173, 
in a 77% yield and with the stereochemical outcome in line with the natural product isolate. 
An unnatural analogue 174, was also prepared through an equivalent cyclisation strategy upon 
the alternative asymmetric building block, 171b, afforded in combination with building block 
171a, in a 1:1 ratio in a combined 45% yield from the condensation of (S)-tryptophan, 81, 
with the chiral keto acid substrate, 172 (Scheme 77).  
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Scheme 77: (i) Dean-Stark conditions, toluene, !, 24 h, 45%;  
(ii) 2 M HCl aq. in EtOH, 70 °C, 72 h, 173 (77%)/ 174 (70%). 
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7.1.4 The !-Hydrazino Pyrroloisoquinoline Template as Potential 
Polycyclic Lactam Scaffold for Peptidomimetics. 
An opportunity was identified to utilise the pyrroloisoquinoline template, trans-25, to design 
peptidomimetic compounds.  In chapter six we have designed a novel approach to access 
aminated pyrroloisoquinoline systems based on an established stereoselective N-acyliminium 
mediated cyclisation reaction to construct the heterocyclic template, trans-25, followed by an 
enolate amination protocol upon the lactam ring using azodicarboxylate based amination 
agents.  We have achieved both symmetrical, 178, and unsymmetrical, 183, electrophilic 
amination products.  Furthermore, we were able to employ an orthogonal deprotection 
strategy upon the aminated intermediates to deliver the pyrroloisoquinoline target, 175 
(Scheme 78). 
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Scheme 78: (i) NaBH4, EtOH; 2M HCl aq. EtOH, 20 h, 52% (over two steps); TiCl4, DCM, 
 "10 °C, 52%; (ii) DMAP, imidazole, TBDMSCl, DCM, rt, 20 h, 98%. (iii) LDA, "78 oC, THF, 15 
mins; DBAD, "78 oC to rt, 20 h, 85%; (iv) TBAF, THF, rt, 5 mins, 45%;  
(v) TFA, rt, 24 h, 70%; (vi) LDA, 182, THF, "78 °C to rt, 20 h, 41%; (vii) (i) NH4
+HCO2
-, Pd/C, 
MeOH, 2h, 88%; (viii) TBAF, THF, rt, 5 mins, 48%; (ix) TFA, 24 h, 55%. 
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7.2 Meeting the Research Objectives 
The aim of this research was to apply N-acyliminium cyclisation strategies to access a range 
of heterocycles with potential biological activity.  This was met by the achievement of four 
projects, which formed the research objectives:  
Objective One 
Objective one to apply an asymmetric N-acyliminium cyclisation methodology towards the 
pyrroloisoquinoline alkaloid (R)-(+)-crispine A has been achieved.  
Objective Two: 
Objective two to apply an asymmetric N-acyliminium cyclisation strategy towards the 
tricyclic pyrrolo[2,1-a]benzazepine template, a sub-unit of the Homoerythrina alkaloids, has 
been achieved. 
Objective Three: 
Objective three to apply an asymmetric N-acyliminium cyclisation strategy towards a 
functionalised dodecahydrobenz[a]indolo[3,2-h]quinolizine template, the heterocyclic core of 
the manadomanzamine alkaloids, has been achieved. 
Objective Four: 
Objective four to apply an asymmetric N-acyliminium cyclisation strategy towards the 
pyrroloisoquinoline template, followed by application of an enolate amination protocol using 
azodicarboxylate functionality to afford a !-hydrazino pyrroloisoquinoline target has been 
achieved. Both symmetrical and unsymmetrical electrophilic amination reagents have been 
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employed and an orthogonal deprotection strategy upon the aminated intermediates has been 
applied.  
7.3  Innovative and Original Contribution  
7.3.1  Asymmetric Synthesis of the Anti-Tumour Alkaloid (R)-(+)-Crispine 
A 
We have manipulated the functionality installed within the established template, trans-35, to 
transform this template into the anti-tumour alkaloid (R)-(+)-crispine A, 127, and with greater 
than 95% enantiomeric excess. Our strategy represents a novel, efficient and highly 
stereoselective approach to this anti-tumour alkaloid in only four synthetic steps from the 
readily available and enantiomerically pure imide substrate, 37 (Scheme 79). This work 
involves the application of a rhodium induced decarbonylation strategy upon an aldehyde 
substrate and increasing the reaction time from the previous literature protocols to 240 hours 
allows a direct approach to the target in a 46% yield, and without the formation of an enamide 
by-product as seen in previous studies.  This synthesis represents only the second 
enantioselective route reported for this alkaloid, and the first involving a highly 
diastereoselective N-acyliminium cyclisation strategy as the key ring forming step. The 
Journal of Organic Chemistry published this work in November 2007. 
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Scheme 79: (i) NaBH4, EtOH, 2M HCl aq. in EtOH, 0 °C to rt, 20 h, 91%; (ii) IBX, EtOAc, !, 4 h, 
98%; (iii) Rh(PPh3)2(CO)Cl, dppp, xylene, !, 240 h, 46%; (iv) LAH, THF, 20 h, 58%. 
 
7.3.2 Asymmetric Synthesis of the Pyrrolo[2,1-a]Benzazepine Ring System 
A new and facile synthesis of the pyrrolo[2,1-a]benzazepine template, (R)-137, the tricyclic 
core of the Homoerythrina alkaloids, has been achieved. The synthesis required a low 
temperature asymmetric N-acyliminium cyclisation strategy applied to a novel chiral lactam 
template, 151. We suggest that the lower temperature of "96 °C, rather than the typical "78 
°C as applied in many reported strategies reviewed in chapter two and strategies reported by 
us for the formation of heterocyclic templates in chapters three and six, acts to promote the 
formation of the kinetic product, 153, by slowing the reversible formation of the chiral lactam 
template, 151, which we suggest is the thermodynamic product.  Further manipulation of the 
template using our 240 hour decarbonylation strategy resulted in the direct formation of the 
target pyrrolo[2,1-a]benzazepine template, (R)-137   (Scheme 80).  This work has been 
accepted for publication in Synthetic Communications.  
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Scheme 80: (i) Dean-Stark conditions, toluene, Et3N, !, 18 h, 60%; (ii) NaBH4, EtOH, 2 M HCl aq. in 
EtOH, 0 °C, 3 h; (iii) 2 M HCl aq. in EtOH, 20 h, 57% (over two steps); (iv) TiCl4 (1.5 eq), DCM, "96 
°C, 97%; (v) IBX, EtOAc, !, 24 h, 53% or DMP, DCM, rt, 2 h, 60%; (vi) Rh(PPh3)2(CO)Cl (5 
mol.%), dppp (20 mol.%), xylene, !,  240 h, 57%. 
 
7.3.3 An Attempt to Access the Homoerythrina Tetracyclic Template 
An attempt was made towards the construction of the Homoerythrina tetracyclic template 
through an analogous low temperature procedure to that applied to access the pyrrolo[2,1-
a]benzazepine template, but without success.  On formation of the N-acyliminium 
intermediate through the application of protic acid conditions, a series of proton losses and 
corresponding double bond migrations through an enamide intermediate afforded the novel 
conjugated lactam product, 157, the structure of which was confirmed by X-ray 
crystallography (Scheme 81). 
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Scheme 81: Proposed formation of the conjugated lactam, 157. 
 
7.3.4 Asymmetric Synthesis Towards the Core of the Manadomanzamine 
Alkaloids 
Access to the funtionalised dodecahydrobenz[a]indolo[3,2-h]quinolizine template, 173, found 
within the core of the manadomanzamine alkaloids, required the N-acyliminium precursor 
171a.  The relative and absolute stereochemistry of 171a, was confirmed by X-ray 
crystallography on a recrystallised sample. The stereochemistry was found to match the 
natural product at centres C-1, C-10 and C-24.  We achieved an N-acyliminium promoted 
cyclisation with simultaneous deprotection of the acetal protecting group by subjecting the 
precursor 171a to protic acid conditions at 70 °C for 72 hours to afford the target 
funtionalised dodecahydrobenz[a]indolo[3,2-h]quinolizine template, 173, as a single product 
diastereoisomer in a 77% yield (Scheme 82). This work was published in Tetrahedron in 
November 2009. 
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Scheme 82: (i) 2 M HCl aq. in EtOH, 70 °C, 72 h, 77%. 
 
7.3.5  Access to Peptidomimetic Building Blocks 
We have manipulated the functionality installed within the template trans-25, to transform 
this template into an aminated pyrroloisoquinoline target with desired !-amino amide 
functionality as an approach towards peptidomimetics. We have applied both symmetrical and 
novel unsymmetrical electrophilic amination protocols based on azodicarboxylate reagents, 
and have demonstrated orthogonal deprotection of our intermediates to yield a novel !-
hydrazino pyrroloisoquinoline target, 175 (Scheme 83). This work has been published by 
Tetrahedron in 2010. 
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Scheme 83: (i) LDA, "78 °C, THF, 15 mins; DBAD, "78 °C to rt, 20 h, 85% (ii) TBAF, THF, rt, 5 
mins, 45%; (iii) TFA, rt, 24 h, 70%; (iv) LDA, CbzN=NBoc (182),  
THF, "78 °C to rt, 20 h, 41%; (v) NH4
+HCO2
-, Pd/C, MeOH, 2 h, 88%; 
(vi) TBAF, THF, rt, 5 mins, 48%; (vii) TFA, 24 h, 55%. 
 
7.4  Implications and Future Work 
Over recent years the application of asymmetric N-acyliminium cyclisation strategies have 
synthetically delivered a wide range of important heterocyclic compounds, many of which are 
inspired by nature. This research has delivered biologically active heterocyclic templates of 
potential interest to the agrochemical, pharmaceutical and biotechnology industries.  Often we 
require a more sustainable source of natural products if they are to be of use to us, and so the 
development of synthetic routes to such targets and their analogues is of great interest. In 
addition, the methodology employed within this thesis to deliver these biologically active 
heterocycles also offers potential for applications beyond the scope of this research.   
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7.4.1  The Anti-Tumour Pyrroloisoquinoline Alkaloid R- (+)- Crispine A 
Our four-step asymmetric approach to the naturally occurring anti-tumour alkaloid (R)-(+)-
crispine A offers a more sustainable source of this alkaloid without detrimental impact upon 
the natural resource Carduus crispus Linn, the wilted thistle.  This thistle occurs naturally in 
parts of Asia and Europe, and by exploiting the natural resource not only would it be 
detrimental to the thistle itself, but to the larger ecosystem to which the thistle belongs.   A 
worthwhile opportunity for further research would be to target analogues of crispine A using 
N-acyliminium cyclisation strategies to investigate further therapeutic applications.  
7.4.2  The Pyrrolo[2,1-a]benzazepine template 
Biological screening of Homoerythrina alkaloids sourced from nature have shown interesting 
biological activity. The Homoerythrina alkaloid dyshomoerythrine is isolated from the New 
Zealand silver pine and has shown insecticidal activity, which is of significant interest to the 
agrochemical sector.  The pyrrolo[2,1-a]benzazepine sub-unit of the Homoerythrina acts as a 
simpler template upon which to apply biological screening studies or to further manipulate the 
functionality to achieve further synthetic templates.  An attempt made during this research 
failed to deliver the tetracyclic core of the Homoerythrina alkaloids and subsequently further 
research is necessary to achieve this target.  The introduction of more electron donating 
substitution patterns, i.e. the introduction of methoxy groups upon the pendant aromatic 
substituent, may enhance the nucleophilic nature of this substituent to encourage it to 
participate in nucleophilic attack upon the N-acyliminium intermediate generated in situ, and 
thus offering a more favourable alternative than the formation of the conjugated lactam that 
we have observed during our work.  The methoxy substitution could be installed through 
application of the appropriately substituted amino alcohol. 
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7.4.3  Functionalised Dodecahydrobenz[a]indolo[3,2-h]quinolizine 
An N-acyliminium cyclisation strategy has enabled access to the functionalised pentacyclic 
dodecahydrobenz[a]indolo[3,2-h]quinolizine template, 173.  This template is found as the 
sub-unit of the manadomanzamine alkaloids, which are therapeutically valuable owing to the 
anti-tuberculosis activity exhibited by these alkaloids during biological screening studies.  A 
worthwhile opportunity for further research would be to biologically screen our simpler core 
system, 173, and the unnatural analogue, 174. The functionalised template, 173, presents a 
‘synthetic handle’ upon which further manipulation may be applied towards achieving a first 
synthetic approach to access the manadomanzamine alkaloids. 
7.4.4 The !-Hydrazino Pyrroloisoquinoline 
The !-hydrazino pyrroloisoquinoline template represents a potential polycyclic lactam 
scaffold for introducing reverse-turn motifs in the study of conformationally restricted 
synthetic peptide analogues.  Reverse turns play a significant role in biological recognition, 
which makes them worthwhile targets of interest to the pharmaceutical, biotechnology and 
agrochemical industries.   Furthermore, the formation of hydrazinopeptides in which the !-
amino acid residue is replaced by the !-hydrazino acid is of significant importance in 
potentially ‘fooling’ nature, since the presence of the hydrazino modification in a peptide 
chain could allow a peptide to withstand certain enzymatic cleavages, which could otherwise 
occur.  In addition, the hydrazine moiety allows further structural modification, i.e. at either 
hydrazino N-atom.  Specifically the use of an unsymmetrical electrophilic aminating reagent 
allows for orthogonal deprotection and derivatisation.  Synthetic hydrazinopeptides have been 
shown to display turn-mimetic activity and wide ranging biological activities.  Further 
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research could couple additional amino acids upon the !-hydrazino pyrroloisoquinoline ring 
system to incorporate novel templates into peptide structures. 
7.5 Overview 
Many naturally derived compounds have been shown to exhibit biological activity, and often 
we require a more sustainable source of these natural products if they are to be of use to us as 
researchers.  The development of synthetic routes to such targets is of great interest and over 
recent years the application of asymmetric N-acyliminium cyclisation strategies have 
delivered a wide range of naturally inspired important biologically active heterocycles. This 
research has delivered biologically interesting heterocyclic templates or their simpler 
analogues as potential targets of interest to the agrochemical, biotechnology and 
pharmaceutical sectors. Even if the heterocycles accessed within the scope of this research are 
not further explored, then the methodologies described herein, be it the various novel 
intramolecular N-acyliminium strategies applied or the functional group manipulations 
employed, present novel contributions to the wider synthetic organic research field, both 
industrially and academically. 
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A.1. General Information 
All reactions described were carried out using commercial dry solvents, with the exceptions 
of light petroleum, ethyl acetate (distilled over calcium chloride or calcium sulfate) and 
dichloromethane (distilled over calcium hydride).  Light petroleum refers to fractions distilled 
between boiling points 40!60 °C.  Sodium hydride was obtained as 60% dispersion in mineral 
oil and subsequently isolated by washing with hexane.  2 M solution of hydrochloric acid in 
ethanol was made using 33 mL of a 6 M hydrochloric acid standard solution made up to 100 
mL with ethanol. Melting points were determined using a Stuart Scientific SMP3 melting 
point apparatus.  All infrared spectra were obtained from a Perkin Elmer Paragon 1000 FT-IR 
spectrophotometer on sodium chloride plates. Rotation values were measured with an Optical 
Activity-Polar 2001 instrument operating at " = 589 nm, corresponding to the sodium D line, 
at the temperatures indicated.  All 400 MHz 
1
H-NMR and 100 MHz 
13
C-NMR spectra were 
collected on a Bruker DPX-400 spectrometer.  Unless otherwise stated, all NMR samples 
were prepared as solutions in CDCl3 with tetramethylsilane as the internal standard for 400 
MHz 
1
H-NMR spectra and CDCl3 the standard for 100 MHz 
13
C-NMR spectra.  Chemical 
shifts are quoted in parts per million (ppm) and the J values in hertz (Hz). Mass spectra were 
recorded using a Jeol-SX102 instrument utilising electron-impact (EI) or fast atom 
bombardment (FAB) or by the National Mass Spectrometry Service Centre at the University 
of Swansea utilising electrospray (ES). All chromatographic manipulations used silica gel as 
the adsorbent. Reactions were monitored using TLC on aluminium-backed plates coated with 
Merck Kieselgel 60 F254 silica gel. TLC plates were visualised by UV radiation at a 
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wavelength of 254 nm, or stained by exposure to an ethanolic solution of phosphomolybdic 
acid (acidified with concentrated sulfuric acid), followed by charring where appropriate. 
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A.2. Chapter Three: Asymmetric Synthesis of the Anti-Tumour 
Alkaloid R-(+)-Crispine A 
(S)-2-Amino-3-(3,4-dimethoxyphenyl)-propan-1-ol 39
114
 
 
MeO
MeO
NH2
OH
 
 
Chlorotrimethylsilane (2.08 ml, 16.4 mmol) was added drop wise to a solution of lithium 
borohydride (0.18g, 8.2mmol) in anhydrous tetrahydrofuran (20 mL) under a nitrogen 
atmosphere. (S)-2-Amino-3-(3,4-dimethoxyphenyl)propanoic acid (0.92 g, 4.1 mmol) was 
added in portions and the mixture was allowed to stir for 24 h.  After this time methanol was 
cautiously added, and the volatiles removed under reduced pressure to afford a colourless 
residue, which was further treated with 20% potassium hydroxide solution (20 mL) and 
extracted into dichloromethane (3 ! 50 mL).  The organic fractions were combined, dried 
over anhydrous magnesium sulfate, filtered and the solvent was removed under reduced 
pressure to yield the target compound as a colourless solid (0.52g, 78%): mp 81"82 ˚C; Lit: 
Mp 78"79 ˚C
115
; [#]
20 
D = –21.0 [c = 1.0, EtOH]; Lit: [#]
20 
D = –21.5 [c = 0.8, EtOH];
115
 $max 
(thin film, DCM)/cm
-1
 3407; %H (400 MHz, CDCl3) 1.75 (2 H, s, NH2), 2.45"2.49 (1 H, m, 
ArCH(H)CHN), 2.72"2.76 (1 H, m, ArCH(H)CHN), 3.12"3.20 (1 H, m, ArCH2CHN), 3.39 
(1 H, dd, J 6.8, 10.4 Hz, CHNC(H)HOH), 3.64 (1 H, dd, J 4.0, 10.4 Hz, CHNCH(H)OH), 
3.86 (3H, s, OCH3), 3.88 (3H, s, OCH3), 6.72"6.83 (3H, m, ArH); %C (100 MHz; CDCl3) 40.5 
(CH2), 54.2 (CH), 55.8 (CH), 55.9 (CH), 66.4 (CH2), 111.3 (C), 112.3 (CH), 121.2 (CH), 
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131.1 (C), 149.0 (C), 149.0 (C); MS (EI) m/z 211 (MH
+
, 100.0%). Calcd. for C11H18NO3: 
212.1281 (MH)
+
; found: 212.1282. 
 
1-(2S)-[2-(3,4-Dimethoxyphenyl)-1-hydroxymethyl-ethyl]pyrrolidine-2,5-dione 36
116
 
 
MeO
MeO
OH
N
O
O
 
 
Succinic anhydride 18 (1.00 g, 9.90 mmol) and (S)-2-amino-3-(3,4-dimethoxyphenyl)-
propan-1-ol 39 (2.11 g, 9.90 mmol) were stirred in toluene (50 mL) under a nitrogen 
atmosphere. Triethylamine (4 mL) was added and the mixture heated at reflux for 18 h.  After 
this time the reaction was cooled to room temperature and the solvent was removed under 
reduced pressure to yield a yellow oil.  The crude product was adsorbed onto silica gel and 
purified by column chromatography using silica gel as adsorbent and ethyl acetate as eluent to 
produce a colourless solid (2.00 g, 72%): mp 124-125 ˚C; [!]
20
D = –73.2 [c = 1.0, DCM]; "max 
(thin film, DCM)/cm
-1
 1697, 2936, 3451; #H (400 MHz, CDCl3) 2.55$2.61 (4 H, m, 
COCH2CH2CO), 3.06$3.08 (2 H, m, ArCH2CHN), 3.82$3.83 (1 H, m, CH(H)OH), 3.85 (3 H, 
s, OCH3), 3.86 (3 H, s, OCH3), 3.99$4.02 (1 H, m, CH(H)OH), 4.48$4.54 (1 H, m, 
ArCH2CHN) and 6.71$6.77 (3 H, m, ArH); #C (100 MHz, CDCl3) 27.9 (2 x CH2), 33.2 
(CH2), 55.6 (CH), 55.8 (OCH3), 55.8 (OCH3), 62.3 (CH2), 111.1 (CH), 112.0 (CH), 121.1 
(CH), 129.5 (C), 147.7 (C), 148.7 (C), 178.1 (CO) and 178.1 (CO); MS (FAB) m/z 293 (MH
+
, 
100.0%). Calcd. for C15H20NO5: 294.1342 (MH
+
); found: 294.1346. 
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(5S,10bR)-5-Hydroxymethyl-8,9-dimethoxy-1,5,6,10b-tetrahydro-2H-pyrrolo[2,1-
a]isoquinolin-3-one 35
116 
 
N
MeO
MeO
O
H
H
OH
 
 
1-(2S)-[2-(3,4-Dimethoxyphenyl)-1-hydroxymethyl-ethyl]pyrrolidine-2,5-dione 36 (2.10 g, 
7.2 mmol) was dissolved in absolute ethanol (100 mL) and the contents cooled to 0 ˚C.  
Sodium borohydride (2.71 g, 71.7 mmol) was added with stirring. 2 M solution of 
hydrochloric acid in ethanol (3.59 ml, 7.2 mmol) was then added over a 3 h period.  The 
resulting mixture was acidified to pH 1!3 by the addition of 2 M solution of hydrochloric acid 
in ethanol over 15 mins.  The resulting suspension was stirred for a further 20 h.  After this 
time, the reaction was quenched with aqueous sodium hydrogen carbonate and extracted into 
dichloromethane (3 x 40 mL). The organic fractions were combined, dried over anhydrous 
magnesium sulfate, filtered and the solvent was removed under reduced pressure to yield a 
colourless oil. The crude product was adsorbed onto silica gel and purified by column 
chromatography using silica gel and 5% methanol in dichloromethane as eluent to yield a 
white solid (1.41 g, 71%): mp 177!179 ˚C; ["]
20
D = +133.6 [c = 1.0, DCM]; #max (thin film, 
DCM)/cm
-1
 1650, 3415; $H (400 MHz, CDCl3) 1.91!1.97 (1 H, m, CH(H)CH2CO), 2.45!2.52 
(1 H, m, CH2CH(H)CO), 2.61!2.69 (3 H, m, CH(H)CH2CO, CH2CH(H)CO and 
ArCH(H)CHN), 2.99 (1 H, dd, J 6.4, 16.0 Hz, ArCH(H)CHN), 3.25 (1H, br, s, OH) 3.64!3.71 
(2 H, m, CH2OH), 3.86 (3 H, s, OCH3), 3.87 (3 H, s, OCH3), 4.47!4.51 (1 H, m, 
ArCH2CHN), 4.76 (1 H, t, J 8 Hz, NCHAr), 6.58 (1 H, s, ArH) and 6.63 (1 H, s, ArH); $C 
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(100 MHz, CDCl3) 27.1 (CH2), 29.1 (CH2), 31.7 (CH2), 49.5 (CH), 54.2 (CH), 55.9 (OCH3), 
56.1 (OCH3), 63.2 (CH2), 107.3 (CH), 111.7 (CH), 124.1 (C), 128.4 (C), 148.0 (C), 148.2 (C) 
and 175.1 (CO); MS (EI) m/z 277 (MH
+
, 100.0%). Calcd. for C15H20NO4: 278.1387 (MH
+
); 
found: 278.1390.   
 
(5S,10bR)-8,9-Dimethoxy-3-oxo-1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinoline-5-
carbaldehyde 135 
N
MeO
MeO
H
O
O
H
 
 
2-Iodoxybenzoic acid  (4.48 g, 16.10 mmol) was added to a solution of (5S,10bR)-5-
hydroxymethyl-8,9-dimethoxy-1,5,6,10b-tetrahydro-2H-pyrrolo[2,1-a]isoquinolin-3-one 35 
(1.49 g, 5.40 mmol) in ethyl acetate (75 mL) and the reaction was heated under reflux for 4 h.  
The resulting mixture was cooled to room temperature, filtered through a sinter funnel and 
evaporated to afford a crude brown residue.  The crude product was adsorbed onto silica gel 
and purified by column chromatography using a 3:1 mixture of light petroleum in ethyl 
acetate as eluent to isolate the target compound as a yellow foam (1.46 g, 99%): [!]
20
D = 
+66.5 [c = 1.3, CHCl3]; "max (thin film, in DCM)/cm
-1
 1696, 2923; #H (400 MHz, CDCl3) 
1.84$1.91 (1 H, m, CH(H)CH2CO), 2.51$2.57 (1 H, m, CH2CH(H)CO), 2.68$2.79 (2 H, m, 
CH(H)CH2CO and CH2CH(H)CO), 3.03$3.09 (1 H, m, ArCH(H)CHN), 3.20 (1 H, m, 
ArCH(H)CHN), 3.85 (3 H, s, OCH3), 3.86 (3 H, s, OCH3), 4.92 (1 H, t, J 6.8 Hz, NCHAr), 
5.02$5.04 (1 H, m, ArCH2CHN), 6.53 (1 H, s, ArH), 6.63 (1 H, s, ArH) and 9.63 (1 H, s, 
CHO); #C (100 MHz; CDCl3) 26.5 (CH2), 28.3 (CH2), 31.5 (CH2), 54.7 (CH), 55.7 (CH), 55.9 
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(OCH3), 56.0 (OCH3), 107.4 (CH), 111.4 (CH), 122.2 (C), 128.0 (C), 148.2 (C), 148.5 (C), 
174.4 (CO) and 198.8 (CHO); MS (FAB) m/z 275 (MH
+
, 22.2%). Calcd. for C15H18NO4: 
276.1236 (MH
+
); found: 276.1240.   
 
(10bR)-8,9-Dimethoxy-1,5,6,10b-tetrahydro-2H-pyrrolo[2,1-a]isoquinolin-3-one 136  
 
N
MeO
MeO
H
O
 
 
Bis(triphenylphosphine)rhodium(I) carbonyl chloride (0.012 g, 0.018 mmol) was added to 
anhydrous xylene (10 mL) under a nitrogen atmosphere.  The mixture was stirred at 80 °C for 
15 mins, 1,3-Bis(diphenylphosphino)propane (0.019 mg, 0.046 mmol) was then added and 
the mixture stirred for a further 30 mins at 80 °C.   
To the stirred reaction mixture, (5S,10bR)-8,9-dimethoxy-3-oxo-1,2,3,5,6,10b-
hexahydropyrrolo[2,1-a]isoquinoline-5-carbaldehyde 135 (0.102 g, 0.371 mmol) in 
anhydrous xylene (10 mL) was added, and the reaction heated under reflux for 240 h.  After 
this time, the solvent was removed under reduced pressure and the crude product was 
adsorbed onto silica gel and purified by column chromatography using silica gel and a 3:1 
mixture of ethyl acetate in hexane as the eluent to produce a yellow oil (0.042 g, 46%): [!]
20
D 
= +203.2 [c = 0.5, CHCl3]; "max (thin film, DCM)/cm
-1
 1681, 2925; #H (400 MHz, CDCl3) 
1.74$1.81 (1 H, m, CH(H)CH2CO), 2.37$2.63 (4 H, m, CH(H)CH2CO, CH2CH2CO and 
ArCH(H)CH2N), 2.78$2.85 (1 H, m, ArCH(H)CH2N), 2.91$2.98 (1 H, m, ArCH2CH(H)N), 
3.79 (3H, s, OCH3), 3.80 (3 H, s, OCH3), 4.26 (1 H, ddd, J 2.0, 6.0, 12.8 Hz, ArCH2CH(H)N), 
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4.66 (1H, t, J 8.0 Hz, NCHAr), 6.50 (1 H, s, ArH), 6.54 (1 H, s, ArH); !C (100 MHz; CDCl3) 
27.8 (CH2), 28.1 (CH2), 31.8 (CH2), 37.1 (CH2), 55.9 (OCH3), 56.0 (OCH3), 56.6 (CH), 107.6 
(CH), 111.6 (CH), 125.5 (C), 129.3 (C), 147.9 (C), 148.1 (C), and 173.2 (CO); MS (FAB) m/z 
248 (MH
+
), 31.3%). Calcd. for C14H18NO3: 248.1287 (MH
+
); found: 248.1278. 
 
(R)-(+)-Crispine A 124 
 
N
MeO
MeO
H  
 
Lithium aluminium hydride (1 M solution in tetrahydrofuran) (8.5 x 10
-3
 mL, 0.225 mmol) 
was added to a pre-dried flask fitted with a reflux condenser under a nitrogen atmosphere.  
Anhydrous tetrahydrofuran (50 mL) was added and the solution cooled to 0 ˚C. (10bR)-8,9-
Dimethoxy-1,5,6,10b-tetrahydro-2H-pyrrolo[2,1-a]isoquinolin-3-one 136 (0.037 g, 0.15 
mmol) in anhydrous tetrahydrofuran (20 mL) was added dropwise to the reaction at 0 ˚C and 
then heated under reflux for 3 h.  After this time, the reaction was stirred for a further 12 h at 
room temperature.  Diethyl ether (20 mL) was then added and the reaction was quenched by 
the careful addition of saturated sodium potassium tartrate.  The mixture was stirred for a 
further 1 h before the addition of anhydrous magnesium sulfate and the mixture was filtered 
through a celite pad.  The filtrate was evaporated under reduced pressure and the resultant 
yellow solid was adsorbed onto silica gel and purified by column chromatography using silica 
gel and a 10:1 mixture of chloroform in methanol as eluent to yield a colourless solid (0.200 
g, 58%): mp 87"89 °C; Lit: 87"89°C;
117
 [#]
20
D = +95.2  [c = 1.5, CH3OH];  Lit: [#]
20
D = 
+91.0  [CH3OH];
117
 $max (thin film, DCM)/cm
-1
 2934; !H (400 MHz; CDCl3) 1.70"1.77 (1 H, 
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m, CH(H)CH2CH2N), 1.84!1.97 (2 H, m, CH2CH2CH2N), 2.30!2.34 (1 H, m, 
CH(H)CH2CH2N), 2.51!2.76 (3 H, m, CH2CH2CH(H)N, ArCH(H)CH2N and 
ArCH2CH(H)N), 2.99!3.11 (2 H, m, CH2CH2CH(H)N and ArCH(H)CH2N), 3.19 (1 H, ddd, J 
2.8, 4.8, 11.2  Hz, ArCH2CH(H)N), 3.40 (1 H, t, J 8.0 Hz, NCHAr), 3.84 (3 H, s, OCH3), 3.85 
(3 H, s, OCH3),  6.57 (1 H, s, ArH), 6.61 (1H, s, ArH); "C (100 MHz; CDCl3) 22.3 (CH), 27.6  
(CH2), 30.7 (CH2), 48.1 (CH2), 53.1 (CH2), 55.9 (OCH3), 56.0 (OCH3), 62.6 (CH), 108.9 
(CH), 111.3 (CH), 125.9 (C), 130.0 (C), 147.4 (C), 147.4 (C). MS (FAB) m/z 233 (M
+
, 
66.6%). Calcd. for C14H19NO2: 233.1416 (M
+
); found: 233.1419.  The ee of our compound 
was determined to be >95% by the 400 MHz 
1
H NMR spectroscopy method of Czarnocki et 
al. 
118
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A.3. Chapter Four: N-Acyliminium Cyclisation as an Approach 
for an Asymmetric Synthesis of the Pyrrolo[2,1-a]benzazepine 
Ring System 
(S)-2-Amino-4-phenylbutan-1-ol 149
114 
 
NH2
OH
 
 
(S)-Homophenylalanine hydrochloride salt 147 (2.44g, 11.34 mmol) was dissolved in a 
minimum amount of methanol.  Sodium carbonate (1.20 g, 11.34 mmol) was added in one 
portion and the mixture allowed to stir for 5 mins. The resulting mixture was filtered and 
evaporated under reduced pressure to yield (S)-homophenylalanine 148 as a white solid (1.90 
g, 98%).  Trimethylsilyl chloride (5.39 mL 42.46 mmol) was added to lithium borohydride 
(10.61 mL, 21.23 mmol) in tetrahydrofuran (30 mL) over 5 mins under a nitrogen atmosphere 
and (S)-homophenylalanine 148 (1.90 g, 10.61 mmol) was added cautiously.  The reaction 
mixture was stirred at room temperature for 24 h. After this time, methanol (20 mL) was 
cautiously added.  The volatiles were removed under reduced pressure to afford a colourless 
residue, which was treated with 20% potassium hydroxide solution (20 mL) and washed with 
dichloromethane (3 ! 50 mL).  The organic fractions were combined, dried over anhydrous 
magnesium sulfate, filtered and the solvent was removed under reduced pressure to yield the 
target compound as a colourless oil (1.31 g, 75%): ["]
20
D = –4.7 (c = 0.5, CH3OH); #max (thin 
film, DCM)/cm
-1
 3343; $H (400 MHz, CH3OD) 1.48–1.55 (1 H, m, ArCH2CH(H)), 1.62–1.71 
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(1 H, m, ArCH2CH(H)), 2.52–2.73 (3 H, m, ArCH2, CHN), 3.19–3.30 (1 H, m, CH(H)OH), 
3.45–3.49 (1 H, m, CH(H)OH), 7.03–7.17 (5 H, m ArH); !C (100 MHz, CDCl3) 32.5 (CH2), 
36.1 (CH2), 52.4 (CH), 66.5 (CH2), 126.0 (CH), 128.3 (CH), 128.3 (CH), 128.5(CH), 128.5 
(CH), 141.7 (C); MS (EI) m/z 166 (MH
+
, 5.0%) 166 (MH
+
, 100.0%). Calcd. for C10H15NO 
165.1154, found: 165.1152. 
 
(S)-1-(1-Hydroxy-4-phenylbutan-2-yl)pyrrolidine-2,5-dione 150 
 
N
OH
O
O
 
 
Succinic anhydride 18 (0.48 g, 4.84 mmol) and (S)-2-amino-4-phenylbutan-1-ol 149 (0.80 g, 
4.84 mmol) were stirred in toluene (100 mL) under a nitrogen atmosphere. Triethylamine (1 
mL) was added and the mixture heated at reflux for 18 h.  After this time, the reaction was 
cooled to room temperature and the solvent removed under reduced pressure to yield brown 
oil. The crude product was adsorbed onto silica gel and purified by column chromatography 
using silica gel as absorbent and ethyl acetate as eluent to produce a colourless solid (0.71 g, 
60%): mp 74–76 °C; ["]
20
D  = –96.0 [c = 0.05, DCM]; #max (thin film, DCM)/cm
-1
 1692, 
1766, 3387; !H (400 MHz, CDCl3) 2.00–2.08 (1 H, m, ArCH2CH(H)), 2.30–2.58 (6 H, m, 
ArCH2CH(H), CH2CH2CO, ArCH(H)CH2), 2.76–2.83 (2 H, m, ArCH(H)CH2, OH), 3.76 (1 
H, dd, J 4.0, 12.0 Hz, CH(H)OH), 3.94–3.98 (1 H, m, CH(H)OH), 4.26–4.32 (1 H, m, CHN), 
7.16–7.29 (5 H, m, ArH); !C (100 MHz, CDCl3) 27.9 (CH2), 28.0 (CH2), 32.8 (CH2), 54.5 
(CH), 63.2 (CH2), 63.7 (CH2), 126.1 (CH), 128.3 (CH), 128.3 (CH), 128.4 (CH), 128.4 (CH), 
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140.8 (C), 178.3 (CO) 178.3 (CO); MS (EI) m/z 248 (MH
+
, 100.0%) Calcd. For C14H18NO3: 
248.1287 (MH
+
); found: 248.1282. 
 
(3S,7aR)-3-Phenethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one 151 
 
O
N O
H  
 
(S)-1-(1-Hydroxy-4-phenylbutan-2-yl)pyrrolidine-2,5-dione 150 (1.68 g, 6.82 mmol) was 
dissolved in absolute ethanol (30 mL) and cooled to 0 °C.  Sodium borohydride (2.58 g, 68.20 
mmol) was then added with stirring.  2 M solution of hydrochloric acid in ethanol (3.40 mL, 
6.82 mmol) was then added over 3 h.  The resulting solution was acidified to pH 1–3 by the 
addition of 2 M solution of hydrochloric acid in ethanol over 15 mins.  This afforded a white 
suspension, which was stirred for a further 20 h.  After this time, the reaction was quenched 
using a saturated sodium hydrogen carbonate aqueous solution and extracted into 
dichloromethane (3 ! 30 mL). The organic fractions were combined and dried over anhydrous 
magnesium sulfate and the solvent was removed under reduced pressure to yield the crude 
product.  The crude product was adsorbed onto silica gel and purified by column 
chromatography using silica gel as adsorbent and ethyl acetate as eluent to yield a colourless 
oil (0.89 g, 57%): ["]
20
D = +16.0 [c = 0.12, MeOH], #max (thin film, DCM)/
cm-1 
1450, 1682; $H 
(400 MHz, CDCl3) 1.74–1.89 (2 H, m, ArCH2CH(H)), ArCH2CH(H)), 2.07–2.10 (1 H, m, 
CH(H)CHO), 2.36–2.40 (1H, m, CH(H)CHO), 2.52–2.57 (1 H, m, CH(H)CH2CHO), 2.63–
2.78 (3 H, m, CH(H)CH2CHO, ArCH2), 3.50–3.54 (1 H, m, CHCH(H)O), 4.08–4.11 (1 H, dd, 
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J 2.4, 6.0 Hz, NCHO), 4.19–4.23 (1 H, m, CHCH(H)O), 5.12 (1 H, dd, J 2.0, 6.0 Hz, NCHO), 
7.18–7.31 (5 H, m, ArH); !C (100 MHz, CDCl3) 24.2 (CH2), 31.6 (CH2), 32.8 (CH2), 36.0 
(CH2), 54.9 (CH), 72.6 (CH2), 91.6 (CH), 126.0 (CH), 128.3 (CH), 128.4 (CH), 128.5 (CH), 
128.5 (CH), 141.4 (C), 179.8 (CO); MS (EI) m/z 232 (MH
+
, 100.0%) Calcd. For C14H18NO2: 
232.1338 (MH
+
); found: 232.1333. 
 
5-(Hydroxymethyl)-5,6,7,11b-tetrahydro-1H-benzo[c]pyrrolo[1,2-a]azepin-3(2H)-one 
153 
 
N
O
OH
H
H
N
O
OH
H
H
 
 
(3S,7aR)-3-Phenethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one 151 (0.37 g, 1.60 mmol) was 
dissolved in anhydrous dichloromethane (25 mL) under a nitrogen atmosphere and cooled to 
–96 °C.  Titanium tetrachloride (0.26 mL, 2.40 mmol) was added over 30 mins. The reaction 
was allowed to reach room temperature and stirred for a further 20 h.  After this time, the 
reaction was quenched with aqueous ammonium chloride and extracted into dichloromethane 
(3 " 30 mL). The organic fractions were combined and dried over anhydrous magnesium 
sulfate and the solvent was removed under reduced pressure to yield the crude product as a 
4:1 mixture of diastereoisomers, which were purified by column chromatography using silica 
gel and a 10% methanol in dichloromethane mixture as eluent to yield both a white solid, 
trans-153, and an opaque oil, cis-153, in a combined yield of 0.36 g (97%).  
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(5S,11bR)-5-(Hydroxymethyl)-5,6,7,11b-tetrahydro-1H-benzo[c]pyrrolo[1,2-a]azepin-3(2H)-
one, trans-153: mp 90–92 °C; [!]
20
D = +296.0 [c = 0.05, CHCl3]; "max (thin film, DCM)/cm
-1
  
1660, 2926, 3386; #H (400 MHz, CDCl3) 1.48–1.57 (1 H, m, CH2CH(H)CHN), 2.08–2.24 (2 
H, m, CH2CH(H)CHN, CH(H)CH2CO), 2.40–2.44 (2 H, m, CH2CH2CO), 2.48–2.56 (1 H, 
CH(H)CH2CO), 2.63–2.68 (1 H, m, ArCH(H)CH2), 2.88–2.94  (1 H, m, ArCH(H)CH2), 3.53–
3.65 (2 H, m, CH2OH), 3.91 (1 H, s, OH), 4.58–4.66 (1 H, m, CHN), 5.06–5.28 (1 H, m, 
ArCHN), 7.11–7.20 (4 H, m, ArH); #C (100 MHz, CDCl3) 27.9 (CH2), 28.6 (CH2), 30.4 
(CH2), 30.6 (CH2), 52.2 (CH), 59.1 (CH), 63.0 (CH2), 126.5 (CH), 126.5 (CH), 127.2 (CH), 
130.5 (CH), 139.5 (C), 140.2 (C), 176.7 (CO); MS (EI) 231 (MH
+
, 100.0%). Calcd. for 
C14H18NO2: 232.1338 (MH
+
) found: 232.1333.  
 
(5S,11bS)-5-(Hydroxymethyl)-5,6,7,11b-tetrahydro-1H-benzo[c]pyrrolo[1,2-a]azepin-3(2H)-
one, cis-153: [!]
20
D = –306.7 [c = 0.03, CHCl3]; "max (thin film, DCM)/cm
-1
 1659, 2925, 
3379; #H (400 MHz, CDCl3) 1.59-1.67 (1 H, m, ArCH2CH(H)), 2.06–2.12 (1 H, m, 
ArCHCH(H)), 2.46–2.53 (2 H, m, ArCHCH(H), ArCHCH2CH(H)), 2.60–2.69 (3 H, m, 
ArCH2CH(H), ArCHCH2CH(H), ArCH(H)), 2.87–2.92 (1 H, m, ArCH(H)), 3.32–3.35 (1 H, 
m, CHCH2OH), 3.72–3.74 (1 H, m, CHCH(H)OH), 4.02–4.06  (1 H, m, CHCH(H)OH), 4.94 
(1 H, dd, J 7.2, 9.2 Hz, ArCHN), 5.54 (1 H, m, OH), 7.08–7.27 (4 H, m, ArH); #C (100 MHz, 
CDCl3) 26.3 (CH2), 30.0 (CH2), 30.3 (CH2), 31.8 (CH2), 56.9 (CH), 62.8 (CH2), 67.5 (CH), 
127.1 (CH), 127.3 (CH), 128.2 (CH), 131.1 (CH), 137.3 (C), 138.5 (C), 176.2 (CO); MS (EI) 
231 (MH
+
, 100.0%). Calcd. for C14H18NO2: 232.1338 (MH
+
); found: 232.1332. 
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(5S, 11bR)-3-oxo-2,3,5,6,7,11b-hexahydro-1H-benzo[c]pyrrolo[1,2-a]azepine-5-
carbaldehyde 154 
 
N
O
O
H
H
 
 
Dess Martin periodinane (0.31 g, 0.74 mmol) was added to a solution of (5S,11bR)-5-
(hydroxymethyl)-5,6,7,11b-tetrahydro-1H-benzo[c]pyrrolo[1,2-a]azepin-3(2H)-one, trans-
153, (0.25 g, 0.74 mmol) in dichloromethane (40 mL) under a nitrogen atmosphere. The 
resulting mixture was allowed to stir at room temperature for 2 h. After this time, the solvent 
was removed under reduced pressure and the resulting brown residue suspended in diethyl 
ether (20 mL), and washed with aqueous sodium hydrogen carbonate (containing sodium 
thiosulfate (25 g)) (100 mL), followed by saturated brine (20 mL). The organic fraction was 
dried over anhydrous magnesium sulfate and the solvent removed under reduced pressure to 
yield a brown oil, which was adsorbed onto silica gel and purified by column chromatography 
using silica gel and ethyl acetate as eluent to yield a light brown oil (96 mg, 60%): [!]
20
D = 
+182.8 [c = 0.07, CHCl3]; "max (thin film, DCM)/cm
-1
 1683, 1750, 2926; #H (400 MHz, 
CDCl3) 2.05–2.88 (8 H, m, ArCH2CH2, NCOCH2CH2), 5.04–5.11 (1 H, m, CHCHO), 7.12–
7.27 (4 H, m, ArH), 9.60 (1 H, d,  J 11.2 Hz, CHO); #C (100 MHz, CDCl3) 25.4 (CH2), 26.6 
(CH2), 30.0 (CH2), 30.5 (CH2), 59.6 (CH), 63.7 (CH), 127.0 (CH), 127.4 (CH), 128.1 (CH), 
130.4 (CH), 137.7 (C), 140.2 (C), 175.3 (CO), 199.3 (CHO); MS (EI) 229 (MH
+
, 100.0%). 
Calcd. for C14H16NO2: 230.1181 (MH
+
); found: 230.1177.  
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2-Iodobenzoic acid (0.58 g, 2.06 mmol) was added to a solution of (5S,11bR)-5-
(hydroxymethyl)-5,6,7,11b-tetrahydro-1H-benzo[c]pyrrolo[1,2-a]azepin-3(2H)-one, trans-
153, (0.16 g, 0.69 mmol), in ethyl acetate (40 mL), and the reaction was heated under reflux 
for 24 h.  The resulting mixture was cooled to room temp, filtered through a sinter funnel, and 
evaporated under reduced pressure to afford a crude brown residue. The crude product was 
adsorbed onto silica gel and purified by column chromatography using silica gel ethyl acetate 
as eluent to yield light brown oil (0.08 g, 53%).  Spectral analysis for this methodology was 
identical to that reported above. 
 
(R)-5,6,7,11b-tetrahydro-1H-benzo[c]pyrrolo[1,2-a]azepin-3(2H)-one 137 
 
N
OH
 
 
[Bis(triphenylphosphine)]rhodium(I) carbonyl chloride (14 mg, 0.02 mmol) was added to 
anhydrous xylene (10 mL) under a nitrogen atmosphere.  The mixture was then stirred at 
80°C for 15 mins. 1,3-bis(diphenylphosphino)propane (19 mg, 0.1 mmol) was added and the 
mixture heated at 80 °C for 30 mins.  To the stirring mixture was added (5S,11bR)-3-oxo-
2,3,5,6,7,11b-hexahydro-1H-benzo[c]pyrrolo[1,2-a]azepine-5-carbaldehyde 154 (90 mg, 0.39 
mmol), and the mixture heated under reflux for 240 h.  After this time, the solvent was 
removed under reduced pressure and the crude product was adsorbed onto silica gel and 
purified by column chromatography using silica gel and ethyl acetate as eluent to yield brown 
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oil (45 mg, 57%): [!]
20
D  = +12.0 [c = 0.70, CHCl3]; "max (thin film, DCM)/cm
-1
 1679, 2926; 
#H (400 MHz, CDCl3) 1.73$1.79 (1 H, m, CH(H)CH2N), 2.00$2.05 (1 H, m, CH(H)CH2N); 
2.17$2.23 (1 H, m, CHCH(H)), 2.36$2.51 (3 H, m, CHCH(H), CH(H)CO , CH(H)CO), 
2.64$2.70 (1 H, m, ArCH(H)), 2.92$2.99 (2 H, m, ArCH(H), CH2CH(H)N), 4.10$4.16 (1 H, 
m, CH2CH(H)N), 4.84–4.86 (1 H, t, J 7.2 Hz, CHN), 7.12$7.27 (4 H, m, ArH); #C (100 MHz, 
CDCl3) 25.7 (CH2), 28.0 (CH2), 31.0 (CH2), 31.2 (CH2), 39.6 (CH2), 64.1 (CH), 126.5 (CH), 
126.8 (CH), 128.4 (CH), 132.1 (CH), 138.6 (C), 139.1 (C), 174.3 (CO); MS (EI) 201 (MH
+
, 
100.0%). Calcd. for C13H16NO: 202.1233 (MH
+
); found: 202.1226.  
 
2-(2-Oxocyclohexyl)ethanoic acid 38
119
 
 
O
OH
O
 
 
Methyl 2-(2-oxocyclohexyl)ethanoate (2.00 g, 10.86 mmol) was dissolved in a mixture of 
tetrahydrofuran (20 mL) and water (10 mL).  Lithium hydroxide (0.70 g, 16.28 mmol) was 
added and the mixture stirred at room temperature for 20 h.  After this time, the reaction 
mixture was concentrated under reduced pressure, re-suspended in water (30 mL) and 
acidified to pH 3 by careful addition of 1 M solution of hydrochloric acid in water. The 
aqueous layer was then extracted into ethyl acetate (3 % 40 mL), and the organic fractions 
were combined and dried over anhydrous magnesium sulfate and the solvent removed under 
reduced pressure to afford a colourless oil (1.66 g, 98%): "max (thin film, DCM)/cm
-1
 1616, 
3365; #H (400 MHz, CDCl3) 1.38$2.44 (10 H, m, 5 % CH2), 2.79$2.87 (1 H, m, CH); #C (100 
Page | 142  
 
MHz, CDCl3) 25.2 (CH2), 27.8 (CH2), 33.8 (CH2), 34.3 (CH2), 41.8 (CH2), 46.9 (CH), 179.5 
(C), 211.2 (CO); MS (EI) 156 (MH
+
, 100.0%). Calcd. for C8H13O3: 157.0865 (MH
+
); found: 
157.0857.  
 
(3S, 6aS, 10R)-3-Phenethylhexahydro-2H-oxazolo[3,2-i]indol-5(3H)-one 156 
 
O N
O
 
 
(S)-2-Amino-4-phenylbutan-1-ol 149 (0.30 g, 1.90 mmol) and 2-(2-oxocyclohexyl)ethanoic 
acid 38 (0.31 g, 1.90 mmol) were dissolved in toluene (100 mL) and refluxed under Dean-
Stark conditions for 48 h.  After this time, the reaction was allowed to cool to room 
temperature and the solvent was removed under reduced pressure. The crude product was 
adsorbed onto silica gel and purified by column chromatography using silica gel and using a 
3:1 ethyl acetate and light petroleum mixture as eluent to yield a yellow oil (0.29 g, 55%): 
[!]
20
D = +89.4 (c = 0.47,  CHCl3); "max (thin film, DCM)/cm
-1
 1707; #H (400 MHz, CDCl3) 
1.39–1.83 (8 H, m, NCCH2CH2CH2, NCCH2CH2CH2, NCCH(H), COCH2CHCH2, 
ArCH2CH(H)), 1.89–1.99 (2 H, m, NCCH(H), ArCH2CH(H)), 2.31–2.45 (2 H, m, NCCH, 
NCOCH(H)), 2.60–2.79 (3 H, m, ArCH2, NCOCH(H)), 3.82–3.86 (1 H, m, CHCH(H)OH), 
4.02–4.08 (1 H, m, CHN), 4.15–4.18 (1 H, m, CHCH(H)OH), 7.17–7.30 (5 H, m, ArH); #C 
(100 MHz, CDCl3) 19.8 (CH2), 20.8 (CH2), 25.3 (CH2), 32.8 (CH2), 33.0 (CH2), 37.0 (CH2), 
39.2 (CH2), 41.8 (CH), 54.6 (CH), 72.6 (CH2), 99.7 (C), 126.0 (CH), 128.4 (CH), 128.4 (CH), 
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128.4 (CH), 128.4 (CH), 141.5 (C), 176.7 (CO); MS (EI) 285 (MH
+
, 100.0%). Cald. for 
C18H24NO2: 286.1807 (MH
+
); found: 286.1810. 
 
(S)-1-((R)-1-Hydroxy-4-phenylbutan-2-yl)-5,6,7,7a-tetrahydro-1H-indol-2(4H)-one 157 
 
N O
OH
H
H
Ph
 
 
(3S, 6aS, 10R)-3-Phenethylhexahydro-2H-oxazolo[3,2-i]indol-5(3H)-one 156 (0.50 g, 1.75 
mmol) was treated with 2 M solution of hydrochloric acid in ethanol (15 mL) and stirred at 
room temperature for 20 h. After this time, the reaction was quenched by the addition of 
saturated sodium hydrogen carbonate and then extracted into ethyl acetate (3 ! 40 mL).  The 
combined organic fractions were then dried over anhydrous magnesium sulfate and the 
solvent was removed under reduced pressure. The crude product was adsorbed onto silica gel 
and purified by column chromatography using silica gel and using a 2:1 mixture of ethyl 
acetate and light petroleum as eluent to yield a colourless solid (0.40 g, 80%), a portion of 
which, was recrystallised from dichloromethane and hexanes to yield colourless crystals: mp 
90–92 °C (DCM/hexanes); ["]
20
D = +52.0 [c = 0.1, MeOH); !max (thin film, DCM)/cm
-1
  
1659, 2920, 3407; #H (400 MHz, CDCl3) 1.02–1.12 (1 H, m, CCHCH(H)), 1.23–1.38 (2 H, m, 
CCH2CH2CH(H), CHCCH2CH(H)), 1.83–1.86 (1 H, m, CCH2CH2CH(H)), 1.98–2.04 (1 H, 
m, CHCCH2CH(H)), 2.05–2.34 (4 H, m, CCHCH(H), ArCCH2CH2, CHCCH(H)), 2.56–2.63 
(1 H, m, ArCCH(H)), 2.71–2.78 (2 H, m, ArCCH(H), CHCCH(H)), 3.45–3.48 (1 H, m, 
CHNCH2OH), 3.67 (1 H, dd, J 6.4, 11.6 Hz, CHN), 3.81-3.93 (2 H, m, CH2OH), 4.81 (1 H, 
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dd, J 2.4, 9.6 Hz, OH), 5.73 (1 H, s, CH), 7.18-7.30 (5 H, m, ArH); !C (100 MHz, CDCl3) 
23.1 (CH2), 27.1 (CH2), 28.4 (CH2), 30.2 (CH2), 32.6 (CH2), 33.5 (CH2), 56.1 (CH), 63.8 
(CH), 64.6 (CH2), 118.7 (CH), 126.0 (CH), 128.3 (CH), 128.3 (CH), 128.5 (CH), 128.5 (CH), 
141.4 (C), 162.7 (C), 173.1 (CO); MS (EI) 285 (MH
+
, 100.0%). Calcd. for C18H24NO2: 
286.1807 (MH
+
); found: 286.1810. 
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A.4. Chapter Five: Facile Asymmetric Construction of a 
Functionalised Dodecahydrobenz[a]indolo[3,2-h]quinolizine 
Template 
 
Ethyl 2 – (8-oxo-1,4-dioxaspiro[4,5]decan-7-yl) acetate 168 
 
O
O O
O
O
 
 
1,4-Cyclohexanedione monoethylene ketal 167 (6.00 g, 38.42 mmol) was dissolved in 
anhydrous tetrahydrofuran (40 mL) under a nitrogen atmosphere and the resulting mixture 
was cooled to –78 °C. 0.5 M KHMDS in toluene (84.48 mL, 42.20 mmol) was added drop 
wise and the reaction stirred at –78 °C for 1 h. After this time, ethyl bromoacetate (4.67 mL, 
42.20 mmol) was added drop wise to the mixture and after 30 mins the reaction was allowed 
to warm to room temperature and stirred for 4 h.  After this time, the reaction was quenched 
with water and extracted into ethyl acetate (3 ! 75 mL).  The organic fractions were 
combined, dried over anhydrous magnesium sulfate and then concentrated under reduced 
pressure to yield a colourless solid (6.70 g, 72%):  mp 65–67 ºC; "max (thin film, CHCl3)/cm
-1
 
1715; !H (400 MHz, CDCl3) 1.16–1.21 (3 H, m, CH2CH3), 1.71–1.79 (1H, m, 
COCH2CH(H)C), 1.91–2.36 (5 H, m, CHCH2C, COCH2CH2C), COCH2CH(H)C), 2.61–2.68 
(2 H, m, CHCH2COO), 3.11-3.16 (1 H, m, COCH), 3.93-3.99 (4 H, m, OCH2CH2O), 4.00-
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4.10 (2 H, m, OCH2CH3); !C(100 MHz, CDCl3) 14.1 (CH3), 34.0 (CH2), 34.6 (CH2), 37.8 
(CH2), 40.2 (CH2), 43.1 (CH), 60.5 (CH2), 64.7 (CH2), 64.8 (CH2), 107.1 (C), 172.5 (CO), 
209.6 (CO); MS (FAB) 242 (M
+
, 20.8%). Calcd. for C12H18O5 : 242.11543 (M
+
); found: 
242.11582. 
 
Ethyl 2-(8-methylene-1,4-dioxaspiro[4.5]decan-7-yl)acetate 169 
  
O O
O
O
 
 
To a mixture of sodium hydride (1.08 g, 27.04 mmol) and methyltriphenylphosphonium 
bromide (9.66 g, 27.00 mmol) under a nitrogen atmosphere was added anhydrous 
tetrahydrofuran (150 mL). After 1 h the mixture developed a yellow colouration. Ethyl 2–(8-
oxo-1,4-dioxaspriro[4,5]decan-7-yl)acetate 168 (4.36 g, 18.00 mmol) in dry tetrahydrofuran 
(100 mL) was added via cannula (steady stream) and allowed to stir for 4 h.  After this time, 
the reaction mixture was cooled to 0 °C and quenched with water (100 mL). The organic 
fractions were combined, then dried over anhydrous magnesium sulfate, and the solvent was 
removed under reduced pressure to yield a yellow solid. This was adsorbed onto silica gel and 
purified by column chromatography using silica gel and using a 2:1 mixture of ether and 
hexanes as eluent to give the product as a white oil (2.67 g, 62%): !max (thin film, CHCl3)/cm
-
1
 1734; !H (400 MHz, CDCl3) 1.20 (3 H, t, J 4.0 Hz, CH2CH3), 1.39"1.91 (6 H, m, CHCH2C, 
CCCH2CH2C, CCCH2CH2C), 2.31"2.36 (1 H, m, CHCH(H)COO), 2.64 (1 H, dd, J  7.2, 15.6 
Hz, CHCH(H)COO), 2.82"2.86 (1 H, m, COCH), 3.93"4.00 (4 H, m, CH2O, CH2O), 
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4.09!4.17 (2 H, m, CH2CH3), 4.63 (1 H, s, CH(H)C), 4.76 (1 H, s, CH(H)C); !C(100 MHz, 
CDCl3) 14.3 (CH3), 32.3 (CH2), 36.2 (CH2), 36.8 (CH), 37.8 (CH2), 41.3 (CH2), 60.3 (CH2), 
64.3 (CH2), 64.4 (CH2), 106.8 (CH2), 108.5 (C), 149.2 (C), 172.6 (CO). MS (FAB) 241 (MH
+
, 
50.8%). Calcd. for C13H21O4 : 241.1440 (MH
+
); found: 241.1435. 
 
Ethyl 2-(8-formyl-1,4-dioxaspiro[4,5]decan-7-yl)acetate 170 
 
O O
O
O
O
 
 
Ethyl 2-(8-methylene-1,4-dioxaspiro[4.5]decan-7-yl)acetate 169 (2.63 g, 10.94 mmol) in 
anhydrous tetrahydrofuran (30 mL) under a nitrogen atmosphere was treated with dimethyl 
sulfide borane complex (2 M) in tetrahydrofuran (5.60 ml 5.47 mmol) and the mixture was 
stirred vigorously for 2.5 h.  After this time, the volatiles were removed under reduced 
pressure to yield colourless oil.  The crude oil was dissolved in a minimum amount of 
dichloromethane and added drop wise to a solution of pyridinium chlorochromate (5.66 g, 
26.26 mmol) in anhydrous dichloromethane (100 mL).  The reaction mixture was then heated 
at reflux for 2 h, then allowed to cool to room temperature and diluted with diethyl ether (50 
mL).  The organic fraction was decanted and filtered through a silica pad and the remaining 
black solids washed exhaustively with further portions of diethyl ether (5 " 30 mL).  All 
volatiles were removed under reduced pressure to yield a crude oil which was adsorbed onto 
silica gel and purified by column chromatography using silica gel and a 2:1 diethyl ether and 
light petroleum mixture as eluent to deliver a colourless oil containing an inseparable mixture 
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of diastereoisomers (4:1 ratio) (1.56 g, 56%): !max(thin film, CHCl3)/cm
-1
  1176, 1734; !H 
(400 MHz, CDCl3) 1.23–1.39 (3 H, m, CH2CH3), 1.42–2.65 ( H, m, CHCH2C, CCCH2CH2C, 
CCCH2CH2C, CHCHO, CHCHCH2COO, CHCHCH2COO), 3.92–3.96 (4 H, m, 
OCH2CH2O), 4.09"4.15 (2 H, m, OCH2CH3), 9.76 (1 H, s, CHO); !C(100 MHz, CDCl3) 14.2 
(CH3), 23.3 (CH2), 31.9 (CH), 33.2 (CH2), 36.7 (CH2), 37.8 (CH2), 39.2 (CH2), 49.3 (CH), 
60.5 (CH2) 64.4 (CH2), 64.5 (CH2), 108.2 (C), 172.5 (C), 203.6 (CO); MS (EI) 257 (MH
+
, 
100.0%). Calcd. for C13H21O5 : 257.1389 (MH
+
); found: 257.1386. 
 
(2S)-2-Amino-3-(1H-indol-3-yl)propan-1-ol 81
114 
 
NH2
OH
N
H  
 
Chlorotrimethylsilane (12.40 mL, 97.90 mmol) was added to a solution of lithium 
borohydride (1.07 g, 49.0 mmol) in anhydrous tetrahydrofuran (80 mL) under a nitrogen 
atmosphere over the course of 2 mins. (S)-Tryptophan (5.00 g, 24.5 mmol) was added over 5 
mins and the mixture allowed to stir for 24 h.  After 24 h, the mixture was cautiously treated 
with methanol (30 mL). The volatiles were removed under reduced pressure to yield an oily 
residue, which was treated with 20% potassium hydroxide solution (20 mL).  The resulting 
solution was washed with ethyl acetate (3 # 100 mL) and the combined organic fractions were 
dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to 
yield a light brown foam which required no further purification (4.20 g, 90%): mp 78"79 ˚C; 
Lit: mp 73"77 ˚C; [$]
20 
D = –20.3 [c = 1.2, MeOH]; Lit: [$]
20 
D = –20.5 [c = 1.0, MeOH]; 
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vmax(thin film, DCM)/cm
-1
 3280; !H (400  MHz, CDCl3) 2.40 (1 H, br, s, OH) 2.67 (1 H, dd, J 
8.4, 14.0 Hz, CH(H)CHNH2), 2.88"2.93 (1 H, m, CH(H)CHNH2), 3.19"3.27 (1 H, m, 
CHNH2), 3.40 (1 H, dd, J 3.2, 7.2 Hz, CH(H)OH), 3.62"3.69 (1 H, m, CH(H)OH), 6.98 (1 H, 
s, CHNH), 7.08"7.10 (1 H, m, ArH), 7.10"7.20 (1 H, m, ArH), 7.34"7.35 (1 H, m, ArH), 
7.57"7.63 (1 H, m, ArH); !C (100 MHz; CDCl3) 30.1 (CH2), 54.4 (CH), 67.1 (CH2), 112.3 
(CH), 112.4 (C), 119.4 (CH), 119.7 (CH), 122.4 (CH), 124.2 (CH), 128.9 (C), 138.3 (C); MS 
(FAB) 190 (M
+
, 23.0%). Calcd. for C11H14N2O: 190. 1106 (M
+
); found: 190.1106. 
 
3’-((1H-Indol-3-yl)methyl)octahydrospiro[[1,3]dioxolane-2,8-oxazolo[2,3-a]isoquinolin]-
5'(6'H)-one 171a and 171b 
 
N
O
O O
O
HN
H
H
H
N
O
O O
O
HN
H
H
H
171a 171b  
 
(S)-2-Amino-3-(1H-indol-3-yl)propan-1-ol 81 (0.41 g, 2.17 mmol) and methyl 2-((7S,8R)-8-
formyl-1,4-dioxaspiro[4.5]decan-7-yl)acetate 170 (0.56 g, 2.17 mmol) were added to toluene 
(50 mL) and heated at reflux under Dean-Stark conditions for 24 h. The mixture was allowed 
to cool to room temperature and the solvent removed under reduced pressure to yield a yellow 
oil.  400 MHz 
1
H-NMR analysis of the crude reaction mixture revealed the formation of a 1:1 
mixture of diastereoisomers.  These diastereoisomers were purified and separated by flash 
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column chromatography over silica gel using a 4:1 light petroleum and ethyl acetate mixture 
to isolate both diastereoisomers as white solids 171a and 171b, and in a combined yield of 
0.32 g 39%.  
 
(3'S,6a'S,10a'R)-3'-((1H-indol-3-yl)methyl)octahydrospiro[[1,3]dioxolane-2,8'-oxazolo[2,3-
a]isoquinolin]-5'(6'H)-one 171a (0.15 g, 18%) was isolated as a white solid, a portion of 
which was recrystallised from dichloromethane and hexanes to yield colourless crystals: mp 
205-207 °C; [!]
20
D = –27.9 [c = 1.0, DCM]; "max(thin film, CHCl3)/cm
-1
 1458, 1632;  !H (400 
MHz, CDCl3) 1.23#1.29 (3 H, m, NCHCH, NCHCHC(H)H, COHCH2CHCH(H)), 1.44-1.51 
(1 H, m, NCHCHCH2CH(H)), 1.72#1.83 (3 H, m, COCH2CH, NCHCHCH2CH(H) and 
COCH2CHCH(H)), 1.93#2.08 (2 H, m, COC(H)H, NCHCHCH(H)), 2.45 (1 H, dd, J 4.0, 
18.0 Hz, COCH(H)), 2.53 (1H, dd, J 10.4, 12.0 Hz, CHCC(H)H), 3.56#3.60 (1 H, m, 
CHOCH(H)), 3.64#3.68 (1H, m, CHOCH(H)), 3.82#3.89 (4 H, m, OCH2CH2O), 3.93 (1 H, d, 
J 9.6 Hz, CHOCH(H)), 4.18#4.27 (2 H, m, CHCCH2CH, NCH), 6.93 (1 H, d, J 2 Hz, 
NHCH), 7.02#7.12 (2 H, m, ArH), 7.25 (1 H, d, J 8.0 Hz, ArH), 7.72 (1 H, d, J 7.6 Hz, ArH), 
8.10 (1 H, s, NH); !C(100 MHz; CDCl3) 24.8 (CH2), 26.9 (CH2), 32.4 (CH), 33.5 (CH2), 38.8 
(CH2), 40.7 (CH2), 42.4 (CH), 56.3 (CH), 64.4 (CH2), 64.5 (CH2), 70.2 (CH2), 92.3 (CH), 
108.0 (C), 111.1 (CH), 112.6 (C), 119.4 (CH), 119.6 (CH), 122.2 (CH), 122.4 (CH), 127.7 
(C), 136.2 (C) 167.1 (NCO); MS (FAB) 382 (MH
+
, 46.4%). Calcd. for  C22H27N2O4: 
383.1971 (MH
+
); found: 383.1978. 
 
(3'S,6a'R,10a'S)-3'-((1H-indol-3-yl)methyl)octahydrospiro[[1,3]dioxolane-2,8'-oxazolo[2,3-
a]isoquinolin]-5'(6'H)-one 171b (0.17 g, 20%): mp 182#183 °C; [!]
20
D = 19.6 [c = 1.0, 
DCM]; "max(thin film, CHCl3)/cm
-1
 1632;  !H( 400 MHz; CDCl3) 1.21#1.33 (3 H, m, 
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NCHCH, NCHCHCH(H), COHCH2CHCH(H)), 1.53-1.59 (1 H, m, NCHCHCH2CH(H)), 
1.75!190 (3 H, m,  COCH2CH, NCHCHCH2CH(H), COCH2CHCH(H)), 1.98!2.08 (2 H, m, 
COC(H)H, NCHCHCH(H)), 2.60 (1 H, dd, J 5.2, 17.6 Hz COCH(H)), 2.98 (1 H, dd, J 9.2, 
14.4 Hz, CHCCH(H), 3.34!3.39 (1 H, m, CHCCH(H)), 3.66!3.70 (1H, m, CHOC(H)H), 
3.89!3.99 (4H, m, OCH2CH2O), 4.05 (1 H, dd, J 7.6, 9.2 Hz, CHOCH(H)), 4.23 (1 H, d, J 8.4 
Hz, NCH), 4.56-4.63 (1 H, m, CHCCH2CH), 7.02 (1 H, d, J 2.4 Hz, NHCH), 7.13 (1 H, m, 
ArH), 7.20 (1H, td. J 1.2, 4.8, 15.2 Hz, ArH), 7.35-7.37 (1 H, m, J 7.2 Hz, ArH), 7.71 (1 H, d, 
J 8.0 Hz, ArH), 8.07 (1 H, s, NH); !C(100 MHz; CDCl3) 25.6 (CH2), 27.4 (CH2), 31.2 (CH), 
33.3 (CH2), 38.6 (CH2), 40.6 (CH2), 42.0 (CH), 54.9 (CH), 64.4 (CH2), 64.5 (CH2), 70.1 
(CH2), 91.0 (CH), 107.9 (C), 111.1 (CH), 111.3 (C), 119.1 (CH), 119.7 (CH), 122.3 (CH), 
122.4 (CH), 127.8 (C), 136.2 (C), 167.7 (NCO); MS (FAB) 382 (MH
+
, 38.7%). Calcd. for  
C22H27N2O4: 383.1971 (MH
+
); found: 383.1963. 
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7-Hydroxymethyl-1,4a’S,5,7’S,8,13,13b’R,13c’R-octahydro-2H,4H-6a,1,3-diaza-
indeno[1,2-c]phenanthrene-3,6-dione 173 
 
N
H
NO
H
OH
H
H
O  
 
(3’S,6a’S,10a’R,10b’S)-3’-((1H-Indol-3-yl)methyl)octahydrospiro[1,3]dioxolane-2,8’-
oxazolo[2,3-a]isoquinolin]-5’(6’H)-one 171a (0.33 g, 0.86 mmol) was treated to 2 M solution 
of hydrochloric acid in ethanol (15 mL), and stirred for 72 h at 70 °C. After this time, the 
reaction was quenched by the addition of saturated aqueous sodium bicarbonate and extracted 
into ethyl acetate (3 ! 30 mL).  The combined organic fractions were dried over anhydrous 
magnesium sulfate and the solvent removed under reduced pressure to yield a crude yellow 
solid.  400 MHz 
1
H-NMR analysis of the crude product mixture revealed the formation of 173 
as a single diastereoisomer.  Purification was achieved using flash column chromatography 
over silica with a 95:5 mixture of ethyl acetate and methanol as eluent to afford an off-white 
solid (0.22 g, 77%): mp 202-204 °C; ["]
20
D  = +49.0 [c = 0.2, CH3OH]; #max(thin film, 
CHCl3)/cm
-1 
1653, 2920, 3428; !H (400 MHz; MeOH) 1.93$2.47 (6 H, m, NCOCH2CH, 
CH2CH2CO and NCHCHC(H)H, NCHCH(H)), 3.00$3.06 (1 H, m, NCHCH(H)), 3.52$3.67 
(6 H, m, NCOCH2, COCH2CH and CHCH2OH), 3.98$3.99 (1 H, m, CHCH2CH(H)CO), 
4.09$4.14 (1 H, m, CHCH2CH(H)CO), 4.49$4.56 (1 H, m, NCHCH), 5.51$5.57 (1 H, m, 
CHN), 7.13$7.16 (2 H, m ArH), 7.35$7.37 (1 H, m, ArH), 7.47 (1 H, d, J 7.6 Hz, ArH), 8.05 
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(1 H, s, NH);  !C(100 MHz; MeOH) 21.6 (CH2), 30.9 (CH2), 36.7 (CH), 39.1 (CH2), 42.6 
(CH2), 44.3 (CH2), 49.4 (CH) 55.5 (CH), 60.0 (CH2) 107.4 (C), 111.0 (CH), 118.3 (CH), 
118.4 (CH), 120.2 (CH), 122.9 (CH), 126.7 (C), 130.7 (C), 136.3 (C), 169.6 (NCO), 208.0 
(CO). 
 
7-Hydroxymethyl-1,4a’R,5,7’S,8,13,13b’R,13c’R-octahydro-2H,4H-6a,1,3-diaza-
indeno[1,2-c]phenanthrene-3,6-dione 174 
 
N
H
NO
H
OH
H
H
O  
 
(3'S,6a'R,10a'S)-3'-((1H-Indol-3-yl)methyl)octahydrospiro[[1,3]dioxolane-2,8'-oxazolo[2,3-
a]isoquinolin]-5'(6'H)-one 171b (0.27 g, 0.71 mmol) was treated to 2 M solution of 
hydrochloric acid in ethanol (15 mL), and stirred for 72 h at 70 °C. After this time, the 
reaction was quenched by the addition of saturated aqueous sodium bicarbonate and extracted 
into ethyl acetate (3 ! 30 mL).  The combined organic fractions were dried over anhydrous 
magnesium sulfate and the solvent was removed under reduced pressure to yield a crude 
yellow solid.  400 MHz 
1
H-NMR analysis of the crude product mixture revealed the 
formation of 174 as a single diastereoisomer.  Purification was achieved using flash column 
chromatography over silica with a 95:5 mixture of ethyl acetate and methanol as eluent to 
afford an off-white solid (0.16 g, 70%): mp 212"213 °C; [#]
20
D  = +9.9 [c = 0.5, CH3OH]; 
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!max(thin film, CHCl3)/cm
-1
  1711, 2921, 3381; !H (400 MHz, CDCl3) 2.02"2.11 (2 H, m, 
COCH2CH, NCHCHC(H)H), 2.32"2.35 (1 H, m, NCHCH), 2.45"2.51 (2 H,  m, 
NCHCHCH(H), NCHCHCH2C(H)H), 2.45"2.63 (5 H, m, NCHCHCH2CH(H), 
COCH2CHCH2, COCH2), 2.60"2.65 (1 H, m, NHCCC(H)H), 3.09"3.15 (1 H, m, 
NHCCCH(H)), 3.65"3.71 (2 H, m, CHCH2OH), 5.05"5.07 (1 H, m, NCHCH), 5.24"5.30 (1 
H, m, CHCH2OH), 7.10"7.22 (2 H, m, ArH), 7.34 (1 H, d, J 8.0 Hz, ArH), 7.46 (1 H, d, J 8.0 
Hz ArH), 8.00 (1 H, s, NH); #C (100 MHz; CDCl3) 21.5 (CH2), 28.3 (CH2), 34.2 (CH), 40.3 
(CH2), 41.1 (CH2), 42.0 (CH), 46.8 (CH2), 51.1 (CH), 52.3 (CH), 61.9 (CH2), 111.1 (CH), 
111.3 (CH), 118.2 (CH), 120.1 (CH), 122.8 (CH), 126.9 (C), 129.9 (C), 136.2 (C), 172.1 
(NCO), 208.6 (CO). 
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A.5. Chapter Six: Enolate Aminations of the Pyrroloisoquinoline 
Template: Towards Novel Peptidomimetics. 
(S)-2-Amino-3-phenyl-1-propanol 59
114
 
 
NH2
OH
 
 
Trimethylchlorosilane (13.20 g, 15.4 mL, 121.11 mmol) was added to a solution of lithium 
borohydride (1.32 g, 60.50 mmol) in anhydrous tetrahydrofuran (80 ml) under a nitrogen 
atmosphere over the course of 5 mins. (S)-Phenylalanine 16 (5.0 g, 30.30 mmol) was 
cautiously added to the resulting mixture and the reaction was stirred at room temperature for 
24 h.  Methanol (50 mL) was cautiously added and the volatiles were removed under reduced 
pressure.  The resulting red residue was treated with 20% potassium hydroxide solution and 
extracted into dichloromethane (3 ! 50 mL).  The organic fractions were combined and dried 
over anhydrous magnesium sulfate, then filtered and evaporated under reduced pressure to 
yield a colourless crystalline solid (4.44 g, 97%): mp 92"94 °C; Lit: mp 92"94 ˚C; [#]
20 
D = –
18.5 [c = 1.1, CH2Cl2]; Lit: [#]
20 
D = –23.0 [c = 5.0, EtOH]; vmax(thin film, CHCl3)/cm
-1
 3408; 
$H (400  MHz, CDCl3) 2.39"2.41 (1 H, m, ArCH(H)CH), 2.62" 2.67 (1 H, m, ArCH(H)CH), 
2.94"3.01 (1 H, m, CHNH2), 3.24 (1 H, dd, J 7.2, 10.4 Hz, CH(H)OH), 3.49 (1 H, dd, J 3.6, 
10.4 Hz, CH(H)OH), 7.03"7.37 (5 H, m, ArH); (100 MHz; CDCl3) 41.0 (CH2), 54.2 (CH), 
66.4 (CH), 126.5 (CH), 128.6 (CH), 128.6 (CH), 129.2 (CH), 129.2 (CH). MS (FAB) 151 
(MH
+
, 100.0%). Calcd. for C9H14NO: 152. 1075 (MH
+
); found: 152.1075 
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(S)-1-(1-Hydroxy-3-phenylpropan-2-yl)pyrrolidine-2,5-dione 27
120
 
121
 
 
N
OH
O
O
 
 
Succinic anhydride 18 (1.20 g, 12.00 mmol) and (S)-2-amino-3-phenyl-1-propanol, 59, (1.80 
g, 12.00 mmol) were stirred in toluene (100 mL) under a nitrogen atmosphere.  Triethylamine 
(3 mL) was added and the mixture heated under reflux for 18 h.  After this time, the reaction 
was cooled to room temperature and the solvent removed under reduced pressure to yield 
colourless oil. Purification was achieved using column chromatography over silica gel using 
ethyl acetate as eluent to yield a colourless solid (1.70 g, 62%): mp 130-131 ºC; !max (thin 
film, DCM)/cm
-1
 1697, 2928, 3351; !H (400 MHz, CDCl3) 2.50–2.63 (4 H, m, 
COCH2CH2CO), 3.07–3.17 (2 H, m, ArCH2CHN), 3.84 (1 H, dd, J 3.2, 12.0 Hz, CH(H)OH), 
4.00 (1 H, dd, J 6.8, 12.0 Hz, CH(H)OH), 4.48–4.55 (1 H, m, ArCH2CHN), 7.18–7.29 (5 H, 
m, ArH); !C (100 MHz, CDCl3) 27.9 (CH2), 27.9 (CH2), 33.7 (CH2), 55.7 (CH), 62.4 (CH2), 
126.8 (CH), 128.5 (CH), 128.5 (CH), 129.1 (CH), 129.1 (CH), 137.2 (C), 178.1 (CO), 178.1 
(CO); MS (FAB) m/z 233 (MH
+
, 100.0%) Calcd. for C13H16NO3: 234.1130 (MH
+
); Found: 
234.1134. 
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(5S,10bR)-5-(hydroxymethyl)-1,2,5,6-tetrahydropyrrolo[2,1-a]isoquinolin-3(10bH)-one, 
trans-25 
N
O
OH
H
 
 
(S)-1-(1-Hydroxy-3-phenylpropan-2-yl)pyrrolidine-2,5-dione 27 (5.00 g, 21.40 mmol) was 
dissolved in absolute ethanol (100 mL) and cooled to 0 °C. Sodium borohydride (8.11 g, 
214.40 mmol) was then added with stirring. 2 M solution of hydrochloric acid in ethanol 
(10.7 mL, 21.40 mmol) was then slowly added via syringe (steady stream) over 3 h. The 
resulting mixture was acidified to pH 1–3 by the addition of 2 M solution of hydrochloric acid 
in ethanol over 15 mins.  This afforded a white suspension, which was stirred for a further 20 
h.  After this time, the reaction was quenched with a saturated solution of sodium hydrogen 
carbonate and extracted into dichloromethane (3 ! 50 mL). The organic fractions were 
combined and dried over anhydrous magnesium sulfate, then filtered and the solvent was 
removed under reduced pressure to afford the ethoxy lactam intermediate as a colourless oil 
(4.60 g). Without isolation and purification the intermediate ethoxy lactam (4.60 g, 17.60 
mmol) was dissolved in anhydrous dichloromethane (100 mL) under a nitrogen atmosphere 
and cooled to "78 °C. Titanium tetrachloride (2.89 mL, 26.40 mmol) was then slowly added 
drop wise over 30 mins.  The reaction was allowed to reach room temperature and stirred for 
a further 20 h. The reaction was quenched with aqueous ammonium chloride and extracted 
into dichloromethane (3 ! 50 mL). The organic fractions were combined and dried over 
anhydrous magnesium sulfate, filtered and the solvent removed under reduced pressure to 
yield a single diastereoisomer, by the limits of 400 MHz 
1
H-NMR spectroscopy.  The crude 
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product was purified by column chromatography using silica gel and a 10% methanol in 
dichloromethane mixture as eluent to yield a pale green solid (2.00 g, 52%): mp 110–111 ºC; 
!max (thin film, DCM)/cm
-1
 1682, 2972, 3419; !H (400 MHz, CDCl3) 1.97–2.08 (1 H, m, 
CH(H)CH2CO), 2.43–2.51 (1 H, m, CH2CH(H)CO), 2.61–2.75 (3 H, m, CH(H)CH2CO, 
CH2CH(H)CO, ArCH(H)CHN), 3.05 (1 H, dd, J 6.4, 16.4 Hz, ArCH(H)CHN), 3.63–3.75 (2 
H, m, CH2OH), 4.39–4.46 (1 H, m, ArCH2CHN), 4.83 (1 H, t, J 8.0 Hz, NCHAr), 7.12–7.29 
(4 H, ArH); !C (100 MHz, CDCl3) 26.4 (CH2), 29.8 (CH2), 31.6 (CH2), 50.0 (CH), 54.7 (CH), 
63.4 (CH2), 124.2 (CH), 126.8 (CH), 127.3 (CH), 129.0 (CH), 132.6 (C), 136.8 (C), 175.4 
(CO); MS (FAB) m/z 217 (MH
+
, 72.0%) Calcd. for C13H16NO2: 218.1181 (MH
+
); Found: 
218.1182. 
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(5S,10bR)-5-((Tert-butyldimethylsilyloxy)methyl)-1,2,5,6 tetrahydropyrrolo[2,1-
a]isoquinolin-3(10bH)-one 177 
 
N
O
OTBS
H
 
 
Imidazole (0.39 g, 5.82 mmol) and 4-dimethylaminopyridine (0.05 g, 0.45 mmol) followed by 
(5S,10bR)-5-(hydroxymethyl)-1,2,5,6-tetrahydropyrrolo[2,1-a]isoquinolin-3(10bH)-one, 
trans-25 (0.97 g, 4.47 mmol) were dissolved in anhydrous dichloromethane (20 mL) under a 
nitrogen atmosphere.  To this mixture, tert-butyldimethylsilyl chloride (0.84 mL, 5.59 mmol) 
was added and the reaction was stirred at room temperature for 20 h.  After this time, the 
resulting mixture was filtered to remove the solid phase and concentrated under reduced 
pressure.  The crude product was adsorbed onto silica gel and purified by column 
chromatography using silica gel and a 10% methanol in dichloromethane mixture as eluent to 
isolate a blue oil (1.45 g, 98%): [!]
20
D = +31.0 [c = 1.70 in CDCl3]; !max (thin film, 
DCM)/cm
-1
 1698; "H (400 MHz, CDCl3) 0.01 (3 H, s, SiCH3), 0.02 (3 H, s, SiCH3), 0.84 (9 
H, s, SiC(CH3)3), 1.90–2.00 (1 H, m, CH(H)CH2CO), 2.48–2.49 (1 H, m, CH2CH(H)CO), 
2.50–2.58 (2 H, m, CH(H)CH2CO, CH2CH(H)CO), 2.91 (1 H, dd, J 3.2, 16.4 Hz, 
ArCH(H)CHN), 3.02 (1 H, dd, J 6.8, 16.4 Hz, ArCH(H)CHN), 3.65–3.69 (1 H, m, 
CH(H)OSi), 3.74–3.78 (1 H, m, CH(H)OSi), 4.46–4.51 (1 H, m, ArCH2CHN), 4.81 (1 H, t, J 
8.0 Hz, NCHAr), 7.14–7.25 (4 H, m, ArH); "C (100 MHz, CDCl3) #5.6 (SiCH3), #5.5 
(SiCH3), 18.0 (C), 25.7 (SiC(CH3)3), 25.7 (SiC(CH3)3), 25.7 (SiC(CH3)3), 26.9 (CH2), 29.3 
(CH2), 31.7 (CH2), 48.0 (CH), 54.9 (CH), 62.7 (CH2), 124.2 (CH), 126.5 (CH), 127.0 (CH), 
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129.2 (CH), 132.8 (CH), 137.1 (C), 173.7 (CO); MS (FAB) m/z 331 (MH+, 18.0%) Calcd. for 
C19H30NO2Si: 332.2046 (MH
+
); Found: 332.2041. 
 
(2S,5S,10bR)-2-N,N’-Bis-(3,3-tert-butyl ester-hydrazino-5-(tert-butyl-dimethyl-
silanyloxymethyl-1-5,6,10b-tetrahydro-2H-pyrrolo[2,1-a]isoquinolin-3-one 178 
 
N
O
OTBS
NBoc
NHBoc
H
 
 
2.5 M n-Butyl lithium in hexanes (1.9 mL, 4.98 mmol) was cautiously added to a stirring 
solution of diisopropylamine (0.71 mL, 4.98 mmol) in anhydrous tetrahydrofuran (20 mL) at 
0 °C and under a nitrogen atmosphere.  The reaction was stirred at 0 °C for 15 mins, then 
cooled to !78 °C.  (5S,10bR)-5-((tert-Butyldimethylsilyloxy)methyl)-1,2,5,6-
tetrahydropyrrolo[2,1-a]isoquinolin-3(10bH)-one 177 (1.20 g, 3.61 mmol) in anhydrous 
tetrahydrofuran (20 mL) was added and the reaction was allowed to stir for 15 mins at !78 
°C.  Di-tert-butyl azodicarboxylate (1.08 g, 4.69 mmol) in anhydrous tetrahydrofuran  (15 
mL) was added drop wise at !78 °C and the reaction was allowed to warm to room 
temperature overnight.  After this time, the reaction was quenched by the addition of saturated 
ammonium chloride solution and the product was extracted into ethyl acetate (3 " 60 mL).  
The combined organic fractions were dried over anhydrous magnesium sulfate and the solvent 
was removed under reduced pressure to yield a 15:1 mixture of diastereoisomeric products by 
the limits of 400 MHz 
1
H-NMR spectroscopy on the crude reaction product. The crude 
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product was adsorbed onto silica and purified by column chromatography using silica gel and 
using a 2:1 light petroleum and ethyl acetate mixture as eluent to yield a yellow solid (1.83 g, 
85%): mp 70!72 °C; ["]
20
D = +7.3 [c = 0.11 in CDCl3]; !max (thin film, DCM)/cm
-1
 1676, 
3389; #H (400 MHz, DMSO, 100 ºC) 0.01 (3 H, s, SiCH3), 0.02 (3 H, s, SiCH3), 0.81!0.83 (9 
H, m, CO2C(CH)3)3, 1.42 (9 H, m, CO2C(CH)3), 1.45 (9 H, s, CO2C(CH)3), 2.33–2.34 (1 H, 
m, CH(H)CH2CO), 2.69–2.73 (1 H, m, CH(H)CHCO), 2.86–2.99 (2 H, m, ArCH2CHN), 
3.68–3.70 (1 H, m, CH(H)OSi), 3.77 (1 H, m, CH(H)OSi), 4.16–4.18 (1 H, m, ArCH2CHN), 
4.55 (1 H, dd, J 6.0, 8.0 Hz, CH2CHCO), 4.75 (1 H, t, J 6.0 Hz, NCHAr), 7.19–7.24 (4 H, m, 
ArH), 8.45 (1 H, s, NH); #C (400 MHz, DMSO, 100 ºC) -6.1 (CH3), -6.1 (CH3), 17.2 (C), 25.2 
(SiC(CH)3), 27.4 (OC(CH3)3), 27.5 (OC(CH3)3), 28.4 (CH2), 28.4 (CH2), 48.2 (CH), 52.0 
(CH), 59.1 (CH), 62.9 (CH2), 79.2 (C), 80.1 (C), 123.3 (CH), 125.8 (CH), 126.3 (CH), 128.2 
(CH), 132.8 (C), 136.8 (C), 153.6 (CO), 155.1 (CO), 168.2 (CO); MS (EI) m/z 561 (MH
+
, 
100.0%) Calcd. for C29H48N3O6Si: 562.3312 (MH
+
); Found:  562.3296. 
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Di-tert-butyl-1-((2S,5S,10bR)-5-(hydroxymethyl)-3-oxo-1,2,3,5,6,10b-
hexahydropyrrolo[2,1-a]isoquinolin-2-yl)hydrazine-1,2-dicarboxylate 179 
 
N
O
OH
NBoc
NHBoc
H
 
 
To a solution of (2S,5S,10bR)-2-N,N’-bis-(3,3-tert-butyl ester-hydrazino-5-(tert-butyl-
dimethyl-silanyloxymethyl-1-5,6,10b-tetrahydro-2H-pyrrolo[2,1-!]isoquinolin-3-one 178 
(0.33 g, 0.59 mmol) in tetrahydrofuran (20 mL) was added a 1 M solution of tetra-
butylammonium fluoride in tetrahydrofuran (0.58 mL, 0.58 mmol) and the reaction was 
stirred for 5 mins at room temperature under a nitrogen atmosphere.  The resulting mixture 
was concentrated under reduced pressure and the resulting residue purified by column 
chromatography using silica gel and using a 2:1 mixture of light petroleum and ethyl acetate 
as eluent to yield a yellow solid (0.12 g, 45%): mp 92–95 °C; [!]
20
D  +13.3 [c = 0.12 in 
DCM]; !max (thin film, DCM)/cm
-1
 1697, 2978, 3274, 3400; "H (400 MHz, DMSO, 100 °C) 
1.40–1.45 (18 H, m, CO2C(CH3)3, CO2C(CH3)3), 2.24–2.35 (1 H, m, CH(H)CHCO), 2.68–
2.77 (1 H, m, CH(H)CHCO), 2.82–2.98 (2 H, m, ArCH2CHN), 3.45–3.60 (2 H, m, CH2OH), 
4.15–4.18 (1 H, m, ArCH2CHN), 4.48–4.53 (1 H, m ArCH2CHCO), 4.70–4.78 (1 H, m, 
NCHAr), 7.14–7.26 (4 H, m, ArH),40 (1 H, br, s, NH); "C (400 MHz, DMSO, 100 °C) 28.4 
(CH3), 28.4  (CH3), 28.4 (CH3), 28.7 (CH3), 28.7  (CH3), 28.7 (CH3), 29.3 (CH2), 30.2 (CH2), 
49.8 (CH), 52.7 (CH), 60.2 (CH), 61.6 (CH2), 80.5 (C), 81.3 (C), 124.3 (CH), 126.9 (CH), 
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127.4 (CH), 129.4 (CH), 133.6 (C), 137.6 (C), 154.6 (CO), 156.1 (CO), 169.5 (CO); MS 
(FAB) m/z 447 (MH
+
, 17.0%) Calcd. for C23H34N3O6: 448.2448 (MH
+
). Found: 448.2443. 
  
2-((2S,5S,10bR)-5-(Hydroxymethyl)-3-oxo-1,2,3,5,6,10b-hexahydropyrrolo[2,1-
a]isoquinolin-2-yl)hydrazine 175 
 
N
O
OH
NH
NH2
H
 
 
Di-tert-butyl-1-((2S,5S,10bR)-5-(hydroxymethyl)-3-oxo-1,2,3,5,6,10b-hexahydropyrrolo[2,1-
a]isoquinolin-2-yl)hydrazinocarboxylate 179 (90 mg, 0.20 mmol) and trifluoroacetic acid 
(0.78 ml, 10.10 mmol) were allowed to stir at room temperature under a nitrogen atmosphere 
for 24 h.  After this time, the mixture was concentrated under reduced pressure, and the 
residue treated with 3 M solution of hydrochloric acid in water (15 mL) and allowed to stir for 
a further 1 h. The solution was then concentrated under reduced pressure and the residue 
dissolved in water (20 mL) and washed with ethyl acetate (3 ! 20 ml).  The aqueous phase 
was evaporated to dryness under reduced pressure to yield a yellow oil (30 mg, 70%): ["]
20
D 
= +14.5 [c = 0.58, MeOH]; #max (thin film, DCM)/cm
-1
  1680, 3386; $H (400 MHz, D2O) 
2.38–2.46 (1 H, m, CH(H)CHNH)), 2.51–2.58 (1 H, m, CH(H)CHNH), 2.67 (1 H, dd, J 3.2, 
16.8 Hz, ArCH(H)), 2.96 (1 H, dd, J  7.2, 16.8 Hz, ArCH(H)), 3.51–3.59 (1 H, m, 
CH(H)OH), 3.62–3.67 (1 H, m, CH(H)OH), 3.83–3.86 (1 H, m, CHNHNH2), 4.22–4.28 (1 H, 
m, CHCH2OH), 4.87–4.98 (1 H, m, ArCHCH2), 7.10–7.37 (4 H, m, ArH); $C (100 MHz, 
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D2O) 28.5 (CH2), 29.5 (CH2), 49.7 (CH), 52.7 (CH), 59.2 (CH), 60.7 (CH2), 124.3 (CH), 
126.9 (CH), 127.6 (CH), 129.2 (CH), 132.3 (C), 135.4 (C), 172.0 (CO); MS (EI) m/z 247 
(MH
+
, 100.0%) Calcd. for C13H18N3O2: 248.1394 (MH
+
); Found: 248.1395. 
 
1-Benzyl 2-tert-butyl hydrazine-1,2-dicarboxylate
122
 
 
H
N N
H
O
O
OO
 
 
A solution of Boc-hydrazine (3.20 g, 24.21 mmol) in dichloromethane (100 mL) was cooled 
to !78 °C under a nitrogen atmosphere.  Benzyl chloroformate (4.09 mL, 29.06 mmol) was 
cautiously added with stirring, followed by sodium carbonate (2.50 g, 24.21 mmol).  The 
reaction was then stirred at room temperature for 24 h.  After this time the reaction mixture 
was evaporated to dryness under reduced pressure and dissolved in ethyl acetate (100 mL) 
and heated under reflux for 1 h.  The hot solution was then filtered and the solvent removed 
under reduced pressure to yield a white solid (6.31 g, 98%): mp 252–253 ºC; "max (thin film, 
DCM)/cm
-1
 1715; #H (400 MHz, CDCl3) 1.53-1.54 (9 H, m, C(CH3)3), 5.17 (2 H, s, CH2), 
6.33 (1 H, s, NH), 6.53 (1 H, s, NH), 7.31-7.37 (5 H, m ArH); #C (400 MHz, CDCl3) 28.1 
(CH3)3, 67.8 (CH2), 81.9 (C), 127.0 (CH), 128.3 (CH), 128.4 (CH), 128.4 (CH), 128.6 (CH), 
135.6 (C), 155.7 (CO), 156.7 (CO); MS (EI) m/z 266 (MH
+
, 100.0%) Calcd. for C13H19N2O4: 
267.1339 (MH
+
). Found: 267.1342. 
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(E)-1-Benzyl 2-tert-butyl diazene-1,2-dicarboxylate 182 
 
N N
O
O
OO
 
 
1-Benzyl 2-tert-butyl hydrazine-1,2-dicarboxylate (3.29 g, 12.48 mmol) was added in one 
portion to a solution of N-bromosuccinimide (1.34 g, 11.32 mmol) and pyridine (0.91 mL, 
11.32 mmol) in dichloromethane (150 mL) in a separating funnel. After 30 mins, during 
which time the funnel was occasionally shaken to ensure dissolution of all the hydrazine, the 
reaction mixture was washed with water (3 ! 75 mL), and the organic fractions were dried 
over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure to yield an 
orange oil (0.66 g, 20%): "max(thin film, DCM)/cm
-1
 1774; #H (400 MHz, CDCl3) 1.53$1.54 
(9 H, m C(CH3)3), 5.36 (2 H, s, CH2), 7.32–7.38 (5 H, m, ArH); #C (100 MHz, CDCl3) 27.7 
(CH3)3, 70.7 (CH2), 87.2 (C), 128.6 (CH), 128.8 (CH), 128.9 (CH), 128.9 (CH), 129.2 (CH),  
133.7 (C), 158.9 (CO), 160.4 (CO).  
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1-Benzyl 2-tert-butyl 1-((2S,5S,10bR)-5-((tert-butyldimethylsilyloxy)methyl)-3-oxo-
1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinolin-2-yl)hydrazine-1,2-dicarboxylate, 183  
 
N
O
OTBS
NCbz
NHBoc
H
 
 
2.5 M n-Butyl lithium in hexanes (0.85 ml, 2.14 mmol) was cautiously added to a stirring 
solution of diisopropylamine (0.30 ml, 2.14 mmol) in anhydrous tetrahydrofuran (20 ml) at 0 
°C and under a nitrogen atmosphere.  The reaction was stirred at 0 °C for 15 mins and then 
cooled to !78 °C.  (5S,10bR)-5-((tert-Butyldimethylsilyloxy)methyl)-1,2,5,6-
tetrahydropyrrolo[2,1-a]isoquinolin-3(10bH)-one 177 (0.52 g, 1.55 mmol) in anhydrous 
tetrahydrofuran (20 mL) was added and the reaction was allowed to stir for 15 mins at !78 
°C. (E)-1-benzyl 2-tert-butyl diazene-1,2-dicarboxylate, 182, (0.41 g, 1.55 mmol) in 
anhydrous tetrahydrofuran  (15 mL) was then added dropwise at !78 °C and the reaction was 
allowed to warm to room temperature overnight.  After this time, the reaction was quenched 
by the addition of saturated ammonium chloride solution and the product was extracted into 
ethyl acetate (3 " 50 mL).  The combined organic fractions were then dried over anhydrous 
magnesium sulfate and the solvent was removed under reduced pressure to afford a yellow 
oil. The crude product was adsorbed onto silica and purified by column chromatography 
using silica gel and using a 2:1 mixture of light petroleum and ethyl acetate as eluent to yield 
a yellow solid (0.34 g, 41%): mp 68–70 °C; [#]
20
D = +9.5 [c = 0.38, MeOH]; $max(thin film, 
DCM)/cm
-1
 1715, 1756, 2921; %H (400 MHz, DMSO, 100 ºC) 0.02–0.04 (6 H, s, SiCH3), 
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0.84–0.90 (9 H, s, SiC(CH3)3), 1.40–1.44 (9 H, m, OC(CH3)3), 2.33–2.37 (1 H, m, 
CHCH(H)CHCO), 2.67–2.68 (2 H, m, ArCH2CHN) 2.76–2.78 (1 H, CHCH(H)CHCO), 3.66–
3.70 (1 H, m, NCHCH(H)O), 3.78 (1 H, dd, J 4.8, 10.4 Hz, NCHCH(H)O), 4.17–4.20 (1 H, 
m, ArCH2CH), 4.64 (1 H, m, NNCHCH2), 4.77–4.79 (1 H, m ArCHCH2), 5.09–5.16 (2 H, m, 
OCH2Ar), 7.18–7.23 (4 H, m, ArH), 7.32-7.40 (5 H,  m, ArH), 8.80 (1 H, s, NH); !C (100 
MHz, DMSO, 100 ºC) "5.1 (CH3), "5.1 (CH3), 18.2 (C), 26.1 (CH), 26.1 (CH), 26.1 (CH), 
28.5 (CH), 28.5 (CH), 28.5 (CH) 29.4 (CH2), 29.5 (CH2),  49.2 (CH), 53.0 (CH), 60.5 (CH), 
63.8 (CH2), 67.7 (CH2),  80.5 (C), 124.2 (CH), 126.8 (CH), 127.3 (CH), 127.9 (CH), 127.9 
(CH),  128.2 (CH), 128.6 (CH), 129.2 (CH), 129.2 (CH), 133.7 (C), 136.7 (C), 137.6 (C), 
155.6 (CO), 156.6 (CO), 168.8 (CO); MS (FAB) m/z 595 (MH
+
, 21.0%) Calcd. for 
C32H46N3O6Si: 596.3156 (MH
+
); Found: 596.3153. 
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Tert-Butyl-2-((2S,5S,10bR)-5-((tert-butyldimethylsilyloxy)methyl)-3-oxo-1,2,3,5,6,10b-
hexahydropyrrolo[2,1-a]isoquinolin-2-yl)hydrazinecarboxylate, 184 
 
N
O
OTBS
NH
NHBoc
H
 
 
1-Benzyl 2-tert-butyl 1-((2S,5S,10bR)-5-((tert-butyldimethylsilyloxy)methyl)-3-oxo-
1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinolin-2-yl)hydrazine-1,2-dicarboxylate 183 (0.35 
g, 0.58 mmol) was dissolved in methanol (10 mL) and added to a suspension of palladium on 
carbon (0.18 g) under a nitrogen atmosphere.  Ammonium formate (3.50 g, 55.00 mmol) in 
methanol (10 mL) was added drop-wise and allowed to stir at room temperature for 2 h. After 
this time, the solution was filtered through a pad of celite and the resulting solution was 
extracted into ethyl acetate (3 ! 30 mL).  The combined organic fractions were dried over 
anhydrous sodium sulfate and the solvent was removed under reduced pressure to yield the 
crude product which was purified by column chromatography using silica gel as adsorbent 
and ethyl acetate as eluent to afford a yellow solid (0.23 g, 88%): mp 118-120 °C; ["]
20
D = 
+4.3 [c = 0.28, MeOH]; #max(thin film, DCM)/cm
-1
 1688, 3283; $H (400 MHz, CDCl3) %0.04 
(6 H, s, Si(CH3)2, 0.82 (9 H, s, SiC(CH3)3), 1.42–1.52 (9 H, m, OC(CH3)3), 2.35–2.36 (1 H, 
m,  CCHCH(H)), 2.49–2.52 (1 H, m, CCHCH(H)), 2.91–2.96 (2 H, m, ArCH2), 3.68–3.70 (2 
H, m. CHCH(H)OSi, ArCHN), 3.76–3.80 (1 H, m, CHCH(H)OSi), 4.28–4.34 (2 H, m, CHN, 
NH), 4.77–4.80 (1 H, m, ArCHN), 6.40 (1 H, s, NH), 7.12–7.24 (4 H, m, ArH); $C (100 MHz, 
CDCl3) -5.5 (SiCH3), -5.44 (SiCH3), 18.1 (C), 25.8 (CH3), 25.8 (CH3), 25.8 (CH3), 28.4 
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(CH3), 28.4 (CH3), 28.4 (CH3), 29.3 (CH2), 30.1 (CH2), 49.1 (CH), 53.1 (CH), 61.0 (CH), 
63.1 (CH), 80.7 (C), 123.7 (CH), 126.5 (CH), 127.3 (CH), 129.1 (CH), 133.6 (CH), 136.9 (C), 
156.7 (CO), 171.9 (CO); MS (EI) m/z 461 (MH
+
, 100.0%) Calcd. for C24H40N3O4Si: 
462.2783 (MH
+
); Found: 462.2780. 
 
Tert-Butyl-1-((2S,5S,10bR)-5-(hydroxymethyl)-3-oxo-1,2,3,5,6,10b-
hexahydropyrrolo[2,1-a]isoquinolin-2-yl)hydrazinocarboxylate 185 
 
N
O
OH
NH
NHBoc
H
 
 
To a solution of tert-butyl 2-((2S,5S,10bR)-5-((tert-butyldimethylsilyloxy)methyl)-3-oxo-
1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinolin-2-yl)hydrazinocarboxylate 184 (0.15 g, 
0.35 mmol) in tetrahydrofuran (20 mL) was added 1 M tetra-butylammonium fluoride in 
tetrahydrofuran (0.35 ml, 0.35 mmol) and the reaction was stirred for 5 mins under a nitrogen 
atmosphere at room temperature.  The resulting mixture was concentrated under reduced 
pressure and purified by column chromatography using silica gel as adsorbent and using ethyl 
acetate as eluent to yield yellow oil (59 mg, 48%): [!]
20
D = +18.9 [c = 0.17, MeOH];  
"max(thin film, DCM)/cm
-1
 1692, 3284, 3400; #H (400 MHz, CDCl3) 1.32–1.52 (9 H, m, 
C(CH3)3), 2.24–2.27 (1 H, m, CHCH(H)CH), 2.69–2.74 (2 H, m, CHCH(H)CH, 
ArCH(H)CHN), 2.99–3.05 (1 H, m, ArCH(H)CHN), 3.40–3.43 (1 H, CH2CHNH), 3.61–3.81 
(2 H, m, CH2OH), 4.37–4.38 (1 H, m, CHN), 4.95 (1 H, t, J 7.2 Hz, ArCHN), 7.11–7.23 (4 H, 
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m, ArH); (100 MHz, CDCl3) 28.2 (CH3), 28.4 (CH3), 28.4 (CH3), 29.5 (CH2), 50.2 (CH), 52.7 
(CH), 61.5 (CH), 62.4 (CH2), 80.9 (C), 124.2 (CH), 126.8 (CH), 127.3 (CH), 129.0 (CH), 
132.6 (C), 136.4 (C), 136.9 (C), 156.7 (CO), 173.0 (CO); MS (EI) m/z 347 (MH
+
, 100.0%) 
Calcd. for C18H26N3O4: 348.1918 (MH
+
); Found: 348.1920. 
 
2-((2S,5S,10bR)-5-(Hydroxymethyl)-3-oxo-1,2,3,5,6,10b-hexahydropyrrolo[2,1-
a]isoquinolin-2-yl)hydrazinium 175 
 
N
O
OH
NH
NH2
H
 
 
tert-Butyl-2-((2S,5S,10bR)-5-(hydroxymethyl)-3-oxo-1,2,3,5,6,10b-hexahydropyrrolo[2,1-
a]isoquinolin-2-yl)hydrazinecarboxylate, 185, (0.11 g, 0.33 mmol) and trifluoroacetic acid 
(0.51 mL, 6.56 mmol) were allowed to stir at room temperature under a nitrogen atmosphere 
for 24 h.  After 24 h, the mixture was concentrated under reduced pressure, and the residue 
treated with 3 M solution of hydrochloric acid in water (15 mL) and allowed to stir for a 
further 1 h.  After this time, the solution was concentrated under reduced pressure and the 
residue was dissolved in water (20 mL) and washed with ethyl acetate (3 ! 20 mL).  The 
aqueous phase was evaporated to dryness using a rotary evaporator to yield a yellow oil (51 
mg, 55%).  Spectral analysis was identical to that reported above. 
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